Document:

exv10w1

Exhibit 10.1

EXECUTION COPY

STOCK

PURCHASE

AGREEMENT

by

and

among

VCA ANTECH, INC.,

SNOW MERGER ACQUISITION, INC.,

PET DRX CORPORATION,

and

each of the

PERSONS

LISTED AS SELLERS ON THE SIGNATURE PAGES HERETO

Dated as of June 2, 2010

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 

	ARTICLE I. DEFINITIONS	 	 	1	 
	 
	 	 	 	 	 	 
	ARTICLE II. Purchase and Sale of Equity Interests	 	 	12	 
	Section 2.1.
	 	Purchase and Sale of Equity Interests	 	 	12	 
	Section 2.2.
	 	Equity Closing	 	 	12	 
	Section 2.3.
	 	Closing Statement	 	 	12	 
	Section 2.4.
	 	Payments and Deliveries at the Equity Closing	 	 	13	 
	Section 2.5.
	 	Post-Closing Adjustments to the Aggregate Transaction Consideration.	 	 	15	 
	 
	 	 	 	 	 	 
	ARTICLE III. REPRESENTATIONS AND WARRANTIES OF PARENT AND BUYER	 	 	16	 
	Section 3.1.
	 	Entity Status	 	 	16	 
	Section 3.2.
	 	Power and Authority; Enforceability	 	 	16	 
	Section 3.3.
	 	No Violation	 	 	17	 
	Section 3.4.
	 	Consents	 	 	17	 
	Section 3.5.
	 	Broker Fees	 	 	17	 
	Section 3.6.
	 	Sufficient Funds	 	 	17	 
	 
	 	 	 	 	 	 
	ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF THE SELLERS	 	 	17	 
	Section 4.1.
	 	Status of Certain Sellers	 	 	17	 
	Section 4.2.
	 	Power and Authority; Enforceability	 	 	17	 
	Section 4.3.
	 	No Violation	 	 	18	 
	Section 4.4.
	 	Brokers’ Fees	 	 	18	 
	Section 4.5.
	 	Equity Interests; Seller Information	 	 	18	 
	Section 4.6.
	 	Litigation	 	 	19	 
	 
	 	 	 	 	 	 
	ARTICLE V. REPRESENTATIONS AND WARRANTIES OF THE COMPANY CONCERNING THE ACQUIRED ENTITIES	 	 	19	 
	Section 5.1.
	 	Corporate Status	 	 	19	 
	Section 5.2.
	 	Power and Authority; Enforceability	 	 	19	 
	Section 5.3.
	 	No Violation	 	 	20	 
	Section 5.4.
	 	Brokers’ Fees	 	 	20	 
	Section 5.5.
	 	Capitalization	 	 	20	 
	Section 5.6.
	 	Company Subsidiaries	 	 	21	 
	Section 5.7.
	 	Records	 	 	21	 
	Section 5.8.
	 	SEC Documents	 	 	21	 
	Section 5.9.
	 	Financial Statements	 	 	22	 
	Section 5.10.
	 	Liabilities	 	 	22	 
	Section 5.11.
	 	Subsequent Events	 	 	22	 
	Section 5.12.
	 	Availability, Title to, and Condition of Assets	 	 	26	 
	Section 5.13.
	 	Legal Compliance	 	 	26	 
	Section 5.14.
	 	No Change of Control Provision	 	 	27	 
	Section 5.15.
	 	Tax Matters	 	 	27	 
	Section 5.16.
	 	Real Property and Leaseholds	 	 	30	 
	Section 5.17.
	 	Intellectual Property	 	 	32	 
	Section 5.18.
	 	Contracts	 	 	32	 
	Section 5.19.
	 	Litigation	 	 	33	 

 i

 

	 	 	 	 	 	 	 

	Section 5.20.
	 	Labor; Employees	 	 	33	 
	Section 5.21.
	 	Employee Benefits	 	 	34	 
	Section 5.22.
	 	Environmental, Health, and Safety Matters	 	 	37	 
	Section 5.23.
	 	Insurance	 	 	37	 
	Section 5.24.
	 	Affiliate Transactions	 	 	38	 
	Section 5.25.
	 	Accounts Receivable and Payable	 	 	38	 
	Section 5.26.
	 	Disclosure and Internal Controls; Complaints	 	 	38	 
	Section 5.27.
	 	Full Disclosure	 	 	39	 
	 
	 	 	 	 	 	 
	ARTICLE VI. PRE-CLOSING COVENANTS	 	 	39	 
	Section 6.1.
	 	General	 	 	39	 
	Section 6.2.
	 	Notices and Consents	 	 	39	 
	Section 6.3.
	 	Operation of the Company’s Business	 	 	40	 
	Section 6.4.
	 	Preservation of Business	 	 	40	 
	Section 6.5.
	 	Full Access; Non-Disclosure	 	 	40	 
	Section 6.6.
	 	Publicity	 	 	41	 
	Section 6.7.
	 	Notification	 	 	42	 
	Section 6.8.
	 	Acquisition Proposals	 	 	42	 
	Section 6.9.
	 	Tax Matters	 	 	42	 
	Section 6.10.
	 	Payment of Liabilities	 	 	43	 
	Section 6.11.
	 	Exercise of Warrants	 	 	43	 
	 
	 	 	 	 	 	 
	ARTICLE VII. POST-CLOSING COVENANTS	 	 	43	 
	Section 7.1.
	 	General	 	 	43	 
	Section 7.2.
	 	Board of Directors	 	 	43	 
	Section 7.3.
	 	Litigation Support	 	 	44	 
	Section 7.4.
	 	Transition	 	 	44	 
	Section 7.5.
	 	Director & Officer Insurance	 	 	44	 
	Section 7.6.
	 	Confidentiality	 	 	44	 
	 
	 	 	 	 	 	 
	ARTICLE VIII. CLOSING CONDITIONS	 	 	45	 
	Section 8.1.
	 	General Conditions	 	 	45	 
	Section 8.2.
	 	Conditions Precedent to Obligation of Parent and Buyer	 	 	46	 
	Section 8.3.
	 	Conditions Precedent to Obligations of the Company and the Sellers	 	 	47	 
	 
	 	 	 	 	 	 
	ARTICLE IX. TERMINATION	 	 	48	 
	Section 9.1.
	 	Termination of Agreement	 	 	48	 
	Section 9.2.
	 	Effect of Termination	 	 	48	 
	 
	 	 	 	 	 	 
	ARTICLE X. INDEMNIFICATION	 	 	49	 
	Section 10.1.
	 	Survival of Representations and Warranties	 	 	49	 
	Section 10.2.
	 	Indemnification Provisions for the Benefit of the Parent Indemnified Parties	 	 	49	 
	Section 10.3.
	 	Indemnification Provisions for Benefit of the Sellers	 	 	50	 
	Section 10.4.
	 	Indemnification Claim Procedures	 	 	50	 
	Section 10.5.
	 	Limitations	 	 	52	 
	Section 10.6.
	 	Calculation of Damages	 	 	53	 
	Section 10.7.
	 	Purchase Price Adjustment	 	 	53	 

 ii

 

	 	 	 	 	 	 	 

	Section 10.8.
	 	Release of Adjusted Holdback Amount	 	 	53	 
	 
	 	 	 	 	 	 
	ARTICLE XI. SELLERS’ REPRESENTATIVE	 	 	54	 
	Section 11.1.
	 	Authorization of the Sellers’ Representative	 	 	54	 
	Section 11.2.
	 	Compensation; Exculpation; Indemnity	 	 	55	 
	Section 11.3.
	 	Removal and Replacement of Sellers’ Representative; Successor Sellers’ Representative	 	 	55	 
	Section 11.4.
	 	Reliance; Limitation as to Parent and the Company	 	 	56	 
	 
	 	 	 	 	 	 
	ARTICLE XII. MISCELLANEOUS	 	 	56	 
	Section 12.1.
	 	Entire Agreement	 	 	56	 
	Section 12.2.
	 	Successors	 	 	57	 
	Section 12.3.
	 	Assignments	 	 	57	 
	Section 12.4.
	 	Notices	 	 	57	 
	Section 12.5.
	 	Submission to Jurisdiction; Process Agent	 	 	58	 
	Section 12.6.
	 	Time	 	 	58	 
	Section 12.7.
	 	Counterparts	 	 	58	 
	Section 12.8.
	 	Headings	 	 	58	 
	Section 12.9.
	 	Governing Law	 	 	58	 
	Section 12.10.
	 	Amendments and Waivers	 	 	59	 
	Section 12.11.
	 	Severability	 	 	59	 
	Section 12.12.
	 	Expenses	 	 	59	 
	Section 12.13.
	 	Construction	 	 	59	 
	Section 12.14.
	 	Remedies	 	 	60	 
	Section 12.15.
	 	Electronic Signatures	 	 	60	 

 iii

 

Exhibits

	 	 	 

	Exhibit A

	 	Sample Computation of Adjusted Net Working Capital
	 
	 	 
	Exhibit B

	 	Form of Closing Statement
	 
	 	 
	Exhibit C

	 	Form of Seller’s Certificate
	 
	 	 
	Exhibit D

	 	Form of Company’s Officers’ Certificate
	 
	 	 
	Exhibit E

	 	Form of Company’s Secretary’s Certificate
	 
	 	 
	Exhibit F

	 	Form of Non-USRPI Certificate
	 
	 	 
	Exhibit G

	 	Form of Resignation Letter
	 
	 	 
	Exhibit H

	 	Form of Limited Release
	 
	 	 
	Exhibit I

	 	Form of Proxy
	 
	 	 
	Exhibit J

	 	Form of Parent’s Secretary’s Certificate
	 
	 	 
	Exhibit K

	 	Form of Press Release
	 
	 	 
	Exhibit L

	 	Form of Redemption Notice

Schedules

	 	 	 

	Schedule A

	 	List of Sellers and Share Ownership
	 
	 	 
	Schedule B

	 	Permitted Encumbrances
	 
	 	 
	Schedule C

	 	List of Persons Executing Proxies
	 
	 	 
	Schedule D

	 	Management Bonuses
	 
	 	 
	Schedule E

	 	Director Nominees
	 
	 	 
	Schedule F

	 	Escrowed Shares
	 
	 	 
	Schedule G

	 	Exercised Company Options
	 
	 	 
	Schedule H

	 	Pre-Closing Actions

	 	 	 

	Sellers Disclosure Schedules
	 
	 	 
	Section 4.5
	 	Capitalization

 iv

 

	 	 	 

	Company Disclosure Schedules
	 
	 	 
	Section 5.3
	 	Required Consents
	 
	 	 
	Section 5.4
	 	Brokers’ Fees
	 
	 	 
	Section 5.5
	 	Capitalization
	 
	 	 
	Section 5.6(a)
	 	Company Subsidiaries
	 
	 	 
	Section 5.6(b)
	 	Veterinary Practices Managed by Acquired Entities
	 
	 	 
	Section 5.8(a)
	 	SEC Documents
	 
	 	 
	Section 5.11
	 	Subsequent Events
	 
	 	 
	Section 5.13(b)
	 	Permits
	 
	 	 
	Section 5.14
	 	No Change of Control Provisions
	 
	 	 
	Section 5.15
	 	Tax Matters
	 
	 	 
	Section 5.16(a)
	 	Owned Real Estate/Leased Real Estate/Facility Leases
	 
	 	 
	Section 5.17(a)
	 	Intellectual Property
	 
	 	 
	Section 5.18(a)
	 	Contracts
	 
	 	 
	Section 5.19
	 	Litigation
	 
	 	 
	Section 5.20(b)
	 	Employment Contracts
	 
	 	 
	Section 5.21
	 	Company Plans
	 
	 	 
	Section 5.23
	 	Insurance Policies
	 
	 	 
	Section 5.24
	 	Affiliate Transactions

 v

 

STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of June 2, 2010, is by and among
(i) VCA Antech, Inc., a Delaware corporation (“Parent”), (ii) Snow Merger Acquisition, Inc., a
Delaware corporation (“Buyer”), (iii) Pet DRx Corporation, a Delaware corporation (the “Company”),
(iv) Harry L. Zimmerman, an individual, in his capacity as the Sellers’ Representative (defined
below), and (v) each Person listed as a seller on the signature pages hereto (individually,
“Seller” and collectively, the “Sellers”).

BACKGROUND:

     A. The Sellers collectively own (or have the right to acquire upon the exercise of Seller
Options owned by each Seller) more than 51% of the shares of Company Common Stock calculated on a
fully-diluted basis.

     B. Subject to the terms and conditions set forth herein, Buyer desires to acquire from the
Sellers, and the Sellers desire to sell to Buyer, all of the Seller Shares (as defined herein) and
the Seller Options (as defined herein).

     C. Concurrently with entering into this Agreement, the Company, Parent and Buyer are executing
and delivering a Merger Agreement (the “Merger Agreement”) pursuant to which the Buyer will merge
with and into the Company (the “Merger”), all in accordance with the terms and conditions of the
Merger Agreement. Immediately following the Merger, the Company will be the surviving corporation
in the Merger, wholly owned by Parent.

     D. The board of directors of the Company has (i) determined that the transactions contemplated
by this Agreement and the Merger Agreement are fair to, and in the best interests of, the Company
and its stockholders, (ii) has approved and adopted this Agreement and the Merger Agreement and the
Transactions (as defined herein) contemplated hereby and thereby and (iii) has recommended the
approval and adoption of the Merger Agreement and the Merger by the stockholders of the Company.

     E. Concurrently with the execution of this Agreement, each of the Sellers has executed a
written consent approving the adoption of the Merger Agreement and the consummation of the Merger
and the other Transactions contemplated therein (the “Stockholder Consent”).

AGREEMENT:

     NOW, THEREFORE, in consideration of the premises and the mutual promises herein made, and of
the representations, warranties, and covenants contained herein, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto hereby agree as follows:

ARTICLE I.

DEFINITIONS

     “2009 Financial Statements” means the audited consolidated balance sheets of the Acquired
Entities as of December 31, 2009, audited consolidated statements of income, changes

 

 

in stockholders’ equity and cash flows for the Acquired Entities for the fiscal year ended
December 31, 2009, including the notes thereto, with the report thereon of Singerlewak LLP
independent certified public accountants, all as filed with the SEC as part of the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2009.

     “Acquired Entities” means the Company and each of the Company Subsidiaries.

     “Action” means any action, appeal, petition, plea, charge, complaint, claim, suit, demand,
litigation, arbitration, mediation, hearing, inquiry, investigation or similar event, occurrence,
or proceeding.

     “Adjusted Current Assets” means the net book value of all of the assets of the Acquired
Entities as of 12:01 a.m. (PST) on the Equity Closing Date that would be classified as “current
assets” under GAAP, the net book value of which shall be determined using the same accounting
methods, policies, practices, principles and procedures with consistent classifications that were
used in the preparation of the 2009 Financial Statements which assets shall include, but not be
limited to, the following: (i) cash (including certificates of deposit) and cash equivalents (net
of any restricted cash), (ii) trade accounts receivable (net of doubtful accounts); (iii) prepaids,
(iv) inventory and (v) other current assets.

     “Adjusted Current Liabilities” means all of the liabilities of the Acquired Entities as of
12:01 a.m. (PST) on the Equity Closing Date that would be classified as “current liabilities” under
GAAP, the net book value of which shall be determined using the same accounting methods, policies,
practices, principles and procedures with consistent classifications that were used in the
preparation of the 2009 Financial Statements, which liabilities shall include, but not be limited
to, the following: (i) accounts payable and other accrued liabilities; (ii) accrued payroll,
accrued vacation and other compensation expenses (including flexible time off (FTO), bonuses (other
than those set forth on Schedule D, flexible spending accounts (FSA/DECAP), 401(k)
withholding, health insurance reserve, and current payroll tax obligations), (iii) accrued taxes
(including, but not limited to, income, sales and property taxes), (iv) all Severance Obligations
in excess of $2,800,000, (v) the Dispute Letter Accrual, and (vi) accrued expenses and other
current liabilities. Notwithstanding the foregoing, Adjusted Current Liabilities shall not include
(w) the current portion of any Debt of the Acquired Entities, (x) any accrued and unpaid interest
and any other accrued payment obligations with respect to Debt included in Company Debt, (y) the
Closing Costs, and (z) the Information Statement Fees.

     “Adjusted Net Working Capital” means Adjusted Current Assets minus Adjusted Current
Liabilities. Attached hereto as Exhibit A is a sample computation of Adjusted Net Working
Capital.

     “Affiliate” or “Affiliated” with respect to any specified Person, means a Person that,
directly or indirectly, through one or more intermediaries, controls or is controlled by, or is
under common control with, such specified Person.

     “Aggregate Transaction Consideration” means (i) $41,250,000, minus (ii) the Company
Debt, minus (iii) all Closing Costs in excess of $2,000,000, minus (iv) the
Purchase Price Adjustment (if any).

2

 

     “Audit” includes any audit, assessment of Taxes, reassessment of Taxes or examination by any
taxing authority of any Acquired Entity or any related judicial or administrative proceedings or
appeal of such proceedings.

     “Balance Sheet Date” means December 31, 2009.

     “Breach” means (i) any breach, inaccuracy, failure to perform, failure to comply, conflict
with, failure to notify when there is an obligation to provide notice, default, or violation or
(ii) any other act, omission, event, occurrence or condition the existence of which would (A)
permit any Person to accelerate any obligation or terminate, cancel, or modify any right or
obligation or (B) require the payment of money or other consideration.

     “Business Day” means a day on which banks are ordinarily open for transaction of normal
banking business in Los Angeles, California.

     “Closing Costs” means the sum of (i) the dollar amount of all out-of-pocket costs, fees and
expenses of investment bankers, financial advisors, legal counsel and accountants incurred or
payable by the Acquired Entities in connection with the negotiation, execution and consummation of
the Transactions through the Equity Closing, plus (ii) the management bonuses set forth on
Schedule D hereto, plus (iii) fifty percent (50%) of the premium for the D&O Tail
Policy. For clarification purposes, if any such fees and expenses incurred through the Equity
Closing are contingent or payable only upon the consummation of the Merger, such expenses will
constitute Closing Costs hereunder notwithstanding that such fees or expenses may not be accrued
under GAAP until the Merger Closing. Closing Costs shall not include the Information Statement
Fees.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Commercially Reasonable Best Efforts” means the efforts, time and costs that a prudent Person
desirous of achieving a result would use, expend, or incur in similar circumstances in an effort to
achieve such result as expeditiously as possible subject to then existing commercial realities.

     “Commitment” means (i) options, warrants, convertible securities, exchangeable securities,
subscription rights, conversion rights, exchange rights, or other Contracts that could require a
Person to issue any of its Equity Interests or sell any Equity Interests it owns in another Person,
(ii) any other securities convertible into, exchangeable or exercisable for, or representing the
right to subscribe for any Equity Interests of a Person or owned by a Person, (iii) statutory
preemptive rights or preemptive rights granted under a Person’s Organizational Documents, and (iv)
stock appreciation rights, phantom stock, profit participation, or other similar rights with
respect to a Person.

     “Company Common Stock” means the common stock, par value $0.0001 per share, of the Company.

     “Company Debt” means the dollar amount of all Debt of the Acquired Entities outstanding as of
the Equity Closing Date, which shall be set forth on the Closing Statement prepared pursuant to
Section 2.3 hereof, including all accrued and unpaid interest relating thereto

3

 

as of the Equity Closing Date, and any accrued late fees or other payment obligations with
respect thereto and any and all penalties, premiums, or other breakage costs incurred as a result
of payment of the Company Debt on the Equity Closing Date; provided that the Disputed Earn-Out
Notes shall not be deemed Company Debt for purposes of this Agreement.

     “Company Option” means an option, warrant or other right to purchase shares of Company Common
Stock.

     “Company Subsidiaries” means each of the direct or indirect Subsidiaries of the Company as set
forth on Section 5.6 of the Company Disclosure Schedule.

     “Consent” means any consent, approval, notification, waiver, amendment or other similar
action.

     “Contract” means any contract, agreement, arrangement, commitment, letter of intent,
memorandum of understanding, heads of agreement, promise, obligation, right, instrument, document,
or other similar understanding, whether written or oral.

     “DGCL” means the General Corporation Law of the State of Delaware as in effect as of the date
hereof.

     “Damages” means all damages, losses, Liabilities, penalties, fines and expenses actually
incurred and paid (including reasonable fees and expenses of outside attorneys) and Taxes with
respect to the foregoing, but in any case excluding consequential, incidental and punitive damages,
losses, lost profits, and Liabilities.

     “Debt” means indebtedness for borrowed money, including any bank debt or notes payable
(including current portion), capitalized lease obligations, the deferred purchase price for assets
or business acquired (including, without limitation, the maximum dollar amount due and payable in
connection with any earn-out, escrow, holdback or contingent payment).

     “Deficit Working Capital” means the amount, if any, by which the Adjusted Net Working Capital
of the Company at the Equity Closing is less than the Target Working Capital.

     “Disputed Earn-Out Notes” means those two (2) Earn-Out Promissory Notes, dated December 31,
2006, each in the principal amount of $150,000 issued to Douglas E. Tomblin, DVM and Thomas J.
Bernhard, DVM, respectively, that are the subject of that certain litigation entitled Tomblin vs.
XLNT Veterinary Care, Inc., etc., et. al, Case #37-2009-00067537 (San Diego Superior Court).

     “Encumbrance” means any chose, encumbrance, security interest, lien, easement, encroachment,
covenant, condition, preemptive purchase right or option, adverse claim or restriction.

     “Environmental, Health, and Safety Requirements” means all Laws concerning or relating to
public health and safety, worker/occupational health and safety, and pollution or protection of the
environment, including those relating to the presence, use, manufacturing, refining, production,
generation, handling, transportation, treatment, recycling, transfer, storage,

4

 

disposal, distribution, importing, labeling, testing, processing, discharge, release,
threatened release, control, or other action or failure to act involving cleanup of any hazardous
materials, substances or wastes, chemical substances or mixtures, pesticides, pollutants,
contaminants, toxic chemicals, petroleum products or byproducts, asbestos, polychlorinated
biphenyls, noise, or radiation, each as amended and as now in effect.

     “Equity Interest” means (i) with respect to a corporation, any and all shares of capital
stock, (ii) with respect to a partnership, limited liability company, trust or similar Person, any
and all units, interests or other partnership/limited liability company interests, and (iii) any
other direct equity ownership or participation in a Person.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

     “Escrowed Shares” means those shares of Company Common Stock subject to that certain Stock
Escrow Agreement, dated as of March 22, 2006, by and among Echo Healthcare Acquisition Corp., the
Corporate Stock Transfer, Inc., and those persons listed on the signature pages thereto and listed
on Schedule F attached hereto.

     “Excess Closing Costs” means the amount, if any, by which the Closing Costs exceed $2,000,000.

     “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

     “Expiration Date” means September 30, 2010.

     “Financial Statements” means audited consolidated balance sheets of the Acquired Entities as
of December 31, 2009 and 2008 and audited consolidated statements of income, changes in
stockholders’ equity and cash flows for the Acquired Entities for the fiscal years ended December
31, 2009 and 2008, including the notes thereto, together with the report thereon of Singerlewak LLP
independent certified public accountants.

     “GAAP” means United States generally accepted accounting principles as in effect as of the
date hereof.

     “Governmental Body” means any legislature, agency, bureau, department, commission, court,
political subdivision, tribunal or other instrumentality of government whether local, state,
federal or foreign.

     “Holdback Amount” means cash in the aggregate amount of $750,000.

     “Indemnified Parties” means, individually and as a group, the Parent Indemnified Parties and
Seller Indemnified Parties.

     “Indemnitor” means any Party having any Liability to any Indemnified Party under this
Agreement.

     “Information Statement Fees” means the reasonable fees of outside legal counsel to the Special
Committee of the Board of Directors of the Company incurred in connection with the

5

 

preparation and filing of the Information Statement, as well as responding to any issues,
questions and inquiries raised or initiated by the SEC through the date that the Information
Statement is mailed to the Company’s shareholders in an amount estimated to be $150,000 and which
shall not exceed $200,000.

     “Intellectual Property” means (i) any and all patents, copyrights, trademarks, trade names,
service marks, service names, domain names, know-how, processes, trade secrets and inventions, and
(ii) any and all rights, licenses, liens, security interests, charges, encumbrances, equities, and
other claims that any Person may have to claim ownership, authorship or invention, to use, to
object to or prevent the modification of, to withdraw from circulation, or control the publication
or distribution of any trademarks, service marks, patents, copyrights, or trade secrets.

     “In-the-Money Company Option” means each Company Option that has an exercise price less than
the quotient obtained by dividing (i) the Aggregate Transaction Consideration by (ii) the sum of
(x) the number of shares of Company Common Stock issued and outstanding immediately prior to the
Equity Closing (excluding any shares of Company Common Stock held as treasury shares), and (y) the
number of shares of Company Common Stock issuable upon exercise of all Company Options issued and
outstanding immediately prior to the Equity Closing determined pursuant to an iterative process
beginning with all Company Options issued and outstanding immediately prior to the Equity Closing
and continuing through successive iterations that exclude those Company Options with the then
highest exercise price per share that is greater than the result obtained pursuant to clauses (i)
and (ii) above in the immediately preceding iteration until such time as the exercise price per
share with respect to each remaining outstanding Company Options is less than the result obtained
pursuant to clauses (i) and (ii) above in the immediately preceding iteration.

     “IRS” means the United States Internal Revenue Service.

     “Knowledge” — an individual will be deemed to have “Knowledge” of a particular fact or other
matter if such individual is actually aware of such fact or other matter. With respect to the
Company “Knowledge” means the Knowledge of Gene Burleson, Steve Ettinger, David Reed, George
Villasana and Harry Zimmerman.

     “Law” means any applicable statute, rule, regulation, administrative requirement, code or
ordinance of any Governmental Body, each as amended and now in effect.

     “Liability” or “Liable” means any liability or obligation, whether known or unknown, asserted
or unasserted, direct or indirect, matured or unmatured, absolute or contingent, accrued or
unaccrued, latent or patent, liquidated or unliquidated, or due or to become due.

     “Material Adverse Change (or Effect)” means any change or effect (any such item, an “Effect”)
on the business, financial condition or results of operations of a Person which Effect,
individually or in the aggregate, is or could reasonably be expected to be materially adverse to
such business, financial condition or results of operations or on the ability of such Person to
consummate the Equity Purchase, the Merger and the other Transactions without material delay;
provided, however, that in no event shall any of the following be deemed, either alone or in
combination, to constitute, nor shall any of the following be taken into account in determining

6

 

whether there has been a Material Adverse Change (or Effect): (i) any Effect that results from
a delisting of the Company Common Stock from the Nasdaq Stock Market, (ii) any Effect that results
from changes in general economic conditions or changes in securities markets in general, including
any changes in interest rates, (iii) any Effect that results from general changes in the veterinary
industry, (iv) any Effect related to the public announcement or the pendency or consummation of the
Transactions, (v) any Effect that results from any action taken at the specific request of the
other Party to this Agreement, (vi) any Effect that results from natural disasters, acts of war,
sabotage or terrorism, military actions or the escalation thereof, or (vii) any Effect resulting
from any actual or proposed change in applicable law or regulation applicable to a Party or any of
its Subsidiaries; except in the case of clauses (ii), (iii), (vi) and (vii), for any Effect that
has a significantly disproportionate adverse impact on such Party and its Subsidiaries, taken as a
whole, compared to other companies of similar size operating in the principal industries in which
such Party and its Subsidiaries operate or (b) when used with reference to the Company, Sellers,
Parent or Buyer, as the case may be, any Effect that is materially adverse to the ability of the
Company, Sellers, Parent or Buyer to perform their respective obligations under this Agreement.

     “Merger Closing” means the date of the closing of the Merger in accordance with the terms of
the Merger Agreement.

     “Ordinary Course of Business” means the ordinary course of business consistent with past
custom and practice (including with respect to quantity, quality and frequency) of the relevant
Person and its Subsidiaries.

     “Organizational Documents” means the articles of incorporation, certificate of incorporation,
charter, bylaws, articles of formation, regulations, operating agreement, certificate of limited
partnership, partnership agreement, and all other similar documents, instruments or certificates
executed, adopted, or filed in connection with the creation, formation, or organization of a
Person, including any amendments thereto.

     “Parent Indemnified Parties” means Parent, Buyer, and the Company (post-Equity Closing), and
their officers, directors, managers, employees, agents, and Representatives.

     “Parties” means the Parent, Buyer, the Company and the Sellers.

     “Permit” means any permit, license, certificate, approval, consent, notice, waiver, franchise,
registration, filing, accreditation, entitlement, or other similar authorization required by any
Law or Governmental Body.

     “Permitted Encumbrances” means (i) Encumbrances disclosed in Schedule B to the Company
Disclosure Schedule, (ii) liens for Taxes, assessments, governmental charges or levies or
mechanics’ and other statutory liens which are not yet delinquent or can be paid without penalty or
are being contested in good faith and by appropriate proceedings in respect thereof and for which
an appropriate reserve has been established in accordance with GAAP, (iii) imperfections of title
which are immaterial in amount relative to the property affected and which do not materially
interfere with the present use of the property subject thereto or affected thereby, and (iv)
restrictions on transfer generally arising under federal and state securities Laws.

7

 

     “Per Option Purchase Price” means (i) with respect to each In-the-Money Company Option, for
each share of Company Common Stock issuable upon exercise of such In-the-Money Company Option, the
Per Share Purchase Price less the per share exercise price payable upon exercise of such
In-the-Money Company Option and (ii) with respect to each Company Option that is not an
In-the-Money Company Option, $0.0001 for all such Company Options held by a Seller.

     “Per Share Holdback Amount” means (i) $750,000 divided by (ii) the aggregate number of
Seller Shares held by the Sellers immediately prior to the Equity Closing as reflected on
Schedule A hereto.

     “Per Share Purchase Price” means (i) the Aggregate Transaction Consideration plus the
aggregate consideration paid or payable upon exercise of all issued and outstanding In-the-Money
Company Options, divided by (ii) the sum of the number of shares of Company Common Stock
issued and outstanding immediately prior to the Equity Closing plus the aggregate number of
shares of Company Common Stock issuable upon exercise of all In-the-Money Company Options issued
and outstanding immediately prior to the Equity Closing.

     “Person” means any individual, partnership, limited liability company, corporation,
association, joint stock company, trust, entity, joint venture, labor organization, unincorporated
organization, or Governmental Body.

     “Purchase Price Adjustment” means the amount of the Deficit Working Capital, if any.

     “Representatives” means Persons acting on behalf of another Person, including such Person’s
officers, directors, employees, representatives, agents, independent accountants, investment
bankers and counsel.

     “SEC” means the United States Securities and Exchange Commission.

     “Securities Act” means the Securities Act of 1933, as amended.

     “Seller Shares” means shares of Company Common Stock owned by a Seller, other than the
Escrowed Shares.

     “Seller Options” means Company Options owned by a Seller.

     “Seller Indemnified Parties” means the Sellers and their respective officers, directors,
managers, employees, agents, and Representatives.

     “Severance Obligations” means all severance and other similar payments (including without
limitation, COBRA benefits), paid or payable to employees of the Acquired Entities in connection
with the consummation of the Transactions, and including all Taxes paid or payable relating
thereto.

     “Special Committee” means the committee of the Company’s Board of Directors that will be
established immediately after the Equity Closing pursuant to Section 7.2, the member or

8

 

members of which will consist of each member of the Company’s Board of Directors who is an
Independent Director.

     “Subsidiary” means, with respect to any Person: (i) any corporation of which more than ten
percent (10%) of the total voting power of all classes of the Equity Interests entitled (without
regard to the occurrence of any contingency) to vote in the election of directors is owned by such
Person directly or through one or more other Subsidiaries of such Person and (ii) any Person other
than a corporation of which at least ten percent (10%) of the Equity Interests (however designated)
entitled (without regard to the occurrence of any contingency) to vote in the election of the
governing body, partners, managers or others that will control the management of such entity are
owned by such Person directly or through one or more other Subsidiaries of such Person.

     “Target Working Capital” means negative $750,000.

     “Tax” means (i) any federal, state, local, or foreign income, gross receipts, license,
payroll, employment, excise, severance, stamp, occupation, premium, windfall profits,
environmental, customs, ad valorem, duties, capital stock, franchise, profits, withholding, social
security, unemployment, disability, real property, personal property, sales, use, transfer,
registration, value added, alternative or add-on minimum, estimated, or other tax of any kind
whatsoever, including any interest, penalty, or addition thereto, whether disputed or not,
including any obligations to indemnify or otherwise assume or succeed to the Tax liability of any
other Person, and (ii) any obligations under any Contracts with respect to any Tax described in
clause (i) above.

     “Tax Return” means any return, form, declaration, report, claim for refund, or information
return or statement relating to Taxes required to be filed with any Governmental Body, including
any schedule or attachment thereto, and including any amendment thereof.

     “Termination Date” means the date on which this Agreement is terminated pursuant to
Section 9.1.

     “Threatened” means a (i) written demand or statement has been made or a written notice has
been given, or (ii) an oral demand or statement made subsequent to January 1, 2009, asserting a
claim for damages, losses, and/or expenses involving an amount in excess of $50,000, as to which
such oral demand or statement, the underlying issues providing the basis for such claim have not
been fully and finally resolved.

     “Transaction Documents” means this Agreement, the Merger Agreement, the Limited Releases, the
Proxies and each of the other documents, instruments and agreements to be executed, delivered, and
performed in connection herewith and therewith, together with any exhibits or schedules
constituting a part thereof.

     “Transactions” means all of the transactions contemplated by the Transaction Documents,
including: (i) the sale of the Seller Shares and Seller Options to Buyer and Buyer’s delivery of
the Per Share Purchase Price therefor; (ii) the Merger; (iii) the execution, delivery, and
performance of all of the documents, instruments and agreements to be executed, delivered, and
performed in connection herewith and therewith; and (iv) the performance by Parent, Buyer,

9

 

the Sellers and the Company of their respective covenants and obligations (pre- and
post-closing, as applicable) under the Transaction Documents.

     “Veterinary Hospitals” means the veterinary hospitals and clinics owned and operated by the
Acquired Entities.

     The following additional terms are defined in the sections of the Agreement set forth across
from such terms as set below:

	 	 	 
	Defined Term	 	Location of Definition
	 
	 	 
	Adjusted Holdback Amount

	 	Section 2.5(c)
	Agreement

	 	Preamble
	Acquisition Proposal

	 	Section 6.8(b)
	Buyer

	 	Preamble
	Closing Statement

	 	Section 2.3(a)
	Company

	 	Preamble
	Company Disclosure Schedule

	 	ARTICLE V
	Company Plans

	 	Section 5.21(a)
	Company SEC Documents

	 	Section 5.8(a)
	Confidentiality Agreement

	 	Section 6.5(b)
	Confidential Information

	 	Section 7.6(a)
	Definitive Post Closing Statement

	 	Section 2.5(b)
	Dispute Letter

	 	Section 5.19 of the Company Disclosure Schedule
	Dispute Letter Accrual

	 	Section 5.19 of the Company Disclosure Schedule
	D&O Tail Policy

	 	Section 7.5
	Equity Closing

	 	Section 2.2
	Equity Closing Date

	 	Section 2.2
	Equity Purchase

	 	Section 2.1
	ERISA Affiliate

	 	Section 5.21(e)
	Facility Lease

	 	Section 5.16(c)
	Indemnification Claim

	 	Section 10.4(a)
	Independent Accountants

	 	Section 2.5(b)
	Independent Directors

	 	Section 7.2
	Information Statement

	 	Section 8.2(g)
	Leased Real Estate

	 	Section 5.16(a)
	Limited Releases

	 	Section 2.4(a)(viii)
	Merger

	 	Recitals
	Merger Agreement

	 	Recitals
	Objection Notice

	 	Section 2.5(b)
	Officer’s Certificate

	 	Section 10.8(a)
	Owned Real Estate

	 	Section 5.16(a)
	Parent

	 	Preamble
	Payment Statement

	 	Section 2.3(b)
	Prepayment Notes

	 	Section 8.2(e)(i)

10

 

	 	 	 
	Defined Term	 	Location of Definition
	 
	 	 
	Post Closing Statement

	 	Section 2.5(a)
	Preferred Stock

	 	Section 5.5
	Proxy

	 	Section 2.4(a)(ix)
	Redemption Notices

	 	Section 6.2(d)
	Sellers’ Representative

	 	Section 11.1(a)
	Sellers

	 	Preamble
	Sellers Disclosure Schedule

	 	ARTICLE IV
	Stockholder Consent

	 	Recitals
	Warrant Shares

	 	Section 6.11

11

 

ARTICLE II.

Purchase and Sale of Equity Interests

     Section 2.1. Purchase and Sale of Equity Interests. On the terms and subject to the conditions set forth
in this Agreement, Buyer agrees to purchase from the Sellers, and the Sellers agree to sell to
Buyer, all of the Seller Shares for the Per Share Purchase Price and all of the Seller Options for
the Per Option Purchase Price (the “Equity Purchase”).

     Section 2.2. Equity Closing. The closing of the Equity Purchase (the “Equity Closing”) will take place at
the offices of Akin Gump Strauss Hauer & Feld LLP, Century Tower Plaza, 2029 Century Park East,
Suite 2400, Los Angeles, California, commencing at 9:00 a.m., local time, on the 1st day
of the month following the satisfaction or waiver of all conditions to the obligations of the
Parties to consummate the Equity Purchase (other than conditions with respect to actions the
respective Parties will satisfy at the Equity Closing itself), or such other date (following the
satisfaction or waiver of all conditions to the obligations of the Parties to consummate the Equity
Purchase) as Parent may determine in its sole discretion, or such other date as the Parties may
mutually determine (the “Equity Closing Date”).

     Section 2.3. Closing Statement.

               (a) At least ten (10) days prior to the expected Equity Closing Date, the Company shall
prepare and deliver to Parent a written statement, dated as of the date of delivery, setting forth
the Company’s good faith estimate of the Company Debt, the Closing Costs, and the Purchase Price
Adjustment as of the Equity Closing Date, prepared in reasonable detail as requested by Parent (the
“Closing Statement”) in the form of Exhibit B. The Closing Statement shall be subject to
review by Parent and Parent shall give notice of any exceptions regarding the Closing Statement no
later than two (2) days prior to the Equity Closing Date and in the absence of any such notice the
Closing Statement as delivered by the Company shall be conclusive and binding upon the Parties for
purposes of the Equity Closing. Parent and the Company shall negotiate in good faith to resolve
any exceptions Parent may have to the Closing Statement, but in the absence of such agreement the
Closing Statement, as modified by Parent, shall be conclusive and binding upon the Parties for
purposes of the Equity Closing unless the difference between the Closing Statement submitted by the
Company and the Closing Statement as modified by Parent is greater than $25,000, in which case the
mid-point between the two positions shall be used for purposes of the Equity Closing. In reviewing
the Closing Statement, Parent shall have the right to discuss such matters with the Company and its
Representatives and to review the work papers, schedules, memoranda, and other documents, including
third party payoff schedules the Company and its Representatives prepared or reviewed in
determining each of the items set forth on the Closing Statement.

               (b) At least five (5) days prior to the expected Equity Closing Date, the Company shall
prepare and deliver to Parent a written statement, dated as of the date of delivery, setting forth
the Company’s good faith estimate, based on the Closing Statement used for purposes of the Equity
Closing, of the amount to be paid to each Seller on the Equity Closing Date pursuant to Section
2.4(b)(i), prepared in reasonable detail as requested by Parent (the “Payment Statement”). The
Payment Statement shall be subject to review by Parent and Parent shall give notice of any
exceptions regarding the Payment Statement no later than two (2) days

12

 

prior to the Equity Closing Date and in the absence of any such notice the Payment Statement
as delivered by the Company shall be conclusive and binding upon the Parties for purposes of the
Equity Closing. Parent and the Company shall negotiate in good faith to resolve any exceptions
Parent may have to the Payment Statement but, in the absence of such agreement, the Payment
Statement as modified by Parent shall be conclusive and binding upon the Parties for purposes of
the Equity Closing.

     Section 2.4. Payments and Deliveries at the Equity Closing. On the Equity Closing Date:

               (a) The Sellers and the Company will deliver to Parent and Buyer:

                    (i) (A) Certificates, stock powers, or other appropriate instruments of transfer representing
the Seller Shares, duly endorsed (or accompanied by duly executed assignments) for transfer to
Buyer, and an agreement executed by the Company and each Seller holding Seller Options cancelling
the Seller Options held by such Seller; and (B) a stock certificate issued in the name of Buyer
representing the Seller Shares, including the Warrant Shares.

                    (ii) A certificate, substantially in the form of Exhibit C, duly executed by each
Seller, as to whether each condition to be satisfied by each Seller specified in Section
8.1 and Section 8.2 has been satisfied as of the Equity Closing Date.

                    (iii) An officer’s certificate, substantially in the form of Exhibit D, duly executed
on the Company’s behalf, as to whether each condition to be satisfied by the Company specified in
Section 8.1 and Section 8.2 has been satisfied as of the Equity Closing Date.

                    (iv) A secretary’s certificate, substantially in the form of Exhibit E, duly executed
on the Company’s behalf.

                    (v) A certification, substantially in the form of Exhibit F, duly executed on the
Company’s behalf, that satisfies the requirements of Treasury Regulation Section 1.1445-2(c)(3) and
any similar certifications required under state law to avoid state law withholding requirements for
foreign entities.

                    (vi) A certification (in form and substance reasonably satisfactory to Parent) that satisfies
the requirements of Treasury Regulation Section 1.1445-2(b)(2), duly executed by each of the
Sellers.

                    (vii) Letters of resignation, substantially in the form of Exhibit G, duly executed by
each officer and director of the Acquired Entities (other than any person to be designated as an
Independent Director of the Company subsequent to the Equity Closing Date), such resignation to be
effective as of the Equity Closing Date.

                    (viii) A limited release (“Limited Release”) in the form of Exhibit H, duly executed
by each of the Sellers.

13

 

                    (ix) A proxy (“Proxy”) in the form of Exhibit I, duly executed by each of the Sellers
listed on Schedule C, relating to the Escrowed Shares owned of record by each such Seller.

                    (x) (A) Except as provided in Section 2.4(a)(x) of the Company Disclosure Schedule,
releases executed by the holder or holders of Encumbrances (other than Permitted Encumbrances) on
any assets of the Acquired Entities irrevocably releasing such Encumbrances and filed copies of any
appropriate Uniform Commercial Code termination statements and/or other applicable release
documents with respect to such Encumbrances, (B) with respect to all Company Debt (other than the
Disputed Earn-Out Notes), payoff letters from the holder or holders of such Company Debt evidencing
such holder’s or holders’ agreement that such Company Debt would be fully satisfied and, to the
extent such Debt is secured Debt, to fully release any Encumbrances secured pursuant thereto
(either by authorizing the filing of appropriate Uniform Commercial Code termination statements
and/or other appropriate release documents or agreeing to file such statements and/or documents),
if such holder or holders receives funds in the specific amount set forth in such letters and (C)
with respect to any other Debt outstanding as of the Equity Closing Date, other than Company Debt
or the Disputed Earn-Out Notes, the existence or amount of which is disputed by the Company, payoff
letters from the holder or holders of such Debt evidencing such holder’s or holders’ agreement that
such Debt would be fully satisfied and, to the extent such Debt is secured Debt, to fully release
any Encumbrances secured pursuant thereto (either by authorizing the filing of appropriate Uniform
Commercial Code termination statements and/or other appropriate release documents or agreeing to
file such statements and/or documents) if such holder or holders receive funds in the amounts
specified in such letters, in each instance on terms reasonably satisfactory to Parent and Buyer.

               (b) Parent will deliver:

                    (i) (A) To each Seller the Per Share Purchase Price less the Per Share Holdback Amount
for each Seller Share owned by such Seller, and (B) to each Seller, the Per Option Purchase Price
in exchange for the cancellation of each Seller Option owned by such Seller. Parent shall make all
payments pursuant to this Section 2.4(b)(i) by check, unless the aggregate amount payable
to a Seller is in excess of $100,000, and such Seller not later than two (2) Business Days prior to
the Equity Closing Date delivers to Parent a request for payment via wire transfer of immediately
available funds together with all necessary wire transfer instructions.

                    (ii) To the Sellers’ and the Company, a secretary’s certificate, substantially in the form of
Exhibit J, duly executed on Parent’s behalf.

               (c) Buyer shall pay the amount of Company Debt, reflected on the Closing Statement, for which
the Company has delivered, to Parent and Buyer, a payoff letter executed by the holder of such
Company Debt pursuant to Section 2.4(a)(x).

               (d) The Parties shall also deliver to each other any agreements, closing certificates and
other documents and instruments required to be delivered pursuant to this Agreement.

14

 

     Section 2.5. Post-Closing Adjustments to the Aggregate Transaction Consideration.

               (a) Delivery of Post Closing Statement. Parent will prepare and deliver to the
Sellers’ Representative a statement (the “Post Closing Statement”) setting forth the computation of
(i) Company Debt outstanding as of the Equity Closing Date, (ii) Closing Costs, (iii) Purchase
Price Adjustment as of the Equity Closing Date, and (iv) the Severance Obligations, within (x)
sixty (60) days following the Equity Closing Date if the Equity Closing Date occurs on the first
day of a month, and (y) sixty (60) days following the last day of the month in which the Equity
Closing Date occurs if the Equity Closing Date occurs on any day other than the first day of the
month.

               (b) Objection. In reviewing the Post Closing Statement, the Sellers’ Representative
shall have the right to discuss such matters with Parent and to review the work papers, schedules,
memoranda, and other documents Parent prepared or caused to be prepared, or reviewed in determining
each of the items set forth on the Post Closing Statement. Unless the Sellers’ Representative
delivers to Parent, within ten (10) Business Days of receipt of the Post Closing Statement, written
notice (an “Objection Notice”) describing its exceptions to the Post Closing Statement, the Post
Closing Statement will be conclusive and binding on the Parties (the “Definitive Post Closing
Statement”). If the Sellers’ Representative submits an Objection Notice within the period set
forth herein, then (i) for ten (10) Business Days after receipt of the Objection Notice, Parent and
the Sellers’ Representative shall use their Commercially Reasonable Best Efforts to agree on the
Definitive Post Closing Statement, and (ii) lacking such agreement, the Post Closing Statement will
be referred to Deloitte & Touche, LLP (the “Independent Accountants”), to resolve the issues in
dispute. The Independent Accountants’ services and authority to make a determination shall be
limited in scope to the disputed issues and the amounts identified in the Objection Notice. The
Independent Accountants shall apply the provisions of this Section 2.5 to the disputed
issues, and shall have no authority or power to alter, modify, amend, add to or subtract from any
term or provision of this Agreement. The Parties shall instruct the Independent Accountants to
render its decision within thirty (30) days of the engagement, which determination shall be set
forth in a written statement delivered to Parent and the Sellers’ Representative and shall be
conclusive and binding upon the parties for all purposes under this Agreement. The Independent
Accountants shall allocate its costs and expenses between Parent and the Sellers based upon the
percentage of the disputed amounts submitted to the Independent Accountants that is ultimately
awarded to the Sellers, on the one hand, or Parent, on the other hand, such that the Sellers shall
bear a percentage of such costs and expenses equal to the percentage of the disputed amount awarded
to Parent (with any costs and expenses payable by the Sellers to be retained by Parent from the
Holdback Amount) and Parent shall bear a percentage of such costs and expenses equal to the
percentage of the disputed amount awarded to the Sellers. The determination of the Independent
Accountants shall be final, binding and conclusive for all purposes hereunder.

               (c) Payment of Adjustment. Within five (5) Business Days after delivery of the
Definitive Post Closing Statement:

                    (i) Subject to the provisions of Section 2.5(b) hereof, Parent shall deduct from the
Holdback Amount and retain for its own account the aggregate of (x) the

15

 

amount, if any, by which the Company Debt reflected on the Definitive Post Closing Statement
exceeded the Company Debt included on the Closing Statement, (y) the amount, if any, by which the
Excess Closing Costs reflected on the Definitive Post Closing Statement exceeded the Excess Closing
Costs included on the Closing Statement and (z) the amount, if any, by which the Purchase Price
Adjustment reflected on the Definitive Post Closing Statement exceeded the Purchase Price
Adjustment included on the Closing Statement; and

                    (ii) Parent shall increase the Holdback Amount by the aggregate of (y) the amount, if any, by
which the Excess Closing Costs included on the Closing Statement exceeded the Excess Closing Costs
reflected on the Definitive Post Closing Statement, and (z) the amount, if any, by which the
Purchase Price Adjustment included on the Closing Statement exceeded the Purchase Price Adjustment
reflected on the Definitive Post Closing Statement.

Any positive and negative adjustments described in clauses (i) and (ii) above shall be netted
against one another to result in a single deduction, or addition, as the case may be, to the
Holdback Amount. The Holdback Amount as adjusted after the application of the foregoing provisions
is hereinafter referred to as the “Adjusted Holdback Amount”.

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

OF PARENT AND BUYER

     Parent and Buyer represent and warrant to the Sellers as follows:

     Section 3.1. Entity Status. Each of Parent and Buyer is an entity duly created, formed or organized,
validly existing and in good standing under the Laws of the jurisdiction of its creation, formation
or organization.

     Section 3.2. Power and Authority; Enforceability. Parent and Buyer have the corporate power and authority
to execute and deliver this Agreement and each other Transaction Document to which they are a
party, and to perform and consummate the Transactions. Parent and Buyer have taken all action
necessary to authorize the execution and delivery of each other Transaction Document to which they
are a party, the performance of Parent’s and Buyer’s obligations thereunder, and the consummation
of the Transactions. This Agreement and each other Transaction Document has been duly authorized,
executed and delivered by Parent or Buyer, if Parent or Buyer is a party thereto, and constitutes
the legal, valid, and binding obligation of Parent or Buyer, if a party thereto, enforceable
against Parent or Buyer, if a party thereto, in accordance with its terms, in each case subject to
applicable bankruptcy, insolvency and similar laws affecting the enforceability of creditors’
rights generally, general principles of equity, the discretion of courts in granting equitable
remedies and matters of public policy.

16

 

     Section 3.3. No Violation. The execution and the delivery of the Transaction Documents to which Parent or
Buyer is a party and the performance and consummation of the Transactions by Parent or Buyer do not
and will not (with or without the passage of time or the giving of notice) (i) Breach any Law to
which Parent or Buyer is subject or any provision of Parent’s or Buyer’s Organizational Documents,
(ii) Breach in any material respect any material Contract to which Parent or Buyer is a party or by
which Parent or Buyer is bound, (iii) require any Consent, except (A) any SEC and other filings
required to be made by Parent or Buyer and (B) any notifications or filings to any relevant state
or federal regulatory agencies, (iv) Breach any resolution adopted by the board of directors or the
stockholders of Parent or Buyer, or (v) give any Governmental Body or other Person the right to
challenge any of the Transactions or to exercise any remedy or obtain any relief under any Law to
which Parent or Buyer may be subject.

     Section 3.4. Consents. No Consent of or filing with any Governmental Body or other Person is required in
connection with the execution or performance of this Agreement or the other Transaction Documents
by Parent or Buyer or the consummation by Parent or Buyer of the Transactions except for such
Consents or filings which have been obtained as of the date hereof or as to which the failure to
obtain or make would not adversely affect Parent’s or Buyer’s ability to consummate the
Transactions in any material respect.

     Section 3.5. Broker Fees. Parent has no Liability to pay any compensation to any broker, finder, or agent
with respect to the Transactions for which the Company could become directly or indirectly Liable.

     Section 3.6. Sufficient Funds. As of (i) the date hereof, (ii) the Equity Closing Date, and (iii) the
Merger Closing Date, Buyer has and will have sufficient funds to consummate the Transactions.

ARTICLE IV.

REPRESENTATIONS AND WARRANTIES

OF THE SELLERS

     Except as is provided in the disclosure letter delivered at or prior to the execution of this
Agreement by the Sellers (the “Sellers Disclosure Schedule”), each Seller, solely as to itself,
represents and warrants, severally and not jointly, to Parent and Buyer as follows:

     Section 4.1. Status of Certain Sellers. Each Seller that is an entity is duly created, formed or
organized, validly existing and in good standing under the laws of the jurisdiction of its
creation, formation or organization. There is no pending or Threatened Action for the dissolution,
liquidation, insolvency, or rehabilitation of any Seller.

     Section 4.2. Power and Authority; Enforceability. Each Seller that is an entity has the entity
power and authority to execute and deliver this Agreement and each other Transaction Document to
which such Seller is a party, and to perform and consummate the Transactions. Each Seller that is
an individual has the requisite competence and authority to execute and deliver this Agreement and
each other Transaction Document to which such Seller is a party, and to perform and to consummate
the Transactions. Each Seller has taken all action necessary to

17

 

authorize the execution and delivery of this Agreement and each other Transaction Document to
which it is a party, the performance of such Seller’s obligations thereunder, and the consummation
of the Transactions. This Agreement and each other Transaction Document has been duly authorized,
executed and delivered by each Seller, if such Seller is a party thereto, and constitutes the
legal, valid and binding obligation of each Seller that is a party thereto, enforceable against
such Seller in accordance with its terms, in each case subject to applicable bankruptcy, insolvency
and similar laws affecting the enforceability of creditors’ rights generally, general principles of
equity, the discretion of courts in granting equitable remedies and matters of public policy.

     Section 4.3. No Violation. The execution and the delivery of the Transaction Documents to which
each Seller is a party and the performance and consummation of the Transactions by each such Seller
will not (i) Breach any Law to which such Seller is subject, and in respect of any Seller that is
an entity, any provision of such Seller’s Organizational Documents, (ii) Breach in any material
respect any material Contract to which such Seller is a party or by which such Seller is bound,
(iii) require any Consent, except (A) any SEC and other filings required to be made by such Seller,
and (B) any notifications or filings to any relevant state or federal regulatory agencies, (iv)
give any Governmental Body or other Person the right to challenge any of the Transactions or to
exercise any remedy or obtain any relief under any Law to which such Seller may be subject, or (v)
result in the imposition or creation of any Encumbrance, other than restrictions on transfer
generally arising under federal and state securities Laws, upon or with respect to the Seller
Shares or the Seller Options.

     Section 4.4. Brokers’ Fees. The Sellers have no Liability to pay any brokers’ or finders’ fee or
any other commission or similar fee or other compensation to any broker, finder, or agent with
respect to the Transactions for which Parent, Buyer or any Acquired Entity could become directly or
indirectly Liable.

     Section 4.5. Equity Interests; Seller Information. Each Seller holds of record and beneficially
owns the number of shares of Company Common Stock and Company Options set forth next to such
Seller’s name in Schedule A, free and clear of any Encumbrances (other than any
restrictions under the Securities Act and state securities laws). With respect to each Seller,
Schedule A also sets forth the exercise price of each Company Option held by such Seller,
the address, state of residence, and federal tax identification number (or social security number,
as applicable) of such Seller as of the date hereof. No Seller is a party to any (i) Contract that
requires such Seller to sell, transfer, or otherwise dispose of the shares of Company Common Stock
or Company Options held by such Seller (other than this Agreement) or (ii) except as set forth in
Section 4.5 of the Sellers Disclosure Schedule, other Contract with respect to any Equity
Interests of the Company. Except with respect to the Escrowed Shares, at the Equity Closing, upon
delivery by Parent to the Sellers of the Per Share Purchase Price in accordance with Section
2.4(b)(i), each Seller will transfer its entire right, title and interest in and to all shares
of Company Common Stock and Company Options held of record or beneficially owned by such Seller to
Buyer and Buyer shall acquire valid and marketable title to the Sellers’ Shares owned by each
Seller, free and clear of any Encumbrances (other than any restrictions under the Securities Act
and state securities laws).

18

 

     Section 4.6. Litigation. No Seller is a party to, the subject of, or Threatened to be made a party to or the
subject of any Action, relating to, in connection with, or challenging, any of the Transactions.

ARTICLE V.

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

CONCERNING THE ACQUIRED ENTITIES

     Except as is provided in the disclosure letter delivered at or prior to the execution of this
Agreement by the Company (the “Company Disclosure Schedule”), the Company represents and warrants
to Parent and Buyer as follows:

     Section 5.1. Corporate Status. Each Acquired Entity is an entity duly created, formed or organized,
validly existing, and in good standing under the Laws of the jurisdiction of its creation,
formation, or organization. Except as set forth in Section 5.1 of the Company Disclosure
Schedule, each Acquired Entity is duly authorized to conduct its business and is in good standing
under the laws of each jurisdiction where such qualification is required. Each Acquired Entity has
the requisite power and authority necessary to own or lease its properties and to carry on its
businesses as currently conducted.

     Section 5.2. Power and Authority; Enforceability. The Company has the corporate power and authority to
execute and deliver this Agreement, the Merger Agreement, and each other Transaction Document to
which it is a party and to perform and consummate the Merger and the Transactions. The Company has
taken all action necessary to authorize the execution and delivery of this Agreement, the Merger
Agreement and each other Transaction Document to which it is a party, the performance of its
obligations hereunder and thereunder, and the consummation of the Transactions. Without limiting
the generality of the foregoing, the board of directors of the Company, at a meeting duly called
and held, unanimously adopted resolutions (a) determining that the Merger is fair and in the best
interests of the Company, the stockholders of the Company and the holders of Company Options, (b)
approving and declaring advisable this Agreement, the Merger Agreement and the Transaction
Documents to which the Company is a party, the Merger and the Transactions, (c) directing that the
Merger Agreement and the Merger be submitted to the Company’s stockholders for their adoption and
approval, and (d) recommending that the Company’s stockholders vote or provide a written consent in
favor of the adoption of the Merger Agreement and the approval of the Merger and the consummation
of the Transactions. In connection with obtaining the Stockholder Consent, the Company did not,
and did not request that any Person, engage in a solicitation (as such term is defined in the
Exchange Act) and the Company complied with all applicable state Law relating to obtaining the
Stockholder Consent. The Stockholder Consent is the only vote or approval of the holders of any
class or series of capital stock of the Company and any Acquired Entity which is necessary to adopt
the Merger Agreement, and approve and consummate the Merger and the Transactions. This Agreement,
the Merger Agreement, and each other Transaction Document to which the Company is a party has been
duly authorized, executed and delivered by the Company, and constitutes the legal, valid and
binding obligation of the Company, if a party thereto, and is enforceable against the Company in
accordance with its terms, in each case subject to applicable bankruptcy, insolvency and similar
laws affecting the enforceability of creditors’ rights generally,

19

 

general principles of equity, the discretion of courts in granting equitable remedies and
matters of public policy.

     Section 5.3. No Violation. The execution and the delivery by the Company of this Agreement, the Merger
Agreement, and the Transaction Documents to which the Company is a party and the performance of the
Company’s obligations thereunder, and consummation of the Transactions by the Company will not (a)
Breach any Law to which any Acquired Entity is subject or any provision of the Organizational
Documents of any Acquired Entity, (b) Breach any Contract identified on Section 5.18(a) of
the Company Disclosure Schedule, or Permit listed on Section 5.13(b) of the Company
Disclosure Schedule, (c) other than as set forth on Section 5.3 of the Company Disclosure
Schedule, require any Consent, (d) Breach any resolution adopted by the board of directors or the
stockholders of the Company, (e) give any Governmental Body or other Person the right to challenge
any of the Transactions or to exercise any remedy or obtain any relief under any Law to which the
Acquired Entities may be subject, or (f) result in the imposition or creation of any Encumbrance
upon or with respect to any of assets of the Acquired Entities.

     Section 5.4. Brokers’ Fees. Except as set forth in Section 5.4 of the Company Disclosure Schedule,
the Acquired Entities do not have any Liability to pay any brokers or finder’s fee or any other
commission or similar fee or other compensation to any broker, finder, or agent with respect to the
Transactions for which the Parent, Buyer or the Acquired Entities could become directly or
indirectly Liable.

     Section 5.5. Capitalization.

               (a) The authorized capital stock of the Company consists of 90,000,000 shares of Company
Common Stock, par value $0.0001 per share, and 10,000,000 shares of the Company’s preferred stock,
par value $0.0001 per share (the “Preferred Stock”). As of the close of business on the date of
this Agreement, (i) 23,753,460 shares of Company Common Stock were issued and outstanding, (ii) no
shares of Preferred Stock were issued and outstanding, and (iii) 1,361,574 shares of Company
Common Stock were held as treasury shares. As of the close of business on the date of this
Agreement there were (A) 2,349,013 shares of Company Common Stock authorized and reserved for
future issuance under any Company Plans, (B) 17,589,147 shares of Company Common Stock authorized
and reserved for issuance upon conversion of convertible notes, and (C) 19,578,275 shares of
Company Common Stock authorized and reserved for issuance upon exercise of Company Options. No
Equity Interests or Commitments have been issued, reserved for issuance or are outstanding, other
than or pursuant to the Company Options and convertible notes referred to above that are
outstanding as of the date of this Agreement. Except as set forth on Section 5.5(a) of the
Company Disclosure Schedule, there are no Contracts with respect to the voting or transfer of the
Company’s Equity Interests. Other than as set forth on Section 5.5(a) of the Company
Disclosure Schedule, no Commitments exist or are authorized with respect to the Equity Interests of
the Company and no Commitments will arise in connection with the Transactions.

               (b) Upon consummation of the Equity Closing and assuming that the Company will have redeemed
all warrants to purchase shares of Company Common Stock with an exercise price of $0.10 per share
outstanding as of the Equity Closing, Buyer shall own of

20

 

record and beneficially, at least 51.0% of the Company Common Stock calculated on a
fully-diluted basis.

     Section 5.6. Company Subsidiaries. Section 5.6 of the Company Disclosure Schedule lists the
Company Subsidiaries and for each Company Subsidiary, (i) its name and jurisdiction of organization
and each jurisdiction in which it is qualified to do business, and (ii) the number of authorized
Equity Interests of each class of its Equity Interests, (iii) the number of issued and outstanding
Equity Interests of each class of its Equity Interests, the names of the holders thereof, and the
number of Equity Interests held by each such holder, and (iv) the number of Equity Interests held
in treasury. All of the issued and outstanding Equity Interests of each Company Subsidiary have
been duly authorized and are validly issued, fully paid, and nonassessable. Except as set forth on
Section 5.6 of the Company Disclosure Schedule, the Acquired Entities hold of record and
own beneficially, and will on the Equity Closing Date be the record and beneficial owners and
holders of, all of the outstanding Equity Interests of the Company Subsidiaries, free and clear of
any Encumbrances (other than restrictions under the Securities Act and state securities Laws). No
Commitments to issue Equity Interests of any Company Subsidiary exist or are authorized. Neither
the Company nor any Company Subsidiary controls, directly or indirectly, or has any direct or
indirect Equity Interest, in any Person that is not a Company Subsidiary.

     Section 5.7. Records. The copies of the Acquired Entities’ Organizational Documents that were provided to
the Parent are accurate and complete and reflect all amendments made through the date hereof. The
Acquired Entities’ minute books and other records of the Acquired Entities made available to Parent
for review were correct and complete as of the date of such review in all material respects, no
further entries have been made through the date of this Agreement, such minute books and records
contain the true signatures of the persons purporting to have signed them, and such minute books
and records contain an accurate record of all actions of the stockholders, directors, members,
managers, or other such representatives of the Acquired Entities taken by written consent, at a
meeting, or otherwise in all cases since January 1, 2008.

      Section 5.8. SEC Documents.

          (a) The Company has filed all forms, documents, schedules, certifications, prospectuses,
reports, and registration, proxy and other statements, required to be filed or furnished by it with
or to the SEC since December 31, 2007 pursuant to the requirements of the Securities Act, the
Exchange Act, or the Sarbanes-Oxley Act, as the case may be, and the applicable rules and
regulations promulgated thereunder (the “Company SEC Documents”), which term shall include such
documents filed during such period on a voluntary basis on Form 8-K, and in each case including
exhibits and schedules thereto and documents incorporated by reference therein. None of the
Company Subsidiaries is required to file periodic reports with the SEC pursuant to the Exchange
Act. As of their respective effective dates (in the case of Company SEC Documents that are
registration statements filed pursuant to the requirements of the Securities Act), and as of their
respective filing dates with the SEC (in the case of all other Company SEC Documents), or in each
case, if amended prior to the date hereof, as of the date of the last such amendment, the Company
SEC Documents complied in all material respects, and all documents filed by the Company between the
date of this Agreement and the date of the Equity Closing shall comply in all material respects,
with the requirements of the Securities Act,

21

 

the Exchange Act or the Sarbanes-Oxley Act, as the case may be, and the applicable rules and
regulations promulgated thereunder, and none of the Company SEC Documents at the time they were
filed or, if amended, as of the date of such amendment contained, or if filed after the date hereof
will contain, any untrue statement of a material fact or omitted to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, or are to be made, not misleading. The Company has made
available to Parent a complete and correct copy of any material amendments or modifications which,
to the Company’s Knowledge, are required to be filed with the SEC, but have not yet been filed with
the SEC, with respect to (i) agreements which previously have been filed by the Company with the
SEC pursuant to the Securities Act or the Exchange Act and (ii) the Company SEC Documents filed
prior to the date hereof. As of the date of this Agreement, there are no outstanding or unresolved
comments received from the SEC staff with respect to the Company SEC Documents.

          (b) The consolidated financial statements (as restated prior to the date hereof, if
applicable, and including all related notes and schedules) of the Company included in the Company
SEC Documents fairly present in all material respects the consolidated financial position of the
Company and its consolidated subsidiaries as at the respective dates thereof and their consolidated
results of operations and consolidated cash flows for the respective periods then ended (subject,
in the case of the unaudited statements, to normal year-end audit adjustments and to any other
adjustments described therein including the notes thereto) in conformity with GAAP (except, in the
case of the unaudited statements, as permitted by the rules related to Quarterly Reports on Form
10-Q promulgated under the Exchange Act) applied on a consistent basis during the periods involved
(except as may be indicated therein or in the notes thereto).

     Section 5.9. Financial Statements. The Financial Statements (i) have been prepared in accordance with GAAP
consistently applied throughout the periods covered thereby, (ii) present fairly the financial
condition and results of operation of the Acquired Entities, changes in stockholders’ equity and
cash flows of the Acquired Entities, as of the respective dates of and for the periods referred to
in the Financial Statements, (iii) are correct and complete in all material respects, and (iv) are
consistent with the books and records of the Acquired Entities. Since the Balance Sheet Date, none
of the Acquired Entities has effected any change in any method of accounting or accounting
practice, except for only such change required pursuant to GAAP.

     Section 5.10. Liabilities. The Acquired Entities do not have any Liabilities, whether or not required by
GAAP to be reflected or reserved against on a balance sheet, other than (a) Liabilities provided
for or reserved against in the Financial Statements, (b) or Liabilities incurred in the Ordinary
Course of Business since the Balance Sheet Date. None of the Liabilities described above relates
to or has arisen out of a breach of contract, breach of warranty, tort or infringement by or
against any Acquired Entity or any Action involving any Acquired Entity.

     Section 5.11. Subsequent Events. Except as set forth in Section 5.11 of the Company Disclosure
Schedule, since the Balance Sheet Date, the Acquired Entities have operated in the Ordinary Course
of Business and there have been no events, series of events or the lack of

22

 

occurrence thereof
which, singularly or in the aggregate could reasonably be expected to have a
Material Adverse Effect on the Acquired Entities taken as a whole. Without limiting the
foregoing, since the Balance Sheet Date, none of the following have occurred:

               (a) There has been no amendment, alteration or modification in the terms of any currently
outstanding Equity Interests of any Acquired Entity or any securities convertible into or
exchangeable for such Equity Interests, including without limitation any reduction in the exercise
or conversion price of any such rights or securities, any change to the vesting or acceleration
terms of any such rights or securities, or any change to terms relating to the grant of any such
rights or securities;

               (b) Except as set forth in Section 5.11(b) of the Company Disclosure Schedule, no
Acquired Entity has issued, sold, or otherwise disposed of any of its Equity Interests;

               (c) There has not been any material closure, shut down, merger or elimination of any of the
Veterinary Hospitals, offices, facilities or any other change in the character of the Company, or
the properties or assets of the Acquired Entities;

               (d) No Acquired Entity has experienced any material damage, destruction or loss with respect
to any of its properties or assets, whether or not covered by insurance;

               (e) No Acquired Entity has suffered any taking or seizure of all or any part of its properties
or assets by condemnation or eminent domain;

               (f) Except as set forth in Section 5.11(f) of the Company Disclosure Schedule, no
Acquired Entity has sold, leased, transferred, or assigned any assets material to the business of
such Acquired Entity;

               (g) No Acquired Entity has cancelled, compromised, waived or released any Action (or series of
related Actions) either involving more than $15,000 or outside the Ordinary Course of Business;

               (h) No Acquired Entity has granted any Contracts or any rights under or with respect to any
Intellectual Property, except in the Ordinary Course of Business;

               (i) Except as set forth in Section 5.11(i) of the Company Disclosure Schedule, no
Acquired Entity has entered into any Contract (or series of related Contracts) either involving
more than $15,000 or outside the Ordinary Course of Business, without the prior approval in writing
of Parent;

               (j) Except as set forth in Section 5.11(j) of the Company Disclosure Schedule, no
Acquired Entity has made or committed to make any capital expenditure (or series of related capital
expenditures) involving more than $15,000 individually, $100,000 in the aggregate, or outside the
Ordinary Course of Business.

23

 

               (k) Except as set forth in Section 5.11(k) of the Company Disclosure Schedule, no
Acquired Entity has paid or committed to pay any bonus or granted any increase in
the base compensation (i) of any director or officer of the Company, or (ii) outside of the
Ordinary Course of Business, of any of its other employees;

               (l) Except as set forth in Section 5.11(l) of the Company Disclosure Schedule, no
Acquired Entity has entered into any employment (other than at-will employment arrangements
terminable without the payment of any severance or other non-statutory obligation), collective
bargaining, or similar Contract or modified the terms of any such existing Contract;

               (m) No Acquired Entity has made any other change in employment terms (i) of any director or
officer of the Company, or (ii) outside of the Ordinary Course of Business, of any of its other
employees;

               (n) Except as set forth in Section 5.11(n) of the Company Disclosure Schedule, no
Acquired Entity has made any loan to, or entered into any other transaction with, any of its
directors, officers, or employees;

               (o) No Acquired Entity has adopted, amended, modified, terminated or increased the payments,
or benefits under, any Company Plan;

               (p) No Acquired Entity has entered into, terminated or received notice of termination of (i)
any license, distributorship, dealer, sales representative, joint venture, credit or similar
Contract to which such Acquired Entity is a party that is material to the business of such Acquired
Entity, or (ii) any Contract or transaction involving a total remaining commitment by such Acquired
Entity of at least $15,000;

               (q) Except as set forth in Section 5.11(q) of the Company Disclosure Schedule, no
Acquired Entity has received written notification or other written communication from any landlord,
insurance company, material customer or material supplier of an intention to discontinue or change
in a material respect the terms of its relationship with such Acquired Entity and, to the Knowledge
of the Company, no such Person has Threatened to discontinue or change in a material respect the
terms of its relationship with such Acquired Entity;

               (r) No Encumbrance, other than Permitted Encumbrances, has been imposed on any of the material
assets of any Acquired Entity;

               (s) Except as set forth in Section 5.11(s) of the Company Disclosure Schedule, there
has not been any material change in accounting methods used by the Company, except for any such
change required because of a concurrent change in GAAP;

               (t) No Acquired Entity has made any capital investment in, any loan to, or any acquisition of
the securities or assets of, any Person involving more than $15,000 singularly, $100,000 in the
aggregate, or outside the Ordinary Course of Business;

               (u) Except as set forth in Section 5.11(u) of the Company Disclosure Schedule, no
Acquired Entity has issued any note, bond, or other debt security or created,

24

 

incurred, assumed, or
guaranteed any Liability for borrowed money either involving more than $10,000 singularly or
$50,000 in the aggregate;

               (v) No Acquired Entity has waived any right, forgiven any debt or released any claim relating
to the business of any Acquired Entity;

               (w) Except as set forth in Section 5.11(w) of the Company Disclosure Schedule, and
except in the Ordinary Course of Business, there has not been any amendment or termination of any
Contract set forth in Section 5.18(a) of the Company Disclosure Schedule or any waiver,
release or assignment of any material rights or claims thereunder;

               (x) There has not been any failure to operate, maintain, repair or otherwise preserve the real
property or the personal property owned or leased by any Acquired Entity consistent with past
practice and in compliance in all material respects with all applicable Laws and requirements of
all applicable Contracts;

               (y) Except as set forth in Section 5.11(y) of the Company Disclosure Schedule, no
Acquired Entity has delayed or postponed payment for more than ninety (90) days to any vendor with
respect to any accounts payables or other liabilities owing to such vendor either involving more
than $10,000 (individually or in the aggregate) or outside the Ordinary Course of Business;

               (z) There has been no change in the manner of collection of the accounts receivable;

               (aa) No Acquired Entity has made or revoked any material tax election, except as required by
applicable Law.

               (bb) There has been no amendment, modification or change (or authorization thereof) to the
Organizational Documents of any Acquired Entity;

               (cc) Except as set forth in Section 5.11(cc) of the Company Disclosure Schedule, no
Acquired Entity has made any payment on any Debt prior to the date such payment was due;

               (dd) Except as set forth in Section 5.11(dd) of the Company Disclosure Schedule, no
Acquired Entity has changed, or permitted any change, in the operating hours or any Veterinary
Hospital or the hours to be worked by any veterinarian at any Veterinary Hospital

               (ee) No Acquired Entity has failed to maintain any of the Permits required by it to operate in
the Ordinary Course of Business

               (ff) Except as set forth in Section 5.11(ff) of the Company Disclosure Schedule, there
has not been any amendment, termination or expiration of any Facility Lease or any waiver, release
or assignment of any material rights or claims thereunder; and

               (gg) No Acquired Entity has committed to any of the foregoing.

25

 

     Section 5.12. Availability, Title to, and Condition of Assets.

               (a) Subject to the Permitted Encumbrances, the Acquired Entities have good and indefeasible
title to, or a valid leasehold interest in, all buildings, machinery, equipment, land and other
tangible assets that are used by the Acquired Entities (i) including all buildings, machinery,
equipment, land and other tangible assets that are reflected on the Financial Statements, or
acquired after the Balance Sheet Date, and (ii) including all assets used by the Acquired Entities
except for assets which are immaterial to the conduct of the Acquired Entities’ business. Upon the
consummation of the Transactions, the Acquired Entities will retain the right to use, and a valid
leasehold interest in, all the assets used in the Acquired Entities’ business consisting of
leasehold interests, subject to the terms of such leasehold interests.

               (b) All buildings, machinery, equipment, land and other tangible assets used by the Acquired
Entities, whether owned or leased, have been maintained in accordance with normal industry
practice, consistent with past practice and in compliance in all material respects with all
applicable Laws and requirements of all applicable Contracts, are in good repair and operating
condition (subject to normal wear and tear), and are suitable for the purposes for which they are
presently used. All such buildings, machinery, equipment, and other tangible assets are (i) in the
possession of the Acquired Entities and (ii) to the extent owned by the Acquired Entities are, or
to the extent leased or otherwise utilized pursuant to Contract such leases or Contract are, free
and clear of all Encumbrances, other than Permitted Encumbrances.

     Section 5.13. Legal Compliance.

               (a) The Acquired Entities have complied in all material respects with all applicable Laws in
connection with the operation of their respective businesses, and no Action is pending or, to the
Knowledge of the Company Threatened against any Acquired Entity alleging any failure to so comply.

               (b) Section 5.13(b) of the Company Disclosure Schedule lists all Drug Enforcement
Agency licenses, premise permits and veterinary licenses required for the operation of the
respective businesses of the Company and the Company Subsidiaries as presently conducted. The
Company and the Company Subsidiaries possess all Permits material to the operation of their
respective businesses as presently conducted, all such Permits are in full force and effect and no
suspension or cancellation is, to the Knowledge of the Company Threatened. To the Knowledge of the
Company, no event has occurred or circumstance exists that (with or without notice or lapse of
time) constitutes or will result in a violation by the Company or any Company Subsidiary of, or a
failure on the part of the Company or any Company Subsidiary to comply in any material respect
with, any applicable Law with respect to their respective businesses. Each Permit listed or
required to be listed in Section 5.13(b) of the Company Disclosure Schedule is valid and in
full force and effect. Except as set forth in Section 5.13(b) of the Company Disclosure
Schedule:

                    (i) The Company and each Company Subsidiary is, and at all times since January 1, 2009 has
been, in full compliance with all of the terms and requirements of each Permit identified or
required to be listed in Section 5.13(b) of the Company Disclosure Schedule;

26

 

                    (ii) No event has occurred or circumstance exists that may (with or without notice or lapse of
time) (A) constitute or result in a violation of or a failure to comply with any material term or
requirement of any Permit listed or required to be listed in Section 5.13(b) of the Company
Disclosure Schedule or (B) result in the revocation, withdrawal, suspension, cancellation or
termination of, or any modification to, any Permit listed or required to be listed in Section
5.13(b) of the Company Disclosure Schedule;

                    (iii) Since January 1, 2009 neither the Company nor any Company Subsidiary has received any
written notice or other communication from any Governmental Body or any other Person regarding (A)
any actual or alleged violation of or failure to comply with any material term or requirement of
any Permit or (B) any actual or proposed revocation, withdrawal, suspension, cancellation,
termination of or modification to any Permit; and

                    (iv) All applications required to have been filed for the renewal of the Permits listed or
required to be listed in Section 5.13(b) of the Company Disclosure Schedule have been duly
filed on a timely basis with the appropriate Governmental Bodies, and all other filings required to
have been made with respect to such Permits have been duly made on a timely basis with the
appropriate Governmental Bodies.

     Section 5.14. No Change of Control Provision. Except as set forth in Section 5.14 of the Company Disclosure Schedule, no Acquired
Entity is a party or subject to any Contract which would require the making of any payment, other
than payment of the Per Share Purchase Price as contemplated by this Agreement, to any employee of
any Acquired Entity or to any other Person as a result of the consummation of the Transactions, and
no employee of any Acquired Entity will accrue additional benefits, severance or accelerated rights
to payment of benefits as a result of the consummation of the Transactions (either alone or
combined with any other event or transaction), excluding, in each case, any payment or accrual of
benefits or severance triggered solely by a termination of an employee without cause by the Company
without giving effect to the consummation of the Transactions.

     Section 5.15. Tax Matters.

               (a) Except as set forth on Section 5.15(a) of the Company Disclosure Schedule, with
respect to all Tax Returns that are required to be filed by or with respect to each Acquired
Entity:

                    (i) such Tax Returns have been duly and timely filed and all such Tax Returns are true,
complete and correct in all material respects;

                    (ii) all material Taxes have been paid in full or where payment is not yet due reserved in the
Financial Statements in accordance with GAAP; and

                    (iii) all material deficiencies asserted or assessments made as a result of any examinations
of any Acquired Entity have been paid in full other than those being contested in good faith by
appropriate proceedings and for which adequate reserves have been established and reflected in the
Financial Statements in accordance with GAAP.

27

 

               (b) Section 5.15(b) of the Company Disclosure Schedule contains a list of all federal
or state income and franchise Tax Returns and all material local and foreign Tax Returns filed with
respect to the Company with regard to any Tax imposed on the Company for taxable periods ending on
or after January 1, 2007.

               (c) Except as set forth on Section 5.15(c) of the Company Disclosure Schedule, no
Acquired Entity currently is the beneficiary of any extension of time within which to file any Tax
Return.

               (d) To the Knowledge of the Company, no taxing authority has a basis upon which to assess any
additional Taxes for any period for which Tax Returns have been filed.

               (e) There is no material Encumbrances for Taxes upon any Acquired Entity’s assets and
properties other than Permitted Encumbrances.

               (f) Each Acquired Entity has withheld and paid over to the appropriate taxing authority all
Taxes which it is required to withhold from amounts paid or owing to any employee, holders of
Equity Interests or other third party.

               (g) No Audit in respect of any Tax Liability is pending with respect to any Tax Liability
shown on a Tax return filed by any Acquired Entity. No information related to Tax matters has been
requested by any foreign, federal, state, or local taxing authority, nor has any such tax authority
notified any Acquired Entity of its intent to open an Audit or other review. To the Knowledge of
the Company, there are no material unresolved claims asserted by any taxing authority concerning
the Acquired Entities’ Tax Liabilities.

               (h) No Acquired Entity has made any payments, is obligated to make any payments or is a party
to an agreement that could obligate it to make any payments that would not be deductible under Code
Section 280G or Code Section 162(m), or any corresponding provision of state, local or foreign Tax
law.

               (i) Since January 1, 2008, no claim has been made to any Acquired Entity by any taxing
authority in a jurisdiction where such Acquired Entity does not file a Tax Return that any Acquired
Entity may be subject to Taxes assessed by such jurisdiction.

               (j) No Acquired Entity has requested nor received an adverse ruling from any taxing authority
or signed a closing or other agreement with any taxing authority.

               (k) No Acquired Entity has been granted any extension or waiver of the statute of limitations
period applicable to any Tax Return or within which any Tax may be assessed or collected by any
taxing authority, which period (after giving effect to such extension or waiver) has not yet
expired.

               (l) The applicable statute of limitations for the assessment of Taxes for taxable periods
ending before December 31, 2001 has expired and no Acquired Entity has waived or agreed to the
extension of the applicable statute of limitations.

28

 

               (m) No Acquired Entity is a party to, or bound by, nor has any obligation under, any Tax
sharing agreement, Tax indemnification agreement or similar contract or arrangement. All such Tax
sharing agreements, Tax indemnification agreements or similar Contracts or arrangements have been
or will be cancelled effective as of the Equity Closing Date.

               (n) No Acquired Entity has distributed the stock of another Person, or has not had its stock
distributed by another Person, in a transaction that was purported or intended to be governed in
whole or in part by Sections 355 or 361 of the Code.

               (o) No Acquired Entity has participated in any “reportable transaction” as defined in Section
6707A of the Code or Treasury Regulation Section 1.6011-4 (or any predecessor provision).

               (p) Except as set forth on Section 5.15(p) of the Company Disclosure Schedule, no
Acquired Entity has been a member of an affiliated, consolidated, combined or unitary group or
participated in any other arrangement whereby any income, revenues, receipts, gain or loss was
determined or taken into account for Tax purposes with reference to or in conjunction with any
income, revenues, receipts, gain, loss, asset or liability of any other Person other than a group
of which the Company was the parent. No Acquired Entity has liability for the Taxes of any Person
(other than an Acquired Entity) under Treasury Regulation Section 1.1502-6 (or any similar
provision of state, local or foreign Law), as a transferee or successor, by contract, or otherwise.

               (q) No Acquired Entity is or has been a United States real property holding company as defined
in Section 897(c)(2) of the Code.

               (r) No Acquired Entity has unpaid Tax liabilities with respect to the income, property and
operations of the Acquired Entities, except for Tax liabilities (i) reflected in the Financial
Statements or (ii) that have arisen after the date of the Financial Statements in the Ordinary
Course of Business and in a manner consistent with prior periods.

               (s) No Acquired Entity will be required to include any item of income in, or exclude any item
of deduction from, taxable income for any period ending on or after the Equity Closing Date (i)
under Section 481 of the Code (or any similar provisions of state, local or foreign Law) as a
result of change in method of accounting for a Pre-Closing Tax Period, (ii) pursuant to the
provisions of any agreement entered into with any Taxing Authority or pursuant to a “closing
agreement” as defined in Section 7121 of the Code (or any similar provisions of state, local or
foreign Law) executed on or prior to the Equity Closing Date, (iii) the installment method of
accounting, the completed contract method of accounting or the cash method of accounting with
respect to a transaction that occurred prior to the Equity Closing Date, (iv) any prepaid amount
received on or prior to the Equity Closing Date, (v) under Section 1502 (or any corresponding or
similar provision of state, local or foreign Tax law) with respect to an intercompany transaction
or excess loss account or (vi) under Section 108(i) of the Code as a result of the discharge of any
Debt on or prior to the Equity Closing Date.

               (t) Each Acquired Entity has previously delivered or made available to Parent complete and
accurate copies of each of: (i) all Audit reports, letter rulings, technical

29

 

advice memoranda and similar documents issued by a taxing authority relating to the federal,
state, local or foreign Taxes due from or with respect to such Acquired Entity, (ii) the federal
income Tax Returns, and those state, local and foreign income Tax Returns filed by such Acquired
Entity, and (iii) any closing agreement entered into by such Acquired Entity with any taxing
authority in each case existing as of the Equity Closing Date and relating to periods subsequent to
January 1, 2007. The Company shall and shall cause each Company Subsidiary to deliver to Parent
all materials with respect to the foregoing for all matters arising after the Equity Closing Date.

     Section 5.16. Real Property and Leaseholds.

               (a) Section 5.16(a) of the Company Disclosure Schedule sets forth a true, correct and
complete list of (i) each parcel of real property owned by any Acquired Entity in fee simple (the
“Owned Real Estate”) and (ii) each parcel of real property in which any Acquired Entity has a
leasehold interest, as tenant (the “Leased Real Estate”). The Owned Real Estate and the Leased
Real Estate constitute all real properties used or occupied by the Acquired Entities in conducting
their business.

               (b) With respect to the Owned Real Estate required to be listed in Section 5.16(a) of
the Company Disclosure Schedule:

                    (i) the identified owner has good, marketable, and indefeasible fee simple title to the Owned
Real Estate, free and clear of any Encumbrance except for Permitted Encumbrances;

                    (ii) Section 5.16(a) of the Company Disclosure Schedule contains accurate and complete
copies of all title reports and title policies any Acquired Entity has obtained with respect to the
Owned Real Estate;

                    (iii) there are no pending or Threatened Actions (or any basis therefor) relating to the
property or other matters affecting adversely the current use, occupancy, or value thereof;

                    (iv) the legal description for the Owned Real Estate contained in the deed thereof describes
such Owned Real Estate fully and adequately, all the buildings and improvements thereon are located
within the boundary lines of the described parcels of land, are not in violation of applicable
setback requirements or zoning Laws, and do not encroach on or violate any easement or Encumbrance
which may burden the land, and the land does not serve any adjoining property for any purpose
inconsistent with the use of the land, and the property is not located within any flood plain or
subject to any similar type restriction for which any Permits necessary to use it have not been
obtained;

                    (v) there are no Contracts granting to any Person the right of use or occupancy of any portion
of the Owned Real Estate;

                    (vi) there are no Contracts to purchase the Owned Real Estate, or any portion thereof, or
interest therein;

30

 

                    (vii) there are no Persons (other than the Acquired Entities) in possession of the Owned Real
Estate, other than tenants under any leases disclosed in Section 5.16(a) of the Company
Disclosure Schedule;

                    (viii) all facilities located on the Owned Real Estate are supplied with utilities and other
services necessary for the operation of the Acquired Entities’ business, including gas,
electricity, water, telephone, sanitary sewer or septic system, and storm sewer or other on-site
storm water management system, all of which services are adequate in accordance with all applicable
Laws and are provided via public roads or via permanent, irrevocable, appurtenant easements
benefiting the Owned Real Estate; and

                    (ix) the Owned Real Estate abuts on and has direct vehicular access to a public road, or has
access to a public road via a permanent, irrevocable, appurtenant easement benefiting the Owned
Real Estate, and access to the property is provided by paved public right-of-way with adequate curb
cuts available.

               (c) With respect to the Leased Real Estate required to be listed in Section 5.16(a) of
the Company Disclosure Schedule and except as set forth in Section 5.16(a) of the Company
Disclosure Schedule:

                    (i) the Company has delivered or made available to Parent true, correct and complete copies of
each lease, license and other documents and amendments thereto by which the Acquired Entities
occupy each parcel of Leased Real Estate (each set of such documents is referred to herein as a
“Facility Lease”). Section 5.16(a) of the Disclosure Schedule sets forth a true and
correct description of each Facility Lease and for each Facility Lease sets forth (i) the start
date, (ii) the expiration date, (iii) the remaining renewal terms and (iv) the lease or other
payments due and payable as of the date of this Agreement under each Facility Lease, including,
without limitation, any base rents and additional rents (i.e., operating expenses, parking costs,
option rent, percentage rent);

                    (ii) to the Knowledge of the Company, all fees, tenant improvement allowances and other
landlord concessions under each Facility Lease have been paid or performed in full;

                    (iii) none of the Facility Leases prohibit the use of the Leased Real Estate for the purposes
each is currently used for, including, as applicable, veterinary services and, to the Knowledge of
the Company, no circumstances exist that would now or in the future limit such uses of any Leased
Real Estate;

                    (iv) all facilities located on the Leased Real Estate are supplied with utilities and other
services necessary for the operation of the Acquired Entities’ business, including gas,
electricity, water, telephone, sanitary sewer or septic system, and storm sewer or other on-site
storm water management system, all of which services are adequate in accordance with all applicable
Laws and are provided via public roads or via permanent, irrevocable, appurtenant easements
benefiting the Leased Real Estate;

31

 

                    (v) no Acquired Entity has granted to any Person any right, option, right of first offer or
right of first refusal to lease, sublease, use or occupy all or part of any Leased Real Estate;

                    (vi) no commission or other payment is due any real estate broker by any Acquired Entity in
connection with the leasing of any of the Leased Real Estate, and there are no agreements, oral or
written, under which any real estate broker is entitled to any future payment or commission by any
Acquired Entity in connection with the leasing of the Leased Real Estate to such Acquired Entity;
and

                    (vii) no Acquired Entity has pledged, encumbered or hypothecated its right, title or interest
in or to any Facility Lease or any Leased Real Estate other than Permitted Encumbrances.

     Section 5.17. Intellectual Property.

               (a) The Acquired Entities own or have the right to use pursuant to an enforceable Contract all
Intellectual Property necessary to operate the Acquired Entities’ business as currently conducted.
Each item of Intellectual Property that the Acquired Entities owned or used immediately prior to
the Equity Closing will be owned or available for use by the Acquired Entities on identical terms
and conditions immediately subsequent to the Equity Closing. Section 5.17(a) of the
Company Disclosure Schedule sets forth a complete list of all Intellectual Property that are
material to the operation of the Acquired Entities’ business.

               (b) To the Knowledge of the Company, the conduct by the Acquired Entities of the Acquired
Entities’ business does not infringe upon, misappropriate or conflict in any material respect with
any Intellectual Property right of any Person, and there are no pending or, to the Knowledge of the
Company, Threatened claims alleging that the conduct of the Acquired Entities’ business infringes
upon, misappropriates or conflicts in any material respect with the Intellectual Property rights of
any Person (including any claim that the Acquired Entities shall license or refrain from using any
other Person’s Intellectual Property).

     Section 5.18. Contracts.

               (a) Section 5.18(a) of the Company Disclosure Schedule lists:

                    (i) each Facility Lease;

                    (ii) each capital lease, note payable, or other contract for borrowed money to which any
Acquired Entity is a party or is otherwise bound ;

                    (iii) Contracts to which any Acquired Entity is a party or is otherwise bound not made in the
Ordinary Course of Business;

                    (iv) each joint venture, partnership, management and other Contract to which any Acquired
Entity is a party, or is otherwise bound that involves a sharing of profits, losses, costs or
Liabilities by such Acquired Entity with any other Person;

32

 

                    (v) each Contract to which any Acquired Entity is a party, or is otherwise bound, providing
for payments to any Person (other than any Acquired Entity) based on sales, purchases or profits
other than Contracts or commitments that can or in reasonable probability will be completed within
thirty (30) days of the Equity Closing Date or can be terminated within such thirty (30) day period
without payment of a penalty in excess of $25,000;

                    (vi) all Contracts entered into by any Acquired Entity that provide for an aggregate payment
from such Acquired Entity in excess of $50,000 in any contract year other than Contracts or
commitments that can or in reasonable probability will be completed within thirty (30) days of the
Equity Closing Date or can be terminated within such thirty (30) day period without payment of a
penalty in excess of $15,000;

                    (vii) any Contract concerning confidentiality or non-competition that is in effect as of the
date of the Agreement; and

                    (viii) each contract with a veterinarian for the performance of services to the Acquired
Entities.

               (b) With respect to each Contract set forth on Section 5.18(a) of the Company
Disclosure Schedule, (i) the Contract is enforceable and in full force and effect, and has not been
terminated, canceled, amended or modified, (ii) the Contract will continue to be enforceable
following the consummation of the Transactions without modification to the terms thereof, (iii) no
Acquired Entity is in Breach of such Contract and the Company has no Knowledge of any Breach by any
other party thereto, and (iv) no party to the Contract has repudiated any provision of the
Contract. To the Knowledge of the Company, there are no renegotiations of, attempts to renegotiate
or outstanding rights to renegotiate any amounts paid or payable to any Acquired Entity under
current or completed Contracts set forth in Section 5.18(a) of the Company Disclosure
Schedule with any Person having the contractual or statutory right to demand or require such
renegotiation and no such Person has made written demand for such renegotiation. The Company has
delivered or made available to Parent true, correct and complete copies of each Contract set forth
in Section 5.18(a) of the Company Disclosure Schedule and all amendments and supplements
thereto.

     Section 5.19. Litigation.

               (a) Except as set forth in Section 5.19 of the Company Disclosure Schedule, no
Acquired Entity is (i) subject to any outstanding order, writ, injunction, judgment or decree of
any Governmental Body or (ii) a party to, the subject of, or is to the Knowledge of the Company,
Threatened to be made a party to or the subject of any Action.

               (b) To the Knowledge of the Company, no event has occurred or circumstance exists that is
reasonably likely to give rise to or serve as a basis for the commencement of any such Action.

     Section 5.20. Labor; Employees.

               (a) No Acquired Entity is a party to or bound by any collective bargaining contract, nor has
any it experienced any strikes, grievances, claims of unfair labor

33

 

practices, or other collective bargaining disputes, nor to the Knowledge of the Company, have
any been Threatened. To the Knowledge of the Company, no Acquired Entity has committed any unfair
labor practice (as determined under Law). To the Knowledge of the Company no organizational effort
is currently being made or Threatened by or on behalf of any labor union with respect to any
Acquired Entity’s employees. There is not pending and no Acquired Entity has been, to the
Knowledge of the Company, Threatened with, an investigation or proceeding under any Law or order
which prohibits discrimination, retaliation or harassment of employees or which requires
affirmative action regarding employment with respect to any Acquired Entity’s employees.

               (b) Section 5.20(b) of the Company Disclosure Schedule contains an accurate list of
(i) all employment Contracts between each Acquired Entity and the employees of such Acquired
Entity, other than Contracts which are terminable at will without any payment becoming due as a
result of such termination other than (x) severance payments pursuant to the Acquired Entities’
employment policies applicable to all similarly situated employees, and (y) payments that are
required by Law, and (ii) a list of all employee handbooks and/or manuals relating to the Acquired
Entities’ employees, true and complete copies of which have been made available to Parent.

               (c) Since January 1, 2008, the Acquired Entities have operated in material compliance with the
applicable provisions of the WARN Act or other similar Laws of any jurisdiction in connection with
any obligations with respect to persons employed by the Acquired Entities that arise prior to and
including the Equity Closing Date.

     Section 5.21. Employee Benefits.

               (a) Section 5.21 of the Company Disclosure Schedule lists all plans and other
arrangements that currently are in effect which provide compensation or benefits to current or
former officers, directors, consultants, employees or leased employees of any Acquired Entity,
including, without limitation, all “employee benefit plans” as defined in Section 3(3) of ERISA,
and all bonus, stock option, stock purchase, incentive, phantom stock, deferred compensation,
supplemental retirement, insurance, severance and other similar fringe or employee benefit plans,
and all employment, consulting or executive compensation agreements covering any current or former
officer, director, employee or consultant of any Acquired Entity or the beneficiaries or dependents
of any such current or former officer, director, employee or consultant (collectively, the “Company
Plans”). No Acquired Entity maintains any deferred compensation which is currently in effect. No
Acquired Entity has any liability with respect to any plan or arrangement of the type described in
the preceding sentence other than the Company Plans.

               (b) The Company has delivered to Buyer and Parent with respect to each Company Plan true and
complete copies of: (i) the most recent documents constituting the Company Plan and all amendments
thereto, (ii) any related trust agreement or other funding instrument currently in effect and all
other material Contracts currently in effect with respect to such Company Plan, (iii) the currently
effective summary plan description and any subsequent summary of material modifications and any
other currently effective material written communication (or a written description of any material
oral communications) by an Acquired

34

 

Entity to its employees generally concerning the extent of the benefits provided, (iv) the
three most recent annual reports (Form 5500 Series) including all relevant schedules (as
applicable), (v) the most recent IRS determination or opinion letter for each Company Plan that is
intended to be a qualified plan under Section 401(a) of the Code, (vi) the most recent audited
financial statements for each funded Company Plan, and (vii) all written correspondence for the
last three years with any Governmental Body regarding the administration or operation of the
Company Plan.

               (c) Except as disclosed on Section 5.21(c) of the Company Disclosure Schedule, each
Company Plan complies with and has been maintained, operated and administered in compliance with
its terms and any related documents or Contracts and in compliance with all applicable Laws.

               (d) No individual who has performed services for any Acquired Entity has been improperly
excluded from participation in any Company Plan.

               (e) Neither the Company nor any member of the same controlled group of businesses as the
Company within the meaning of Section 4001(a) (14) of ERISA (an “ERISA Affiliate”) is or ever was a
sponsor or obligated to contribute to, or has any liability (whether contingent or otherwise) with
respect to, any plan that is or has been covered by Title IV of ERISA or Section 412 of the Code,
any “multiemployer plan” as defined in Section 3(37) of ERISA, any “multiple employer plan” within
the meaning of Section 210(a) of ERISA or Section 413(c) of the Code, a “multiple employer welfare
arrangement” as defined in Section 3(40) of ERISA, funded by a voluntary employees’ beneficiary
association within the meaning of Section 501(c)(9) of the Code, or a “pension plan” as defined in
Section 3(2) of ERISA that is not intended to be qualified under Section 401(a) of the Code.

               (f) Each Company Plan that is required to comply with the provisions of Part 6 of Subtitle B
of Title I of ERISA and Code Section 4980B, and the provisions of Part 7 of Subtitle B of Title I
of ERISA and Code Section 4980D, has complied in all material respects with such provisions.

               (g) Except as set forth on Section 5.21(g) of the Company Disclosure Schedule, no
Acquired Entity has any obligation to provide or make available any post-employment or post-service
benefit under any Company Plan that is a “welfare plan” as defined in Section 3(1) of ERISA for any
current or former officer, director, consultant, employee or leased employee (or their respective
beneficiaries) of any Acquired Entity, except as may be required by Part 6 of Subtitle B of Title I
of ERISA and Section 4980B of the Code, and at the sole expense of such individual. There are no
reserves, assets, surpluses or prepaid premiums with respect to any Company Plan that is a “welfare
plan” as defined in Section 3(1) of ERISA.

               (h) Except as set forth on Section 5.21(h) of the Company Disclosure Schedule, no
Acquired Entity or ERISA Affiliate has failed to make any material contributions or to pay any
material amounts due and owing as required by the terms of any Company Plan. All unpaid
liabilities or expenses of any Acquired Entity in respect of any Company Plan (including workers’
compensation) have been properly accrued on such Acquired Entity’s most recent financial statements
in compliance with GAAP.

35

 

               (i) Each Company Plan that is intended to be a qualified plan under Section 401(a) of the Code
and has received a favorable determination letter (if such plan is an individually designed plan)
or favorable opinion letter (if such plan is a prototype plan) from the IRS to the effect that the
Company Plan satisfies the requirements of Section 401(a) of the Code as to its form and that its
related trust is exempt from taxation under Section 501(a) of the Code as to its form and nothing
has occurred that could reasonably be expected to cause the loss of such qualification or exemption
or the imposition of any material liability, penalty or tax under ERISA, the Code or other
applicable Law.

               (j) No amounts payable under the Company Plans will fail to be deductible for federal income
tax purposes by virtue of Sections 162(m) or 280G of the Code.

               (k) Except as set forth in Section 5.21(k) of the Company Disclosure Schedule, other
than routine claims for benefits under the Company Plans, there are no pending or Threatened or, to
the Knowledge of the Company, contemplated disputes, Actions, Encumbrances, audits or controversies
involving the Company Plans or the fiduciaries, administrators or trustees of any of the Company
Plans or the Acquired Entities or any ERISA Affiliate either as the employer or sponsor under any
Company Plan, with any Governmental Body, any participant in or beneficiary of any Company Plan or
any other Person whomsoever. Except as set forth in Section 5.21(k) of the Company
Disclosure Schedule, neither the Company nor any other Acquired Entity has Knowledge of any
reasonable basis for any such dispute, Action, Encumbrance or controversy.

               (l) None of the Company Plans has any material unfunded liabilities not reflected on the
Financial Statements on the Balance Sheet Date.

               (m) No Acquired Entity or ERISA Affiliate has engaged in a “listed transaction” as defined in
Treas. Reg. §1.6011-4(b)(2).

               (n) Except as set forth on Section 5.21(n) of the Company Disclosure Schedule, there
have been no “prohibited transactions” within the meaning of Section 406 of ERISA or of Section
4975 of the Code, or breaches of any duty imposed by ERISA on “fiduciaries” as defined in Section
3(21) of ERISA, with respect to any Company Plan that could result in any liability or excise tax
under ERISA or the Code being imposed on any Acquired Entity.

               (o) All assets attributable to any Company Plan have been held in trust unless a statutory or
an administrative exemption to the trust requirements of Section 403(a) of ERISA applies.

               (p) Each Company Plan that is a “nonqualified deferred compensation plan,” as defined in
Section 409A(d)(1) of the Code, and any award thereunder, in each case that is subject to Section
409A of the Code, has been operated in compliance with Section 409A of the Code since January 1,
2005, and has complied in documentation since January 1, 2009. No Company Plan that would be such
a nonqualified deferred compensation plan but for the effective date provisions applicable to
Section 409A of the Code, as set forth in Section 885(d) of the American Jobs Creation Act of 2004,
has been “materially modified” within the meaning of

36

 

Section 1.409A-6(a)(4) of the Treasury Regulations after October 3, 2004, in a manner that
would cause it not to comply with Section 409A of the Code.

               (q) Except as set forth in Section 5.21(q) of the Company Disclosure Schedule, no
current or former officer, director, employee, leased employee or consultant (or their respective
beneficiaries) has or will obtain a right to receive a gross-up payment from any Acquired Entity
with respect to any taxes that may be imposed upon such individual under Section 409A of the Code,
Section 4999 of the Code or otherwise.

               (r) No Acquired Entity has any plan or Contract, whether legally binding or not, to create any
additional employee benefit or compensation plans, policies or arrangements or, except as may be
required by Law, to modify any Company Plan.

               (s) Except as set forth in Section 5.21(s) of the Company Disclosure Schedule, the
Company has reserved all rights necessary to amend or terminate each of the Company Plans without
the consent of any other Person.

               (t) No Company Plan covers any current or former officers, directors, employees, leased
employees or consultants agents (or their respective beneficiaries) of an Acquired Entity outside
of the United States.

     Section 5.22. Environmental, Health, and Safety Matters. The Acquired Entities are in compliance in all material respects with all Environmental,
Health, and Safety Requirements in connection with the ownership, use, maintenance or operation of
the Acquired Entities’ assets. There are no Actions pending or, to the Knowledge of the Company,
Threatened by any Person claiming that any properties or assets used in the Acquired Entities’
business are not, or that the Acquired Entities’ business has not been conducted, in compliance in
all material respects with all Environmental, Health and Safety Requirements.

     Section 5.23. Insurance. Section 5.23 of the Company Disclosure Schedule sets forth a true and accurate list of
each insurance policy currently maintained by or at the expense of or for the direct or indirect
benefit of the Acquired Entities and, with respect to each such insurance policy: (i) the name of
the insurance carrier that issued such policy and the policy number of such policy; (ii) whether
such policy is a “claims made” or “occurrences” policy; and (iii) a description of the coverage
provided by such policy. All such summaries are true and correct in all material respects and each
policy described therein is valid, enforceable, and in full force and effect. Since the Balance
Sheet Date, no Acquired Entity has received any notice or other communication regarding any actual
or possible (a) cancellation or invalidation of any such insurance policy, (b) refusal of any
coverage or rejection of any material claim under any such insurance policy, or (c) material
adjustment in the amount of the premiums payable with respect to any such insurance policy. Except
as set forth on Section 5.23 of the Company Disclosure Schedule, there are no pending
claims under or based upon any of the insurance policies of the Acquired Entities listed on
Section 5.23 of the Company Disclosure Schedule.

37

 

     Section 5.24. Affiliate Transactions. Except as set forth in Section 5.24 of the Company Disclosure Schedule:

               (a) no current officer, director, or Affiliate of any Acquired Entity has any direct or
indirect interest of any nature in any Acquired Entity, other than Company Common Stock and Company
Options;

               (b) no current or former officer, director or Affiliate of any Acquired Entity is indebted to
any Acquired Entity;

               (c) no current officer, director, or Affiliate of any Acquired Entity is a party to, or to the
Knowledge of the Company, has had, at any time since January 1, 2008 any direct or indirect
financial interest in, any Contract to which any Acquired Entity is a party;

               (d) to the Knowledge of the Company, no current officer, director or Affiliate of any Acquired
Entity is competing, directly or indirectly, with any Acquired Entity in any market served by any
Acquired Entity; and

               (e) no current officer, director or Affiliate of any Acquired Entity has or has asserted any
claim or right against any Acquired Entity that is unresolved.

     Section 5.25. Accounts Receivable and Payable.

               (a) All of the accounts receivable of the Acquired Entities as reflected in the 2009 Financial
Statements and any additional accounts receivable of the Company recorded in the books and records
of the Acquired Entities thereafter are, and as of the Equity Closing Date will be (in each case if
not previously paid), accounts receivable that arose in the Ordinary Course of Business and
represent bona fide claims of the Acquired Entities against debtors for sales, services performed
or other charges arising on or before the date hereof and all goods delivered and services
performed which gave rise to said accounts were delivered or performed in accordance with the
applicable orders, contracts or customer requirements in all material respects. To the Knowledge
of the Company, the accounts receivable are subject to no defenses, counterclaims or rights of
set-off.

               (b) The accounts payable of the Acquired Entities reflected on the 2009 Financial Statements
represented valid obligations arising from purchases actually made in bona fide arms’ length
transactions entered into in the Ordinary Course of Business.

     Section 5.26. Disclosure and Internal Controls; Complaints.

               (a) Disclosure and Internal Controls. The Company (i) has established and maintained
disclosure controls and procedures and internal control over financial reporting (as such terms are
defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required
by Rule 13a-15 under the Exchange Act, and (ii) has disclosed, based on its most recent
evaluations, to its outside auditors and the audit committee of the board of directors of the
Company, (A) all significant deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting (as defined in Rule 13a-15(f) of the
Exchange Act) which are reasonably likely to adversely affect the Company’s ability to record,

38

 

process, summarize and report financial data and (B) any fraud, whether or not material, that
involves management or other employees who have a significant role in the Company’s internal
controls over financial reporting.

               (b) Complaints. Since the Balance Sheet Date, no Acquired Entity nor, to the
Knowledge of the Company, any director, officer, employee, auditor, accountant or outside corporate
or securities legal counsel of any Acquired Entity, has received or otherwise had or obtained
knowledge of any complaint, allegation, assertion, or claim, whether made in writing or made orally
to any director, executive officer, or inside legal counsel or, to the Knowledge of the Company,
outside legal counsel to the Acquired Entities, regarding the accounting or auditing practices,
procedures, methodologies, or methods of Acquired Entities or its respective internal accounting
controls, including any complaint, allegation, assertion, or claim that any of the Acquired
Entities has engaged in questionable accounting or auditing practices.

     Section 5.27. Full Disclosure. To the Knowledge of the Company, all written information provided to the Parent or its
Representatives by on or behalf of the Acquired Entities or any of their Representatives do not
contain any untrue statement or omit to state a material fact necessary to make any statement
contained therein, in light of the circumstances in which it was made, not misleading.

ARTICLE VI.

PRE-CLOSING COVENANTS

     The Parties agree as follows with respect to the period between the execution of this
Agreement and the earlier of the Equity Closing and the Termination Date, unless otherwise stated:

     Section 6.1. General. Each Party will use its Commercially Reasonable Best Efforts to take all actions and to do all
things necessary, proper or advisable to consummate, make effective, and comply with all of the
terms of this Agreement and the Transactions including satisfaction of all of the conditions to
Equity Closing for which it is responsible or otherwise controls as set forth in ARTICLE
VIII.

     Section 6.2. Notices and Consents.

               (a) The Company will, and will cause each Company Subsidiary, to give any notices to third
parties, and will use its Commercially Reasonable Best Efforts to obtain any third party Consents
listed on Section 5.3(c) of the Company Disclosure Schedule or that Parent reasonably
requests. The Company will and will cause each Company Subsidiary to give any notices to, make any
filings with, and use its Commercially Reasonable Best Efforts to obtain any Consents of
Governmental Bodies, if any, required pursuant to any applicable Law in connection with the
Transactions including in connection with the matters referred to in Section 5.3(c) of the
Company Disclosure Schedule. Parent shall reasonably cooperate with the Company in obtaining such
third-party Consents, which cooperation shall include, without
limitation, making available to the Company on a timely basis information concerning Parent
and Buyer that is reasonably necessary or otherwise required to be furnished in connection with

39

 

obtaining any such Consents; provided, notwithstanding anything contained in this
Section 6.2(a) or this Agreement to the contrary, neither Parent nor Buyer shall be
obligated to provide any material non-public information to the Company, or to any Person, or be
required to make public disclosure of any material non-public information.

               (b) Each Party will cooperate and use its Commercially Reasonable Best Efforts to agree
jointly on a method to overcome any objections by any Governmental Body to the Transactions.

               (c) Nothing in this Section 6.2 will require that (i) Parent or its Affiliates divest,
sell, or hold separately any of its assets or properties, or (ii) Parent, its Affiliates, or the
Company (the determination with respect to which Parent will make) take any actions that could
materially adversely affect the normal and regular operations of Parent, its Affiliates, or the
Company after the Equity Closing.

               (d) The Company shall use its Commercially Reasonable Best Efforts to deliver, within three
(3) Business Days of the date of this Agreement, a redemption notice, in the form of Exhibit
L, to all holders of outstanding warrants to purchase shares of Company Common Stock with an
exercise price of $0.10 per share (the “Redemption Notices”).

               (e) The Company will, and will cause each Company Subsidiary, to use its Commercially
Reasonable Best Efforts to give the notices, make the filings and payments, and take such other
actions as described in Schedule H.

     Section 6.3. Operation of the Company’s Business.
Without the prior written consent of Parent, which consent shall not be unreasonably withheld,
conditioned or delayed, the Company shall not, and shall cause each Company Subsidiary not to,
engage in any practice, take any action, or enter into any transaction outside the Ordinary Course
of Business or engage in any practice, take any action, or enter into any transaction of the sort
described in Section 5.11, or settle any pending or Threatened Action. Subject to
compliance with applicable Law, from the date hereof until the earlier to occur of the Equity
Closing or the Termination Date, the Company will confer on a regular and frequent basis with one
or more designated Representatives of Parent to report on operational matters and the general
status of the Acquired Entities’ ongoing business and will promptly provide to Parent or its
designated Representatives copies of all filings any Acquired Entity makes with any Governmental
Body during such period.

     Section 6.4. Preservation of Business. The Company will, and will cause each Company Subsidiary, to use its Commercially Reasonable
Best Efforts to keep its business and properties substantially intact, including its present
operations, physical facilities, Permits, Facility Leases and working conditions, and relationships
and goodwill with lessors, licensors, suppliers, customers, and employees.

     Section 6.5. Full Access; Non-Disclosure.

               (a) The Company will, and will cause each Company Subsidiary, to (a) permit Representatives of
Parent (including financing providers) to have full access at all reasonable times, and in a manner
so as not to unreasonably interfere with the normal business operations of the Company, to all
premises, properties, personnel, books, records, Permits,

40

 

Contracts, and documents and all
financial, operating and any other data pertaining to the Acquired Entities, including for the
avoidance of doubt, the right to have Representatives of Parent present on a daily basis at the
Company’s corporate offices, provided that such Representatives’ activities are consistent with the
foregoing provisions; (b) furnish copies of all such books, records, Permits,
Contracts and
documents and all financial, operating and other data, and other information as Parent may
reasonably request; and (c) otherwise cooperate and assist, to the extent reasonably requested by
Parent, with Parent’s investigation of the properties, assets and financial condition of the
Acquired Entities. In addition, Parent shall have the right to have the Owned Real Estate, Leased
Real Estate and tangible personal property of any Acquired Entity inspected by Parent at Parent’s
sole cost and expense, for purposes of determining the physical condition and legal characteristics
of the Owned Real Estate, Leased Real Estate and such tangible personal property. No investigation
pursuant to this Section 6.5(a) will affect any representations or warranties made herein
or the conditions to the Parties’ obligations to consummate the Transactions. If this Agreement is
terminated or expires, Parent shall reimburse the Company for the reasonable and necessary costs
actually paid to repair any damage to property directly caused by any Representative of Parent
during the course of any on-site investigation of the properties of the Company.

               (b) Prior to the Equity Closing, except as may be required by Law, stock exchange or otherwise
contemplated herein or in the Confidentiality Agreement (defined below) any information provided to
Parent or its Representatives pursuant to this Agreement shall be held by Parent and its
Representatives in accordance with, and shall be subject to the terms of, the Confidentiality
Agreement dated as of January 5, 2010 by and between Parent and the Company (the “Confidentiality
Agreement”).

     Section 6.6. Publicity. Upon execution of this Agreement, Parent and the Company shall issue the press release
attached hereto as Exhibit K, which press release has been mutually agreed to by Parent,
the Company and the Sellers’ Representative. The Company and the Sellers shall afford Parent a
reasonable opportunity to review, comment on and discuss with the Company and the Sellers, as
applicable, (i) any press release, filing with any regulatory agencies, or other written public
announcement or statement to be issued by the Company, or (ii) any press release, filing with any
regulatory agencies, or other written public announcement or statement to be issued by any Seller
relating to the Transactions, and the Company and the Sellers shall make such changes reasonably
requested by Parent; provided, however, that in no event will the Company or any Seller be required
to delay any filing or announcement required to be made by any applicable Law beyond the relevant
due date for such filing or announcement. Parent and the Company shall cooperate with each other
to mutually determine in good faith the means by which the Company’s employees, customers and
suppliers will be informed of the Transactions.

41

 

     Section 6.7. Notification. The Company will give prompt written notice to Parent of any development occurring after the
date of this Agreement, or any item about which such Person did not have Knowledge on the date of
this Agreement, which causes or reasonably could be expected to cause a Breach of any of the
representations and warranties in ARTICLE V or any covenant set forth in this ARTICLE
VI. Parent will give prompt written notice to the Company of any development occurring after
the date of this Agreement, or any item about which Parent did not have Knowledge on the date of
this Agreement, which causes or reasonably could be expected to cause a Breach of any of the
representations and warranties in ARTICLE III or any covenant set forth in this ARTICLE
VI. No disclosure by any Party pursuant to this Section 6.7 will be deemed to amend or
supplement the Company Disclosure Schedules or to prevent or cure any misrepresentation or Breach
of any representation, warranty, or covenant.

     Section 6.8. Acquisition Proposals.

               (a) None of the Sellers or the Acquired Entities shall, nor shall any of the foregoing
authorize or permit any Representative of, the Sellers or any Acquired Entity to, (i) directly or
indirectly solicit or initiate the submission of, any Acquisition Proposal (as defined below), (ii)
enter into any agreement with respect to any Acquisition Proposal or (iii) directly or indirectly
participate in any discussions or negotiations regarding, or furnish to any person any information
with respect to, or take any other action to facilitate any inquiries or the making of any proposal
that constitutes, or may reasonably be expected to lead to, any Acquisition Proposal.

               (b) For purposes of this Agreement: “Acquisition Proposal” means any offer or proposal (other
than an offer or proposal by Parent or an Affiliate of Parent) for (i) a merger, acquisition
consolidation, purchase or similar transaction involving any equity security of the Company or (ii)
the acquisition (other than an acquisition by Parent or an Affiliate of Parent) of all or
substantially all of the assets of the Company.

     Section 6.9. Tax Matters.

               (a) Tax Matters. Without the prior written consent of Parent, which consent shall not
be unreasonably withheld, conditioned or delayed, neither the Company nor any of its Subsidiaries,
shall make or change any Tax election, change any annual Tax accounting period, adopt or change any
method of Tax accounting, file any amended Tax Return, enter into any closing agreement, settle any
Tax claim or assessment, surrender any right to claim a Tax refund, consent to the extension or
wavier of the limitations period applicable to any Tax claim or assessment, or take or omit to take
any other action if such action or omission would have the effect of materially increasing the Tax
Liability of any Acquired Entity, Parent, or Buyer.

               (b) Certain Taxes and Fees. All transfer, documentary, sales, use, stamp,
registration and other such Taxes, and all conveyance fees, recording charges and other fees and
charges (including penalties and interest) incurred in connection with consummation of the
transactions contemplated by this Agreement shall by paid by the Sellers when due, and the Sellers
will, at their own expenses, file all necessary Tax Returns and other documentation with
respect to all such Taxes, fees and charges, and, if required by applicable law, Parent will,
and

42

 

will cause the Company, to join in the execution of any such tax returns and other
documentation.

     Section 6.10. Payment of Liabilities. From the date hereof until the Equity Closing Date, the Company shall, and shall cause each of
the Company Subsidiaries to, pay or otherwise satisfy the Liabilities arising in the Ordinary
Course of Business in a manner consistent with past custom and practice.

     Section 6.11. Exercise of Warrants. Each Seller hereby agrees, without taking any further action, that immediately prior to the Equity
Closing each Seller shall be deemed to have exercised, on a cashless basis at the Per Share
Purchase Price, that number of warrants to purchase shares of Company Common Stock with an exercise
price of $0.10 per share set forth next to such Seller’s name on Schedule G attached hereto
(the “Warrant Shares”), to the extent not previously exercised.

ARTICLE VII.

POST-CLOSING COVENANTS

     Section 7.1. General.
In case at any time after the Equity Closing any further action is necessary or desirable to
carry out the purposes of this Agreement, each Seller will take such further action (including
executing and delivering such further instruments and documents) as Parent or Buyer reasonably may
request, all at the Parent’s or Buyer’s sole cost and expense (unless Parent or Buyer is entitled
to indemnification therefor under ARTICLE X). After the Equity Closing, Buyer will be
entitled to possession of all documents, books, records, agreements, and financial data of any sort
relating to the Acquired Entities.

     Section 7.2. Board of Directors.
Immediately following the Equity Closing, the remaining directors of the Company shall take
all necessary or desirable action to appoint those persons identified on Schedule E to the
Company’s board of directors. Following the Equity Closing Date and prior to the closing of the
Merger, Parent shall be entitled to designate, at its option, upon notice to the Company the
members of the Board of Directors, provided that until earlier of the Merger Closing and the
termination or expiration of the Merger Agreement, the Company’s Board of Directors shall have at
least two directors who are not officers, directors, or employees of Parent (the “Independent
Directors”). To the fullest extent permitted by applicable law, the Company shall take all actions
requested by Parent which are reasonably necessary to effect the election of any such designee or
designees, including the inclusion in the Information Statement, or a separate mailing, of the
information required by Section 14(f) of the Exchange Act and Rule 14f-1 promulgated thereunder,
and the making of such mailing as part of the Information Statement or otherwise, as requested by
Parent (provided that Parent shall have provided to the Company on a timely basis all information
required to be included with respect to Parent’s designees to the Board of Directors). Following
the election or appointment of Parent’s designees pursuant to
this Section 7.2 and prior to the Merger Closing, any amendment, or waiver of any term
or condition, of this Agreement, the Merger Agreement or any other Transaction Document to which
the Company is a party, or any termination of this Agreement or the Merger Agreement by the
Company, any extension by the Company of the time for the performance of any of the obligations or
other acts of Parent or Buyer or waiver or assertion of any of the Company’s rights hereunder or
thereunder, or any other consents or actions by the

43

 

Board of Directors with respect to this
Agreement or the Merger Agreement, will require, and will require only, the concurrence of the
Independent Directors, except to the extent that applicable law requires that such action be acted
upon by the full Board of Directors, in which case such action will require the concurrence of the
Independent Directors, and no other action by the Company shall be required for purposes of this
Agreement or the Merger Agreement. The Independent Directors shall be constituted as a Special
Committee of the Company’s Board of Directors on the Equity Closing Date.

     Section 7.3. Litigation Support.
So long as any Party actively is contesting or defending against any Action in connection with
(a) the Transactions or (b) any fact, situation, circumstance, status, condition, activity,
practice, plan, occurrence, event, incident, action, failure to act, or transaction on or prior to
the Equity Closing Date involving any Acquired Entity, each other Party will cooperate with such
Party and such Party’s counsel in the contest or defense, make available their personnel, and
provide such testimony and access to their books and records as will be necessary in connection
with the contest or defense, at the sole cost and expense of the contesting or defending Party
(unless the contesting or defending Party or one of its Affiliates is entitled to indemnification
therefor under ARTICLE X).

     Section 7.4. Transition.
No Seller will take any action that is designed or intended to have the effect of discouraging
any lessor, licensor, customer, supplier, or other business associate of any of the Acquired
Entities from maintaining its existing business relationships with the Acquired Entities after the
Equity Closing on the same terms as it maintained with the Acquired Entities prior to the Equity
Closing. Each Seller will, and will cause its Affiliates to, refer all customer, supplier, and
other inquiries relating to the businesses of the Acquired Entities to Parent, or an Affiliate
thereof.

     Section 7.5. Director & Officer Insurance.
Subject to commercial availability, Parent will purchase a six (6) year run-off director and
officer liability insurance policy, effective as of the Equity Closing, for the benefit of the
directors and officers of the Company prior to the Equity Closing Date (the “D&O Tail Policy”).
The D&O Tail Policy will provide substantially the same coverage and amounts and contain terms and
conditions as the Company’s current directors and officers insurance policy and which are in the
aggregate substantially no less advantageous with respect to claims arising from or related to acts
or omissions prior to the Equity Closing Date by the directors and officers of the Company in their
capacities as such.

     Section 7.6. Confidentiality.

               (a) From and after the Equity Closing Date through the second (2nd) anniversary of
the Equity Closing Date, the Sellers shall not and shall cause their Representatives not to,
directly or indirectly, disclose, reveal, divulge or communicate to any Person other than
authorized officers, directors and employees of Parent or Buyer or use or otherwise exploit for its
own benefit or for the benefit of anyone other than Parent or Buyer, any Confidential Information
(as defined below). The Sellers shall not have any obligation to keep confidential (or cause its
Representatives or Affiliates to keep confidential) any Confidential Information if and to the
extent disclosure thereof is specifically required by applicable Law; provided, however, that in
the event disclosure is required by applicable Law, the Sellers shall, to the extent reasonably
possible, provide Parent and Buyer with prompt notice of such requirement prior to

44

 

making any
disclosure so that Parent or Buyer may seek an appropriate protective order. For purposes of this
Section 7.6, “Confidential Information” means any information with respect to the Acquired
Entities including methods of operation, customer lists, products, prices, fees, costs, technology,
inventions, trade secrets, know-how, software, marketing methods, plans, personnel, suppliers,
competitors, markets or other specialized information or proprietary matters. “Confidential
Information” does not include, and there shall be no obligation hereunder with respect to,
information that (i) is or becomes available to the public other than as a result of a disclosure
by the Sellers in violation of this Agreement, or (ii) is or becomes available to the Sellers on a
non-confidential basis from a source other than the Acquired Entities or any of its
Representatives, provided that such Sellers did not know, or have reason to believe, after
reasonable inquiry, that such source was subject to an obligation not to disclose such information.

               (b) The covenants and undertakings contained in this Section 7.6 relate to matters
which are of a special, unique and extraordinary character and a violation of any of the terms of
this Section 7.6 will cause irreparable injury to Parent and Buyer, the amount of which
will be impossible to estimate or determine and which cannot be adequately compensated.
Accordingly, the remedy at law for any breach of this Section 7.6 will be inadequate.
Therefore, Parent and Buyer will be entitled to a temporary or permanent injunction, restraining
order or other equitable relief from any court of competent jurisdiction in the event of any breach
of this Section 7.6 without the necessity of proving actual damage or posting any bond
whatsoever. The rights and remedies provided by this Section 7.6 are cumulative and in
addition to any other rights and remedies which Parent and Buyer may have hereunder or at law or in
equity.

ARTICLE VIII.

CLOSING CONDITIONS

     Section 8.1. General Conditions.
The obligations of the Parties to effect the Equity Closing shall be subject to the
satisfaction of the following conditions unless waived in writing by Parent, the Sellers’
Representative and the Company:

               (a) No Injunction. No Law or order, injunction, judgment, decree, ruling, assessment,
or award shall have been enacted, entered, issued or promulgated by any
Governmental Body (and be in effect) which prohibits the consummation of the Equity Purchase
or any of the other Transactions.

               (b) Legal Proceedings. No Governmental Body shall have initiated proceedings to
restrain or prohibit the Equity Purchase or any of the other Transactions or force rescission,
unless such Governmental Body shall have withdrawn and abandoned any such proceedings prior to the
time which otherwise would have been the Equity Closing Date and there shall not have been any Law
or order which would require the divestiture by the Company of a material portion of the assets of
the Company used in the Company’s Business, taken as a whole, or impose any material limitation on
the ability of the Company to conduct the Company’s Business, taken as a whole, following the
Equity Closing.

45

 

               (c) Regulatory Approval. All regulatory approvals or waivers required to consummate
the Transactions shall have been obtained and shall remain in full force and effect and all
statutory waiting periods in respect thereof shall have expired, and no such approvals or waivers
shall contain any conditions, restrictions or requirements which would reduce the benefits of the
Transactions to Parent in any material respect.

     Section 8.2. Conditions Precedent to Obligation of Parent and Buyer. Parent’s and Buyer’s obligation to consummate the Equity Closing is subject to the
satisfaction on or prior to the Equity Closing Date of each condition precedent listed below, any
of which may be waived in writing by Parent and/or Buyer.

               (a) Accuracy of the Sellers Representations and Warranties. All representations and
warranties of the Sellers set forth in ARTICLE IV, shall have been accurate and complete in
all respects on the date when made and on the Equity Closing Date (unless the representations and
warranties address matters as of a particular date, in which case they shall remain accurate and
complete in all respects as of such date) with the same effect as if made on and as of the Equity
Closing Date, without giving effect to any supplements to the Sellers Disclosure Schedule.

               (b) Accuracy of Representations and Warranties of the Company. All representations
and warranties of the Company set forth in ARTICLE V shall have been accurate and complete
in all material respects on the date when made and on the Equity Closing Date (unless the
representations and warranties address matters as of a particular date, in which case they shall
remain accurate and complete in all material respects as of such date and except with respect to
any provisions including the word “material” or words of similar import, with respect to which such
representations and warranties shall have been accurate and complete in all respects) with the same
effect as if made on and as of the Equity Closing Date, without giving effect to any supplements to
the Company Disclosure Schedule.

               (c) Compliance with Obligations. The Sellers and the Company shall have performed and
complied with all of their covenants and obligations under the Transaction Documents to be
performed or complied with at or prior to the Equity Closing (singularly and in the aggregate).

               (d) No Material Adverse Effect. Since the Balance Sheet date there shall have been no
event, series of events or the lack of occurrence thereof which, singularly or in the aggregate,
could reasonably be expected to have a Material Adverse Effect on the Acquired Entities taken as a
whole.

               (e) Consents.

                    (i) The Company shall have obtained a written consent to the consummation of the Transactions
from each of the parties identified in Section 5.3 of the Company Disclosure Schedule,
other than with respect to each note payable identified in Section 5.3 that requires
Consent for prepayment thereof (the “Prepayment Notes”); and

                    (ii) The Company shall have obtained a written consent from the holder of each Prepayment Note
to the prepayment of each Prepayment Note, other than with

46

 

respect to a maximum aggregate amount of
Prepayment Notes, including all accrued and unpaid interest relating thereto as of the Equity
Closing Date, and any accrued late fees or other payment obligations with respect thereto, not to
exceed $1,000,000 as of the Equity Closing Date.

                    (f) Transaction Documents. Each of the Sellers and the Company shall have duly
executed or caused the execution of the Transaction Documents to which it is a party, and delivered
each of the documents and instruments required to be delivered by it pursuant to Section
2.4(a).

                    (g) Information Statement. An information statement (the “Information Statement”), in
form and substance reasonably satisfactory to Parent, that complies in all material respects with
the requirements of the Exchange Act (and the rules and regulations promulgated thereunder) and the
DGCL, relating to the written consent of the stockholders of the Company approving the adoption of
the Merger Agreement and the consummation of the Merger and the other Transactions, shall have been
prepared and delivered to Parent.

                    (h) Payoff Letters. The payoff letters shall have been delivered to Parent in
accordance with Section 2.4(a)(ix); provided, however that notwithstanding the foregoing
the Company shall not be deemed in Breach of this condition to Closing if it does not obtain a
payoff letter from the holders of Prepayment Notes from whom the Company does not obtain a consent
as specifically permitted and in accordance with Section 8.2(e)(ii) hereof.

                    (i) Pre-Closing Actions. The Company shall have given the notices, made the filings
and payments, and taken such other actions as described in Schedule H.

     Section 8.3. Conditions Precedent to Obligations of the Company and the Sellers.
The obligation of the Company and the Sellers to consummate the Transactions contemplated to
occur in connection with the Equity Closing is subject to the satisfaction on or prior to the
Equity Closing Date of each condition precedent listed below, any of which may be waived by the
Company and the Sellers’ Representative.

                    (a) Accuracy of Representations and Warranties. All representations and warranties of
Parent and Buyer set forth in ARTICLE III, shall have been accurate and complete in all respects on
the date when made and on the Equity Closing Date (unless the representations and warranties
address matters as of a particular date, in which case they shall remain accurate and complete in
all respects as of such date) with the same effect as if made on and as of the Equity Closing Date,
without giving effect to any supplements to the Parent Disclosure Schedule.

                    (b) Compliance with Obligations. Parent and Buyer shall have performed and complied
with all of its covenants and obligations under the Transaction Documents to be performed or
complied with at or prior to Equity Closing (singularly and in the aggregate).

                    (c) Transaction Documents. Parent and Buyer shall have duly executed and delivered
each of the documents and instruments required to be delivered by it pursuant to Section
2.4(b).

47

 

                    (d) D&O Tail Policy. Parent shall have purchased the D&O Tail Policy to be effective
on the Equity Closing Date.

ARTICLE IX.

TERMINATION

     Section 9.1. Termination of Agreement.
The Parties may terminate this Agreement upon written notice thereof to each of the other
Parties hereto and the Transactions may be abandoned at any time prior to the Equity Closing Date,
as provided below:

               (a) by the mutual written consent of Parent and the Sellers; or

               (b) by Parent if the Merger Agreement has been terminated or expired or if any Action seeking
to prohibit, restrain, invalidate, or collect Damages as a result of, the consummation of the
Equity Purchase, the Merger or the other Transactions, is pending; or

               (c) by either the Sellers on the one hand, or Parent, on the other hand, if the Transactions
are not consummated on or before the Expiration Date, provided, however, that the right to
terminate this Agreement pursuant to this Section 9.1(c) shall not be available to any
Party if the failure to consummate the Transactions on or before the Expiration Date resulted from
such Party’s Breach of any representation, warranty, agreement or obligation under any Transaction
Document; or

               (d) by Parent if any of the conditions provided for in Section 8.1 or Section
8.2 of this Agreement has not been satisfied on or before the Expiration Date or shall have
become incapable of satisfaction or fulfillment on or before the Expiration Date (other than as a
result of a Breach of this Agreement by Parent) and Parent has not waived such conditions; or

               (e) by the Sellers if any of the conditions provided for in Section 8.1 or Section
8.3 of this Agreement has not been satisfied on or before the Expiration Date or shall have
become incapable of satisfaction or fulfillment on or before the Expiration Date (other than as a
result of a Breach of this Agreement by the Sellers or the Company) and the Sellers have not waived
such conditions; or

               (f) by Parent, if (i) the board of directors of the Company (A) withdraws, modifies or changes
its recommendation of this Agreement, the Merger Agreement or the Merger in a manner adverse to
Parent or shall have resolved pursuant to valid board action to do any of the foregoing, or (B)
shall have recommended to the stockholders of the Company any Acquisition Proposal or resolved by
valid board action to do so; or (ii) the Transactions shall not have been consummated prior to the
Expiration Date and (A) a third party shall have made or caused to be made an Acquisition Proposal
or (B) any “group” (as defined in Section 13(d)(3) of the Exchange Act) or Person (including the
Company or any of its Affiliates), other than Parent or any of its Affiliates, shall have become
the beneficial owner of more than fifty percent (50%) of the outstanding shares of the Company
Common Stock.

     Section 9.2. Effect of Termination.
Except for the obligations under this ARTICLE IX and ARTICLE XII, if this
Agreement is terminated under Section 9.1, then all further

48

 

obligations of the Parties
under this Agreement will terminate. Except as otherwise set forth herein, such termination shall
be without liability of any Party to any other Party; provided, however that notwithstanding the
foregoing, such termination shall not relieve any Party of Liability for any Breach of this
Agreement which occurs prior to termination. If any Party hereto terminates this Agreement
pursuant to Section 9.1(d) or Section 9.1(e), which right of termination arises as
a result of a Breach of any representation, warranty or covenant, then the rights of the
non-Breaching Party(ies) to pursue all legal remedies for Damages such Party(ies) suffer will
survive such termination unimpaired and no election of remedies will have been deemed to have been
made.

ARTICLE X.

INDEMNIFICATION

     Section 10.1. Survival of Representations and Warranties.

               (a) Each representation and warranty of the Sellers contained in ARTICLE IV, in any of
the Transaction Documents, or any certificate related to such representations and warranties shall
survive the Equity Closing and will continue in full force and effect in perpetuity.

               (b) Each representation and warranty of the Company contained in ARTICLE V or in any
of the Transaction Documents, and any certificate related to such representations and warranties
will survive the Equity Closing and will continue in full force and effect until the first to occur
of (i) the Merger Closing, or (ii) 11:59 p.m. Los Angeles time on the one hundred and twentieth
(120th) day following the Equity Closing.

               (c) Each representation and warranty of Parent and Buyer contained herein, and any certificate
related to such representations and warranties will survive the Equity Closing and will continue in
full force and effect in perpetuity.

     Section 10.2. Indemnification Provisions for the Benefit of the Parent Indemnified Parties.

               (a) Indemnification by the Sellers Regarding the Acquired Entities. Subject to the
provisions of Section 10.5 and Section 10.6, each Seller shall, jointly and
severally, indemnify and hold the Parent Indemnified Parties harmless, from and pay any and all
Damages directly or indirectly resulting from, relating to, arising out of, or attributable to any
one of the following:

                    (i) Any Breach of any representation or warranty of the Acquired Entities in this Agreement or
any Transaction Document as if such representation or warranty were made on and as of the Equity
Closing Date (except for representations and warranties made as of a specified date, which shall be
deemed to have been made only as of such specified date) without giving effect to any supplement to
the Company Disclosure Schedule; and

                    (ii) Any Breach by the Acquired Entities of any covenant or obligation of the Acquired
Entities in this Agreement or the Transaction Documents;

49

 

                    (iii) Any failure to give the notices, make the filings and payments, and take such
other actions as described in Schedule H.

               (b) Indemnification by each Seller. Subject to the provisions of Section 10.5
and Section 10.6, each Seller shall, severally and not jointly, indemnify and hold the
Parent Indemnified Parties harmless, from and pay any and all Damages directly or indirectly
resulting from, relating to, arising out of, or attributable to any one of the following:

                    (i) Any Breach of any representation or warranty such Seller has made in ARTICLE IV,
the certificate provided pursuant to Section 2.4(a)(ii), or any Transaction Document, as if
such representation or warranty were made on and as of the Equity Closing Date (except for
representations and warranties made as of a specified date, which shall be deemed to have been made
only as of such specified date); and

                    (ii) Any Breach by such Seller of any covenant or obligation of such Seller in this Agreement
or the Transaction Documents.

     Section 10.3. Indemnification Provisions for Benefit of the Sellers. Parent will indemnify and hold the Seller Indemnified Parties harmless, from and pay any and
all Damages directly resulting from, relating to, or arising out of (i) the Transactions (which
shall not include, without limitation, indemnification with respect to any transactions entered
into by any Seller relating to the Company prior to the date hereof), and (ii) the operation and
ownership of, or conditions first occurring with respect to, any Acquired Entity after 11:59 p.m.
on the Equity Closing Date. Notwithstanding the foregoing, Parent will not indemnify the Seller
Indemnified Parties for Damages directly or indirectly resulting from, relating to, arising out of,
or attributable to events or circumstances existing, or claims made or Threatened, prior to the
Equity Closing Date of which the Company or any Seller had Knowledge at the time of the Equity
Closing unless such events, circumstances or claims were disclosed to Parent in the Sellers
Disclosure Schedule or the Company Disclosure Schedule or a supplement thereto.

     Section 10.4. Indemnification Claim Procedures.

               (a) If any third party notifies any Indemnified Party with respect to the commencement of any
Action that may give rise to a claim for indemnification against any Indemnitor under this
ARTICLE X (an “Indemnification Claim”), then the Indemnified Party will promptly give
notice to the Indemnitor. Failure to notify the Indemnitor will not relieve the Indemnitor of any
Liability that it may have to the Indemnified Party, except to the extent the defense of such
Action is materially and irrevocably prejudiced by the Indemnified Party’s failure to give such
notice.

               (b) An Indemnitor will have the right to defend against an Indemnification Claim, with counsel
of its choice reasonably satisfactory to the Indemnified Party if (i) within fifteen (15) days
following the receipt of notice of the Indemnification Claim the Indemnitor notifies the
Indemnified Party in writing that the Indemnitor will indemnify the Indemnified Party from and
against the entirety of any Damages the Indemnified Party may suffer resulting from, relating to,
arising out of, or attributable to the Indemnification Claim, (ii) the Indemnitor provides the
Indemnified Party with evidence reasonably acceptable to the

50

 

Indemnified Party that the Indemnitor will have the financial resources to defend against the
Indemnification Claim and pay, in cash, all Damages the Indemnified Party may suffer resulting
from, relating to, arising out of, or attributable to the Indemnification Claim, (iii) the
Indemnification Claim involves only money Damages and does not seek an injunction or other
equitable relief, (iv) settlement of, or an adverse judgment with respect to, the Indemnification
Claim is not in the good faith judgment of the Indemnified Party likely to establish a precedential
custom or practice materially adverse to the continuing business interests of the Indemnified
Party, and (v) the Indemnitor actively and diligently conducts the defense of the Indemnification
Claim. Subject to Section 10.5, the Indemnitor will be liable for the reasonable fees and
expenses of counsel employed by the Indemnified Party for any period during which the Indemnitor
has not assumed the defense thereof (other than during any period in which the Indemnified Party
will have failed to give notice of the Indemnification Claim as provided above).

               (c) So long as the Indemnitor is conducting the defense of the Indemnification Claim in
accordance with Section 10.4(b), (i) the Indemnified Party may retain separate co-counsel
at its sole cost and expense and participate in the defense of the Indemnification Claim, (ii) the
Indemnified Party will not consent to the entry of any order with respect to the Indemnification
Claim without the prior written Consent of the Indemnitor (not to be withheld unreasonably), and
(iii) the Indemnitor will not Consent to the entry of any order with respect to the Indemnification
Claim without the prior written Consent of the Indemnified Party (not to be unreasonably withheld,
conditioned or delayed provided that it will not be deemed to be unreasonable for an Indemnified
Party to withhold its Consent (A) with respect to any finding of or admission (1) of any Breach of
any Law, order or Permit, (2) of any violation of the rights of any Person, or (3) which
Indemnified Party believes could have a material adverse effect on any other Actions to which the
Indemnified Party or its Affiliates are a party or to which Indemnified Party has a good faith
belief it may become a party, or (B) if any portion of such order would not remain sealed).

               (d) Notwithstanding the foregoing, if an Indemnified Party determines in good faith that there
is a reasonable probability that an Indemnification Claim may adversely affect it or its Affiliates
other than as a result of monetary Damages for which it would be entitled to indemnification under
this Agreement, the Indemnified Party may, by notice to the Indemnitor, assume the exclusive right
to defend, compromise or settle such Indemnification Claim, but the Indemnitor will not be bound by
any determination of any Indemnification Claim so defended for the purposes of this Agreement or
any compromise or settlement effected without its Consent (which may not be unreasonably withheld,
conditioned or delayed).

               (e) Each Party hereby consents to the non-exclusive jurisdiction of any Governmental Body,
arbitrator, or mediator in which an Action is brought against any Indemnified Party for purposes of
any Indemnification Claim that an Indemnified Party may have under this Agreement with respect to
such Action or the matters alleged therein, and agrees that process may be served on such Party
with respect to such claim anywhere in the world.

51

 

     Section 10.5. Limitations.

               (a) Notwithstanding anything to the contrary contained herein, the Company and the Sellers
shall not have any Liability under Section 10.2(a)(i) (other than in respect of claims
relating to (i) Breaches of Section 5.5, and (ii) the failure by the Company to give the
notices, make the filings and payments, and take such other actions as described in Schedule
H, which for the avoidance of doubt shall not be subject to the limitations of this Section
10.5(a)) unless the aggregate of all Damages relating thereto for which the Sellers would, but
for this proviso, be liable exceeds on a cumulative basis an amount equal to $250,000; upon which
the Company and the Sellers shall be Liable for the full extent of cumulative Damages, relating
back to and including the first dollar of all Damages so claimed.

               (b) Notwithstanding anything to the contrary contained herein, the Sellers shall have no
Liability (i) under Section 10.2(a) (other than for Breaches of Section 5.5(b)) in
excess of $750,000 less the amount of any adjustment made pursuant to Section
2.5(c)(i), and (ii) under Section 10.2(a) for Breaches of Section 5.5(b)) in
excess of the amounts paid or payable to such Seller pursuant to this Agreement for any Sellers
Shares or Seller Options owned by such Seller, and the indemnification obligations of the Sellers
set forth in Section 10.2(a) shall constitute the sole and exclusive remedy of Parent
against the Sellers for any claim or cause of action arising out of or in connection with the
matters identified in Section 10.2(a)(i) and Section 10.2(a)(ii) absent actual
fraud or willful Breach. For the avoidance of doubt, any amounts credited to the Holdback Amount
pursuant to Section 2.5(c)(ii) that cause the Adjusted Holdback Amount to exceed $750,000
shall not be available to satisfy any Indemnification Claims that may be asserted pursuant to this
ARTICLE X.

               (c) Notwithstanding anything to the contrary contained herein, no Seller shall have any
Liability (i) under Section 10.2(b)(i) (other than for Breaches of Section 4.5) in
excess of the amounts paid or payable to such Seller pursuant to this Agreement for any Sellers
Shares or Seller Options owned by such Seller, and (ii) under Section 10.2(b)(i) for
Breaches of Section 4.5 in excess of the amounts paid or payable to such Seller pursuant to
this Agreement for any Sellers Shares or Seller Options owned by such Seller, plus amounts
paid or payable to such Seller with respect to any Company Debt pursuant to this Agreement, and the
indemnification obligations of the Sellers set forth in Section 10.2(b) shall constitute
the sole and exclusive remedy of Parent against the Sellers for any claim or cause of action
arising out of or in connection with the matters identified in Section 10.2(b)(i) and
Section 10.2(b)(ii) absent actual fraud or willful Breach by any such Seller.

               (d) For purposes of this ARTICLE X, once a determination has been made that a specific
breach of a representation, warranty, covenant or agreement has occurred for purposes of the
indemnification obligations hereunder, the calculation of Damages with respect to such specific
breach shall be made without regard to any limitation or qualification as to materiality set forth
in such representation, warranty, covenant or agreement.

               (e) Neither the exercise of, nor failure to exercise, its rights under this Section
10.2 or Section 10.3, as applicable, by a Party will constitute an election of remedies
or limit a Party in any manner in the enforcement of any other remedies available to such Party.

52

 

     Section 10.6. Calculation of Damages. The calculation of damages under, or related to the Transactions contemplated by this
Agreement, shall in all cases be determined taking into account the purposes of the Transactions to
acquire one hundred percent (100%) of the Equity Interests of the Company. No Party shall be
entitled to assert or pursue a claim for Damages if such Damages have been accounted for in the
Definitive Post Closing Statement.

     Section 10.7. Purchase Price Adjustment. The Parties acknowledge that it is intended that payments for indemnification made
pursuant to this ARTICLE X will be treated as adjustments to the Final Purchase Price and
the Parties agree that, unless otherwise required by law, neither they nor any of their respective
Affiliates will take any position in a filing for U.S. federal, state or local income Tax purposes
that is inconsistent with this intention.

     Section 10.8. Release of Adjusted Holdback Amount.

               (a) Distributions Relating to Indemnification Claims. If any Parent Indemnified Party
has a claim for indemnity under Section 10.2(a) or Section 10.2(b), Parent may
deliver a certificate (an “Officer’s Certificate”) to the Sellers’ Representative, stating that one
of more of the Parent Indemnified Parties or any of their respective successors or assigns has
paid, properly accrued, or reasonably anticipates that it will have to pay or accrue Damages in an
amount specified in such Officer’s Certificate, with the basis for such claim set forth in
reasonable detail. If within five (5) Business Days after delivery to the Sellers’ Representative
of a copy of an Officer’s Certificate, Parent has not received written notice from the Sellers’
Representative that the Sellers’ Representative disputes in good faith the claim set forth in such
Officer’s Certificate, with the basis for such dispute set forth in reasonable detail, Parent shall
deduct from the Adjusted Holdback Amount and retain for its own account an amount equal to the
amount of Damages set forth in the applicable Officer’s Certificate.

               (b) Distribution Upon Termination of the Representations and Warranties. On that date
which is two (2) Business Days following the termination of the Company’s representations and
warranties contained in ARTICLE V, as provided above, Parent shall, or shall cause the
Buyer to, distribute the remaining portion of the Adjusted Holdback Amount as of such date
minus any amounts claimed due and owing to a Parent Indemnified Party as certified to the
Sellers’ Representative in an Officer’s Certificate, on or prior to the date of termination,
minus any amounts for which the Sellers’ Representative is entitled to reimbursement
pursuant to Section 11.2(c) as certified to Parent in a certificate delivered by the
Sellers’ Representative (which amounts (to the extent available) will be promptly delivered to the
Sellers’ Representative following the termination of the Company’s representations and warranties
contained in ARTICLE V), to the Sellers (pro rata based on the number of Seller Shares they
each held immediately prior to the Equity Closing) together with interest accrued thereon from the
Equity Closing Date until the second (2nd) Business Day prior to the date of payment at
an annual rate equal to 0.10%. For purposes of clarification, to the extent the funds in the
Holdback Account are less than the amounts claimed due and owing to a Parent Indemnified Party as
certified to the Sellers’ Representative in one or more Officer’s
Certificates, Parent shall be entitled to retain all of the funds in the Holdback Amount until such
Indemnification Claims have been definitively and finally resolved and only in the event that there
remain funds in the Holdback Account in excess of the amounts claimed due and owing to a Parent
Indemnified Party, as certified to the Sellers’ Representative in one or more Officer’s

53

 

Certificates, shall Parent be required to distribute such excess funds from the Holdback Amount to
the Seller’s Representative in full satisfaction of Parent’s obligations pursuant to this
Section 10.8(b). With respect to any Indemnification Claim asserted against an individual
Seller pursuant to Section 10.2(b), the amount of any such claim shall be deducted from the
amount otherwise distributable to such Seller.

ARTICLE XI.

SELLERS’ REPRESENTATIVE.

     Section 11.1. Authorization of the Sellers’ Representative.

               (a) Harry Zimmerman (the “Sellers’ Representative”) (and each successor appointed in
accordance with Section 11.3) hereby is appointed, authorized, and empowered to act, on
behalf of each Seller, in connection with, and to facilitate the consummation of, the Transactions
and in connection with the activities to be performed on the Sellers’ behalf under this Agreement,
for the purposes and with the powers and authority set forth in this Section 11.1(a), which
will include the power and authority:

                    (i) to execute and deliver such Consents in connection with this Agreement and the
Transactions as the Sellers’ Representative, in its reasonable discretion, may deem necessary or
desirable to give effect to the purposes and intentions of this Agreement;

                    (ii) as the Sellers’ Representative, to enforce and protect the Sellers’ rights and interests
arising out of or under or in any manner relating to this Agreement (including in connection with
any claims related to the Transactions) and, in connection therewith, to (A) assert any claim or
institute any Action, (B) investigate, defend, contest or litigate any Action, initiated by any
Parent Indemnified Party, or any other Person, against the Sellers and/or the Holdback Amount, and
receive process on behalf of each Seller in any such Action and compromise or settle on such terms
as the Sellers’ Representative will determine to be appropriate, give receipts, releases and
discharges on behalf of all or any Sellers with respect to any such Action, (C) file any proofs,
debts, claims and petitions as the Sellers’ Representative may deem advisable or necessary, (D)
settle or compromise any claims related to the Transactions, (E) assume, on each Seller’s behalf,
the defense of any claims related to the Transactions, and (F) file and prosecute appeals from any
decision, judgment or award rendered in any of the foregoing Actions, it being understood that the
Sellers’ Representative will not have any obligation to take any such actions, and will not have
Liability for any failure to take any such action;

                    (iii) to enforce payment of the Holdback Amount on the Sellers’ behalf, in the Sellers’
Representative’s name or, if the Sellers’ Representative so elects, upon at least fifteen (15)
days’ prior written notice to the Sellers and in the absence of written instructions to the
contrary, in the names of one or more Sellers;

                    (iv) to refrain from enforcing any right of any Seller and/or of the Sellers’ Representative
arising out of or under or in any manner relating to this Agreement;

                    (v) to make, execute, acknowledge and deliver all such other Contracts, guarantees, orders,
receipts, endorsements, notices, requests, instructions, certificates,

54

 

stock powers, letters and other writings, and, in general, to do any and all things and to take any and all action that the
Sellers’ Representative, in its sole and absolute discretion, may consider necessary or proper or
convenient in connection with or to carry out the activities described in Section
11.1(a)(i) through Section 11.1(a)(iv) and the Transactions.

               (b) The grant of authority provided for in this Section 11.1: (i) is coupled with an
interest and is being granted, in part, as an inducement to the Company and Parent to enter into
this Agreement, and will be irrevocable and survive the death, incompetency, bankruptcy or
liquidation of any Seller and will be binding on any successor thereto; (ii) subject to Section
11.3, may be exercised by the Sellers’ Representative acting by signing as Sellers’
Representative of any Seller; and (iii) will survive any distribution of the Holdback Amount.

     Section 11.2. Compensation; Exculpation; Indemnity.

               (a) The Sellers’ Representative will not be entitled to any fee, commission or other
compensation for the performance of its service hereunder but will be entitled to reimbursement for
any of its out-of-pocket expenses incurred as Sellers’ Representative pursuant to the undertaking
provided by each Seller in Section 11.2(c).

               (b) In dealing with this Agreement and any instruments, agreements or documents relating
thereto, and in exercising or failing to exercise all or any of the powers conferred upon the
Sellers’ Representative hereunder or thereunder, (i) the Sellers’ Representative will not assume
any, and will incur no, Liability whatsoever to any Seller because of any error in judgment or
other act or omission performed or omitted hereunder or in connection with this Agreement, and (ii)
the Sellers’ Representative will be entitled to rely on the advice of counsel, public accountants
or other independent experts experienced in the matter at issue, and any error in judgment or other
act or omission of the Sellers’ Representative pursuant to such advice will not subject the
Sellers’ Representative to Liability to any Seller, the Company, Parent, or any other Person.

               (c) The Sellers’ Representative will be indemnified by the Sellers, jointly and severally,
from and against any and all claims, demands, liabilities, costs and expenses (including, without
limitation, reasonable attorneys’ fees), arising from or related to any acts undertaken (and any
omissions to act) in his capacity as the Sellers’ Representative, except to the extent attributable
to the Sellers’ Representative’s willful misconduct. Each Seller, by the execution and delivery of
this Agreement, agrees (i) to reimburse the Sellers’ Representative for any and all fees, costs and
expenses incurred by the Sellers’ Representative promptly following submission by the Sellers’
Representative of appropriate documentation substantiating the amount thereof and (ii) as among
themselves, to bear their pro rata share of any such fees, costs and expenses of the Sellers’
Representative based on the number of Seller Shares they held immediately prior to the Equity
Closing Date. For the avoidance of doubt, any claims by the Sellers’ Representative for
indemnification may be asserted by the Sellers’ Representative
against any individual Seller who shall then seek reimbursement for all other Sellers as
contemplated in this Section 11.2.

     Section 11.3. Removal and Replacement of Sellers’ Representative; Successor Sellers’
Representative.

55

 

               (a) If the Sellers’ Representative or his heir or personal representative, as the case may be,
advise the Sellers that the Sellers’ Representative is unavailable to perform its duties hereunder,
within three (3) Business Days of notice of such advice, a Sellers’ Representative, who shall be a
Seller, will be appointed by the affirmative vote of those Sellers who held, as of immediately
prior to the Equity Closing, a majority of the Seller Shares and Seller Options as of the Equity
Closing.

               (b) Any Sellers’ Representative may be removed at any time by a written notice, delivered by
the Sellers who held, as of immediately prior to the Equity Closing, a majority of the Seller
Shares and Seller Options, to the Sellers’ Representative, the other Sellers, and Parent. No
Sellers’ Representative may be removed until the Sellers who held, as of immediately prior to the
Equity Closing, a majority of the Seller Shares and Seller Options have replaced such Sellers’
Representative by written notice delivered to the Sellers and Parent.

               (c) If any successor Sellers’ Representative is appointed under Section 11.3(a) or
Section 11.3(b), such appointment will be effective upon delivery of written notice
thereof, executed by the Sellers who held, as of immediately prior to the Equity Closing, a
majority of the Seller Shares and Seller Options, to each of the Sellers’ Representative, the other
Sellers and Parent. Any successor Sellers’ Representative will have all of the authority and
responsibilities conferred upon or delegated to a Sellers’ Representative pursuant to this
Section 11.3.

     Section 11.4. Reliance; Limitation as to Parent and the Company.

               (a) Parent and the Company may conclusively and absolutely rely, without inquiry, and until
the receipt of written notice of a change of the Sellers’ Representative under Section
11.3, may continue to rely, without inquiry, upon the action of the Sellers’ Representative as
the action of each Seller in all matters referred to in Section 11.1(a); provided, however,
that if Parent is given written notice of the appointment of a successor Sellers’ Representative
under Section 11.3, Parent, the Company, and the Sellers will be obligated to recognize,
and will only be able to so rely upon the action of, such successor Sellers’ Representative as the
Sellers’ Representative for all purposes under this Agreement.

               (b) Except as set forth in this Section 11.4, nothing in this ARTICLE XI
creates any enforceable obligations between Parent or the Company, on the one hand, and the
Sellers, on the other hand.

ARTICLE XII.

MISCELLANEOUS

     Section 12.1. Entire Agreement. The Transaction Documents, together with the exhibits and schedules hereto and the
certificates, documents, instruments and writings that are delivered pursuant hereto, constitute
the entire agreement and understanding of the Parties in respect of the subject matter contemplated
thereby and supersede all prior understandings, agreements, or representations by or among the
Parties, written or oral, to the extent they relate in any way to the subject matter thereof or the
Transactions. Except as (i) expressly

56

 

contemplated by ARTICLE IX and (ii) the Sellers’
Representative as contemplated by ARTICLE XI, there are no third party beneficiaries having
rights under or with respect to this Agreement.

     Section 12.2. Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this
Agreement are binding upon, and inure to the benefit of and are enforceable by, the Parties and
their respective successors.

     Section 12.3. Assignments. No Party may assign either this Agreement or any of its rights, interests, or obligations
hereunder without the prior written approval of Parent and the Sellers who held, as of immediately
prior to the Equity Closing, a majority of the Seller Shares and Seller Options; provided, however,
that Parent may (a) assign any or all of its rights and interests hereunder to one or more of its
Affiliates and (b) designate one or more of its Affiliates to perform its obligations hereunder (in
any or all of which cases Parent nonetheless will remain responsible for the performance of all of
its obligations hereunder).

     Section 12.4. Notices. All notices, requests, demands, claims and other communications hereunder will be in writing.
Any notice, request, demand, claim or other communication hereunder will be deemed duly given if
(and then three (3) Business Days after) it is sent by registered or certified mail, return receipt
requested, postage prepaid, and addressed to the intended recipient as set forth below:

If to Parent, Buyer and after Equity Closing to the Company:

VCA Antech, Inc.

12401 West Olympic Boulevard

Los Angeles, California 90064-1022

Attn: Chief Financial Officer

Tel: (310) 571-6505

Fax: (310) 571-6905

Copy to (which will not constitute notice):

Akin Gump Strauss Hauer & Feld LLP

Century Tower Plaza, 2029 Century Park East, Suite 2400

Los Angeles, CA 90067

Attn: Frank Reddick

Tel: (310) 229-1000

Fax: (310) 229-1001

If to the Company (prior to Equity Closing):

Pet DRx Corporation

215 Centerview Drive, Suite 360

Brentwood, Tennessee

Attn: Chief Executive Officer

Tel: (615) 369-1914

Fax: (404) 365-0107

57

 

Copy to (which will not constitute notice):

Bryan Cave LLP

1201 W. Peachtree Street, 14th Floor

Atlanta, Georgia 30309-3488

Attn: Rick Miller

Tel: (404) 572-6787

Fax: (404) 420-0787

If to Sellers’ Representative the address set forth in Section 12.4 of the Company Disclosure Schedule.

Any Party may send any notice, request, demand, claim, or other communication hereunder to the
intended recipient at the address set forth above using any other means (including personal
delivery, expedited courier, messenger service, telecopy, telex, ordinary mail, or electronic
mail), but no such notice, request, demand, claim, or other communication will be deemed to have
been duly given unless and until it actually is received by the intended recipient. Any Party may
change the address to which notices, requests, demands, claims, and other communications hereunder
are to be delivered by giving the other Parties notice in the manner herein set forth.

     Section 12.5. Submission to Jurisdiction; Process Agent. Each Party submits to the jurisdiction of any federal or state court located in Delaware, in
any Action arising out of or relating to this Agreement and agrees that all claims in respect of
the Action may be heard and determined in any such court. Each Party also agrees not to bring any
Action arising out of or relating to this Agreement in any other court. Each Party agrees that a
final judgment in any Action so brought will be conclusive and may be enforced by Action on the
judgment or in any other manner provided at Law or in equity. Each Party waives any defense of
inconvenient forum to the maintenance of any Action so brought and waives any bond, surety, or
other security that might be required of any other Party with respect thereto. Process in any such
action, suit or proceeding may be served on any party anywhere in the world, whether within or
without the jurisdiction of any such court.

     Section 12.6. Time. Time is of the essence in the performance of this Agreement.

     Section 12.7. Counterparts. This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument.

     Section 12.8. Headings. The article and section headings contained in this Agreement are inserted for convenience only
and will not affect in any way the meaning or interpretation of this Agreement.

     Section 12.9. Governing Law. This Agreement and the performance of the Transactions and obligations of the Parties
hereunder will be governed by and construed in accordance with the laws of the State of Delaware,
without giving effect to any choice of Law principles.

58

 

     Section 12.10. Amendments and Waivers. No amendment, modification, replacement, termination or cancellation of any provision of this
Agreement will be valid, unless the same will be in writing and signed by Parent, the Company and
the Sellers’ Representative. Neither any failure nor any delay by any Party in exercising any
right, power or privilege under the Transaction Documents will operate as a waiver of such right,
power or privilege, and no single or partial exercise of any such right, power or privilege will
preclude any other or further exercise of such right, power or privilege or the exercise of any
other right, power or privilege. To the maximum extent permitted by applicable law, (a) no claim or
right arising out of this Agreement or any of the Transaction Documents can be discharged by one
Party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing
signed by the other Party; (b) no waiver that may be given by a Party will be applicable except in
the specific instance for which it is given; and (c) no notice to or demand on one Party will be
deemed to be a waiver of any obligation of that Party or of the right of the Party giving such
notice or demand to take further action without notice or demand as provided in the Transaction
Documents.

     Section 12.11. Severability. The provisions of this Agreement will be deemed severable and the invalidity or
unenforceability of any provision will not affect the validity or enforceability of the other
provisions hereof; provided that if any provision of this Agreement, as applied to any Party or to
any circumstance, is adjudged by a Governmental Body, arbitrator or mediator not to be enforceable
in accordance with its terms, the Parties agree that the Governmental Body, arbitrator, or mediator
making such determination will have the power to modify the provision in a manner consistent with
its overall objectives such that it is enforceable, and/or to delete specific words or phrases, and
in its reduced or revised form, such provision will then be enforceable and will be enforced.

     Section 12.12. Expenses. Except as otherwise expressly provided in this Agreement, each Party will bear its own costs
and expenses incurred in connection with the preparation, execution and performance of this
Agreement and the Transactions including all fees and expenses of agents, Representatives,
financial advisors, legal counsel and accountants.

     Section 12.13. Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. If
an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if
drafted jointly by the Parties and no presumption or burden of proof will arise favoring or
disfavoring any Party because of the authorship of any provision of this Agreement. Any reference
to any federal, state, local, or foreign Law will be deemed also to refer to such Law as amended
and all rules and regulations promulgated thereunder, unless the context requires otherwise. The
words “include,” “includes,” and “including” will be deemed to be followed by “without limitation”
unless preceded by a negative predicate. Pronouns in masculine, feminine, and neuter genders will
be construed to include any other gender, and words in the singular form shall be construed to
include the plural and vice versa, unless the context otherwise requires. The words “this
Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this
Agreement as a whole and not to any particular subdivision unless expressly so limited. The
Parties intend that each representation, warranty, and covenant contained herein will have
independent significance. If any Party has Breached any representation, warranty, or covenant
contained herein in any respect, the fact that there exists another representation, warranty or
covenant relating to the same subject matter (regardless of the relative levels of specificity)
which the Party has not Breached will not detract

59

 

from or mitigate the fact that the Party is in
Breach of the first representation, warranty, or covenant.

     Section 12.14. Remedies. Except as expressly provided herein, the rights, obligations and remedies created by this Agreement are cumulative and in addition to any other rights, obligations, or remedies otherwise
available at Law or in equity. Except as expressly provided herein, nothing herein will be
considered an election of remedies.

     Section 12.15. Electronic Signatures.

               (a) Notwithstanding the Electronic Signatures in Global and National Commerce Act (15 U.S.C.
Sec. 7001 et. seq.), the Uniform Electronic Transactions Act, or any other Law relating to or
enabling the creation, execution, delivery, or recordation of any contract or signature by
electronic means, and notwithstanding any course of conduct engaged in by the Parties, no Party
will be deemed to have executed a Transaction Document or other document contemplated thereby
(including any amendment or other change thereto) unless and until such Party shall have executed
such Transaction Document or other document on paper by a handwritten original signature or any
other symbol executed or adopted by a Party with current intention to authenticate such Transaction
Document or such other document contemplated.

               (b) Delivery of a copy of a Transaction Document or such other document bearing an original
signature by facsimile transmission (whether directly from one
facsimile device to another by means of a dial-up connection or whether mediated by the
worldwide web), by electronic mail in “portable document format” (“.pdf”) form, or by any other
electronic means intended to preserve the original graphic and pictorial appearance of a document,
will have the same effect as physical delivery of the paper document bearing the original
signature. “Originally signed” or “original signature” means or refers to a signature that has not
been mechanically or electronically reproduced.

[SIGNATURE PAGE FOLLOWS]

60

 

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above
written.

	 	 	 	 	 
	 	PARENT:

PET DRX CORPORATION

 	 
	 	By:  	/s/
Gene E. Burleson 	 
	 	 	Name:  	Gene E. Burleson 	 
	 	 	Title:  	Chief
Executive Officer 	 
	 
	 	BUYER:

SNOW MERGER ACQUISITION, INC.

 	 
	 	By:  	/s/
Robert L. Antin 	 
	 	 	Name:  	Robert L. Antin 	 
	 	 	Title:  	President
& CEO 	 
	 
	 	COMPANY:

VCA ANTECH, INC.

 	 
	 	By:  	/s/
Robert L. Antin 	 
	 	 	Name:  	Robert L. Antin 	 
	 	 	Title:  	President
& CEO 	 
	 
	 	SELLERS’ REPRESENTATIVE:

 	 
	 	/s/
Harry L. Zimmerman
	 	HARRY L. ZIMMERMAN 	 

Signature page to Stock Purchase Agreement

 

SELLERS:

Camden Partners Strategic Fund III, L.P.

	 	 	 	 	 

	By:

	 	Camden Partners Strategic III, LLC	 	 
	Its:

	 	General Partner	 	 
	 
	 	 	 	 
	By:

	 	Camden Partners Strategic Manager, LLC	 	 
	Its:

	 	Managing Member	 	 
	 
	 	 	 	 
	By:

	 	/s/ Richard M. Johnston	 	 
	 

	 	 

Richard M. Johnston
	 	 
	 

	 	Managing Member	 	 
	 
	 	 	 	 
	Camden Partners Strategic Fund III-A, L.P.
	 
	 	 	 	 
	By:

	 	Camden Partners Strategic III, LLC	 	 
	Its:

	 	General Partner	 	 
	 
	 	 	 	 
	By:

	 	Camden Partners Strategic Manager, LLC	 	 
	Its:

	 	Managing Member	 	 
	 
	 	 	 	 
	By:

	 	/s/ Richard M. Johnston	 	 
	 

	 	 

Richard M. Johnston
	 	 
	 

	 	Managing Member	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	Galen Partners IV, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Bruce F. Wesson	 	 
	 

	 	Name:
	 	 

Bruce F. Wesson
	 	 
	 

	 	Title:
	 	Managing Director	 	 

 Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:
	 
	 	 	 	 	 	 
	 	 	Galen Partners International IV, L.P.
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Bruce F. Wesson	 	 
	 

	 	Name:
	 	 

Bruce F. Wesson
	 	 
	 

	 	Title:
	 	Managing Director	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:
	 
	 	 	 	 	 	 
	 	 	Galen Employee Fund IV, L.P.
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Bruce F. Wesson	 	 
	 

	 	Name:
	 	 

Bruce F. Wesson
	 	 
	 

	 	Title:
	 	Managing Director	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:
	 
	 	 	 	 	 	 
	 	 	Chicago Investments, Inc.
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Joshua S. Kanter	 	 
	 

	 	Name:
	 	 

Joshua S. Kanter
	 	 
	 

	 	Title:
	 	President	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:
	 
	 	 	 	 	 	 
	 	 	CIBC Trust Company (Bahamas) Limited

     As Trustee
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Linda G. Williams/Helen M. Carroll	 	 
	 

	 	Name:
	 	 

Linda G. Williams/Helen M. Carroll
	 	 
	 

	 	Title:
	 	Authorised Signatories	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	Kanter Family Foundation	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Joel Kanter	 	 
	 

	 	Name:
	 	 

Joel Kanter
	 	 
	 

	 	Title:
	 	President	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	Windy City, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Joel Kanter	 	 
	 

	 	Name:
	 	 

Joel Kanter
	 	 
	 

	 	Title:
	 	President	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	Knott Partners L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ David M. Knott	 	 
	 

	 	Name:
	 	 

David M. Knott
	 	 
	 

	 	Title:
	 	Investment Advisor	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	Knott Partners Offshore Master Fund L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ David M. Knott	 	 
	 

	 	Name:
	 	 

David M. Knott
	 	 
	 

	 	Title:
	 	Investment Advisor	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

Finderne LLC

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

Good Steward Trading Co. S.P.C.

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Mulsanne Partners, L.P.

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Knott Partners Offshore (SRI) Fund Limited

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Shoshone Partners, L.P.

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Commonfund Hedged Equity Co.

 	 
	 	By:  	/s/ David M. Knott
 	 
	 	Name:  	David M. Knott 	 
	 	Title:  	Investment Advisor 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Wynnefield Partners Small Cap Value LP

 	 
	 	By:  	/s/ Nelson Obus
 	 
	 	Name:  	Nelson Obus 	 
	 	Title:  	Managing Member 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Wynnefield Partners Small Cap Value LP I

 	 
	 	By:  	/s/ Nelson Obus
 	 
	 	Name:  	Nelson Obus 	 
	 	Title:  	Managing Member 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

Wynnefield Partners Small Cap Value Offshore 

Fund, Ltd.

 	 
	 	By:  	/s/ Nelson Obus
 	 
	 	Name:  	Nelson Obus 	 
	 	Title:  	President 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	SELLERS:

St. Cloud Capital Partners, L.P.

 	 
	 	By:  	/s/ Robert Lautz
 	 
	 	Name:  	Robert Lautz 	 
	 	Title:  	Managing Director 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	KFT Limited Partnership	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Joshua Trust, General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Solomon A. Weisgal	 	 
	 

	 	Name:
	 	 

Solomon A. Weisgal
	 	 
	 

	 	Title:
	 	Trustee	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 	 	 

	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	MPW Trust	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Solomon A. Weisgal	 	 
	 

	 	Name:
	 	 

Solomon A. Weisgal
	 	 
	 

	 	Title:
	 	 Trustee	 	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Gene E. Burleson
 	 
	 	 	Gene Burleson 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Harry Zimmerman
 	 
	 	 	Harry Zimmerman 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Stephen Ettinger
 	 
	 	 	Stephen Ettinger 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ David Reed
 	 
	 	 	David Reed 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Richard Martin
 	 
	 	 	Richard Martin 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Zubeen Shroff
 	 
	 	 	Zubeen Shroff 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreement

 

 

	 	 	 	 	 
	 	SELLERS:

 	 
	 	By:  	/s/ Joel Kanter
 	 
	 	 	Joel Kanter 	 
	 	 	 	 
	 

Signature page to Stock Purchase Agreementexv10w2

Exhibit 10.2

     EXECUTION COPY

MERGER

AGREEMENT

by

and

among

VCA ANTECH, INC.,

SNOW MERGER ACQUISITION, INC.,

and

PET DRX CORPORATION

Dated as of June 2, 2010

 

 

TABLE OF CONTENTS

	 	 	 	 	 

	ARTICLE I. DEFINITIONS
	 	 	1	 
	 
	 	 	 	 
	ARTICLE II. THE MERGER
	 	 	9	 
	Section 2.1. Merger
	 	 	9	 
	Section 2.2. Closing
	 	 	9	 
	Section 2.3. Closing Statement
	 	 	9	 
	Section 2.4. Payments and Deliveries at the Merger Closing
	 	 	9	 
	Section 2.5. Taking of Necessary Action; Further Action
	 	 	10	 
	Section 2.6. Effect of the Merger
	 	 	10	 
	Section 2.7. Charter and Bylaws
	 	 	10	 
	Section 2.8. Directors and Officers
	 	 	10	 
	Section 2.9. Effect on Capital Stock
	 	 	11	 
	Section 2.10. Surrender of Certificates
	 	 	12	 
	Section 2.11. Stock Options and Warrants
	 	 	14	 
	Section 2.12. Shares of Dissenting Stockholders
	 	 	15	 
	 
	 	 	 	 
	ARTICLE III. REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
	 	 	15	 
	Section 3.1. Entity Status
	 	 	15	 
	Section 3.2. Power and Authority; Enforceability
	 	 	16	 
	Section 3.3. No Violation
	 	 	16	 
	Section 3.4. Consents
	 	 	16	 
	Section 3.5. Sufficient Funds
	 	 	16	 
	 
	 	 	 	 
	ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	 	 	16	 
	Section 4.1. Corporate Status
	 	 	17	 
	Section 4.2. Power and Authority; Enforceability
	 	 	17	 
	Section 4.3. No Violation
	 	 	17	 
	Section 4.4. Capitalization
	 	 	17	 
	 
	 	 	 	 
	ARTICLE V. COVENANTS
	 	 	18	 
	Section 5.1. General
	 	 	18	 
	Section 5.2. Information Statement
	 	 	18	 
	 
	 	 	 	 
	ARTICLE VI. CLOSING CONDITIONS
	 	 	19	 
	Section 6.1. General Conditions
	 	 	19	 
	Section 6.2. Conditions Precedent to Obligation of Parent and Merger Sub
	 	 	20	 
	 
	 	 	 	 
	ARTICLE VII. TERMINATION
	 	 	20	 
	Section 7.1. Termination of Agreement
	 	 	20	 
	Section 7.2. Effect of Termination
	 	 	21	 
	 
	 	 	 	 
	ARTICLE VIII. MISCELLANEOUS
	 	 	21	 
	Section 8.1. Entire Agreement
	 	 	21	 
	Section 8.2. Successors
	 	 	21	 
	Section 8.3. Assignments
	 	 	21	 
	Section 8.4. Notices
	 	 	21	 
	Section 8.5. Submission to Jurisdiction; Process Agent
	 	 	22	 
	Section 8.6. Time
	 	 	23	 

i

 

	 	 	 	 	 

	Section 8.7. Counterparts
	 	 	23	 
	Section 8.8. Headings
	 	 	23	 
	Section 8.9. Governing Law
	 	 	23	 
	Section 8.10. Amendments and Waivers
	 	 	23	 
	Section 8.11. Severability
	 	 	23	 
	Section 8.12. Expenses
	 	 	23	 
	Section 8.13. Construction
	 	 	24	 
	Section 8.14. Remedies
	 	 	24	 
	Section 8.15. Electronic Signatures
	 	 	24	 

ii

 

	 	 	 	 	 

	Exhibits
	 	 	 	 
	Exhibit A Sample Computation of Adjusted Net Working Capital  
	 	 	 	 
	Exhibit B Form of Closing Statement
	 	 	 	 
	Exhibit C Form of Merger Certificate
	 	 	 	 
	Exhibit D Form of Company’s Officers’ Certificate
	 	 	 	 
	Exhibit E Form of Company’s Secretary’s Certificate
	 	 	 	 
	Exhibit F Form of Parent’s Secretary’s Certificate
	 	 	 	 
	Exhibit G Letter of Transmittal
	 	 	 	 
	Exhibit H Form of Press Release
	 	 	 	 
	 
	 	 	 	 
	Schedules
	 	 	 	 
	Schedule A Management Bonuses
	 	 	 	 
	Schedule B Company Subsidiaries
	 	 	 	 

iii

 

MERGER AGREEMENT

     This Merger Agreement (this “Agreement”), dated as of June 2, 2010, is by and among (i) Snow
Merger Acquisition, Inc., a Delaware corporation (“Merger Sub”), (ii) VCA Antech, Inc., a Delaware
corporation (“Parent”), and (iii) Pet DRx Corporation, a Delaware corporation (“Company”).

BACKGROUND:

     A. The Company and Parent jointly desire that Parent acquire the Company through the statutory
merger of Merger Sub with and into the Company (the “Merger”), in accordance with this Agreement’s
terms and conditions.

     B. Pursuant to the Merger all of the Company’s issued and outstanding shares of common stock,
par value $0.0001 per share (the “Company Common Stock”) will be converted into the right to
receive cash.

     C. Concurrently with entering into this Agreement, Parent, Merger Sub, the Company and certain
stockholders (the “Sellers”)of the Company are executing and delivering a Stock Purchase Agreement
(the “Stock Purchase Agreement”) pursuant to which Merger Sub will acquire all Company Common Stock
and options and warrants exercisable into shares of Company Common Stock beneficially owned by the
Sellers (the “Equity Purchase”) prior to the consummation of the Merger, all in accordance with the
terms and conditions of the Stock Purchase Agreement.

     D. The board of directors of the Company has (i) determined that the transactions contemplated
by this Agreement and the Stock Purchase Agreement are fair to, and in the best interests of, the
Company and its Stockholders, (ii) has approved and adopted this Agreement and the Stock Purchase
Agreement and the Transactions (as defined herein) contemplated hereby and thereby and (iii) has
recommended the approval and adoption of this Agreement and the Merger by the Stockholders of the
Company.

     E. Concurrently with the execution of this Agreement, stockholders owning a majority of the
issued and outstanding shares of Company Common Stock have executed a written consent approving the
adoption of this Agreement, and the consummation of the Merger and the other Transactions
contemplated herein (the “Stockholder Consent”).

AGREEMENT:

     NOW, THEREFORE, in consideration of the premises and the mutual promises herein made, and of
the representations, warranties, and covenants contained herein, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto hereby agree as follows:

ARTICLE I.

DEFINITIONS

     “2009 Financial Statements” means the audited consolidated balance sheets of the Acquired
Entities as of December 31, 2009, audited consolidated statements of income, changes

1

 

in stockholders’ equity and cash flows for the Acquired Entities for the fiscal year ended
December 31, 2009, including the notes thereto, with the report thereon of Singerlewak LLP
independent certified public accountants all as filed with the SEC as part of the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2009.

     “Acquired Entities” means the Company and each of the Company Subsidiaries.

     “Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent
or an Affiliate of Parent) for (i) a merger, acquisition consolidation, purchase or similar
transaction involving any equity security of the Company or (ii) the acquisition (other than an
acquisition by Parent or an Affiliate of Parent) of all or substantially all of the assets of the
Company.

     “Action” means any action, appeal, petition, plea, charge, complaint, claim, suit, demand,
litigation, arbitration, mediation, hearing, inquiry, investigation or similar event, occurrence,
or proceeding.

     “Adjusted Current Assets” means the net book value of all of the assets of the Acquired
Entities as of 12:01 a.m. (PST) on the Equity Closing Date, that would be classified as “current
assets” under GAAP, the net book value of which shall be determined using the same accounting
methods, policies, practices, principles and procedures with consistent classifications that were
used in the preparation of the 2009 Financial Statements: which assets shall include, but not be
limited to, the following: (i) cash (including certificates of deposit) and cash equivalents (net
of any restricted cash), (ii) trade accounts receivable (net of doubtful accounts); (iii) prepaids
(iv) inventory and (v) other current assets.

     “Adjusted Current Liabilities” means all of the liabilities of the Acquired Entities as of
12:01 a.m. (PST) on the Equity Closing Date that would be classified as “current liabilities” under
GAAP, the net book value of which shall be determined using the same accounting methods, policies,
practices, principles and procedures with consistent classifications that were used in the
preparation of the 2009 Financial Statements, which liabilities shall include, but not be limited
to, the following: (i) accounts payable and other accrued liabilities; (ii) accrued payroll,
accrued vacation and other compensation expenses (including flexible time off (FTO), bonuses (other
than those set forth on Schedule A), flexible spending accounts (FSA/DECAP), 401(k)
withholding, health insurance reserve, and current payroll tax obligations), (iii) accrued taxes
(including, but not limited to, income, sales and property taxes), (iv) all Severance Obligations
in excess of $2,800,000, (v) the Dispute Letter Accrual, and (vi) accrued expenses and other
current liabilities. Notwithstanding the foregoing, Adjusted Current Liabilities shall not include
(w) the current portion of any Debt of the Acquired Entities, (x) any accrued and unpaid interest
and any other accrued payment obligations with respect to Debt included in Company Debt (y) the
Closing Costs, and (z) the Information Statement Fees.

     “Adjusted Net Working Capital” means Adjusted Current Assets minus Adjusted Current
Liabilities. Attached hereto as Exhibit A is a sample computation of Adjusted Net Working
Capital.

2

 

     “Affiliate” or “Affiliated” with respect to any specified Person, means a Person that,
directly or indirectly, through one or more intermediaries, controls or is controlled by, or is
under common control with, such specified Person.

     “Aggregate Transaction Consideration” means (i) $41,250,000, minus (ii) the Company
Debt, minus (iii) all Closing Costs in excess of $2,000,000, minus (iv) the
Purchase Price Adjustment (if any).

     “Breach” means (i) any breach, inaccuracy, failure to perform, failure to comply, conflict
with, failure to notify when there is an obligation to provide notice, default, or violation or
(ii) any other act, omission, event, occurrence or condition the existence of which would (A)
permit any Person to accelerate any obligation or terminate, cancel, or modify any right or
obligation or (B) require the payment of money or other consideration.

     “Business Day” means a day on which banks are ordinarily open for transaction of normal
banking business in Los Angeles, California.

     “Closing Costs” means the sum of (i) the dollar amount of all out-of-pocket costs, fees and
expenses of investment bankers, financial advisors, legal counsel and accountants incurred or
payable by the Acquired Entities in connection with the negotiation, execution and consummation of
the Transactions through the Equity Closing, plus (ii) the management bonuses set forth on
Schedule A hereto, plus (iii) fifty percent (50%) of the premium for the D&O Tail Policy.
For clarification purposes, if any such fees and expenses incurred through the Equity Closing are
contingent or payable only upon the consummation of the Merger, such expenses will constitute
Closing Costs hereunder notwithstanding that such fees or expenses may not be accrued under GAAP
until the Merger Closing. Closing Costs shall not include the Information Statement Fees.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Commercially Reasonable Best Efforts” means the efforts, time and costs that a prudent Person
desirous of achieving a result would use, expend, or incur in similar circumstances in an effort to
achieve such result as expeditiously as possible subject to then existing commercial realities.

     “Commitment” means (i) options, warrants, convertible securities, exchangeable securities,
subscription rights, conversion rights, exchange rights, or other Contracts that could require a
Person to issue any of its Equity Interests or sell any Equity Interests it owns in another Person,
(ii) any other securities convertible into, exchangeable or exercisable for, or representing the
right to subscribe for any Equity Interests of a Person or owned by a Person, (iii) statutory
preemptive rights or preemptive rights granted under a Person’s Organizational Documents, and (iv)
stock appreciation rights, phantom stock, profit participation, or other similar rights with
respect to a Person.

     “Company Debt” means the dollar amount of all Debt of the Acquired Entities outstanding as of
the Equity Closing Date, which shall be set forth on the Closing Statement prepared pursuant to
Section 2.3 hereof, including all accrued and unpaid interest relating thereto as of the
Equity Closing Date, and any accrued late fees or other payment obligations with

3

 

respect thereto and any and all penalties, premiums, or other breakage costs incurred as a
result of payment of the Company Debt on the Equity Closing Date; provided that the Disputed
Earn-Out Notes shall not be deemed Company Debt for purposes of this Agreement.

     “Company Option” means an option, warrant or other right to purchase shares of Company Common
Stock.

     “Company Plans” means all plans and other arrangements that currently are in effect which
provide compensation or benefits to current or former officers, directors, consultants, employees
or leased employees of any Acquired Entity, including, without limitation, all “employee benefit
plans” as defined in Section 3(3) of ERISA, and all bonus, stock option, stock purchase, incentive,
phantom stock, deferred compensation, supplemental retirement, insurance, severance and other
similar fringe or employee benefit plans, and all employment, consulting or executive compensation
agreements covering any current or former officer, director, employee or consultant of any Acquired
Entity or the beneficiaries or dependents of any such current or former officer, director, employee
or consultant.

     “Company Subsidiaries” means each of the direct or indirect Subsidiaries of the Company as set
forth on Schedule C.

     “Consent” means any consent, approval, notification, waiver, amendment or other similar
action.

     “Contract” means any contract, agreement, arrangement, commitment, letter of intent,
memorandum of understanding, heads of agreement, promise, obligation, right, instrument, document,
or other similar understanding, whether written or oral.

     “D&O Tail Policy” means a six (6) year run-off director and officer liability insurance
policy, effective as of the Equity Closing, for the benefit of the directors and officers of the
Company prior to the Equity Closing Date

     “DGCL” means the General Corporation Law of the State of Delaware as in effect as of the date
hereof.

     “Damages” means all damages, losses, Liabilities, penalties, fines and expenses actually
incurred and paid (including reasonable fees and expenses of outside attorneys) and Taxes with
respect to the foregoing, but in any case excluding consequential, incidental and punitive damages,
losses, lost profits, and Liabilities.

     “Debt” means indebtedness for borrowed money, including any bank debt or notes payable
(including current portion), capitalized lease obligations, the deferred purchase price for assets
or business acquired (including, without limitation, the maximum dollar amount due and payable in
connection with any earn-out, escrow, holdback or contingent payment).

     “Deficit Working Capital” means the amount, if any, by which the Adjusted Net Working Capital
of the Company at the Equity Closing is less than the Target Working Capital.

4

 

     “Disputed Earn-Out Notes” means those two (2) Earn-Out Promissory Notes, dated December 31,
2006, each in the principal amount of $150,000 issued to Douglas E. Tomblin, DVM and Thomas J.
Bernhard, DVM, respectively, that are the subject of that certain litigation entitled Tomblin vs.
XLNT Veterinary Care, Inc., etc., et. al, Case #37-2009-00067537 (San Diego Superior Court).

     “Encumbrance” means any chose, encumbrance, security interest, lien, easement, encroachment,
covenant, condition, preemptive purchase right or option, adverse claim or restriction.

     “Equity Closing” means the closing of the Equity Purchase.

     “Equity Closing Date” means the date of the closing of the Equity Purchase.

     “Equity Interest” means (b) with respect to a corporation, any and all shares of capital
stock, (b) with respect to a partnership, limited liability company, trust or similar Person, any
and all units, interests or other partnership/limited liability company interests, and (c) any
other direct equity ownership or participation in a Person.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

     “Excess Closing Costs” means the amount, if any, by which the Closing Costs exceed $2,000,000.

     “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

     “GAAP” means United States generally accepted accounting principles as in effect as of the
date hereof.

     “Governmental Body” means any legislature, agency, bureau, department, commission, court,
political subdivision, tribunal or other instrumentality of government whether local, state,
federal or foreign.

     “Information Statement Fees” means the reasonable fees of outside legal counsel to the Special
Committee of the Board of Directors of the Company incurred in connection with the preparation and
filing of the Information Statement, as well as responding to any issues, questions and inquiries
raised or initiated by the SEC through the date that the Information Statement is mailed to the
Company’s shareholders in an amount estimated to be $150,000 and which shall will not exceed
$200,000.

     “In-the-Money Company Option” means each Company Option that has an exercise price less than
the quotient obtained by dividing (i) the Aggregate Transaction Consideration by (ii) the sum of
(x) the number of shares of Company Common Stock issued and outstanding immediately prior to the
Equity Closing (excluding any shares of Company Common Stock held as treasury shares), and (y) the
number of shares of Company Common Stock issuable upon exercise of all Company Options issued and
outstanding immediately prior to the Equity Closing determined pursuant to an iterative process
beginning with all Company Options issued and outstanding immediately prior to the Equity Closing
and continuing through successive iterations

5

 

that exclude those Company Options with the then highest exercise price per share that is
greater than the result obtained pursuant to clauses (i) and (ii) above in the immediately
preceding iteration until such time as the exercise price per share with respect to each remaining
outstanding Company Options is less than the result obtained pursuant to clauses (i) and (ii) above
in the immediately preceding iteration

     “Law” means any applicable statute, rule, regulation, administrative requirement, code or
ordinance of any Governmental Body, each as amended and now in effect.

     “Liability” or “Liable” means any liability or obligation, whether known or unknown, asserted
or unasserted, direct or indirect, matured or unmatured, absolute or contingent, accrued or
unaccrued, latent or patent, liquidated or unliquidated, or due or to become due.

     “Merger Expiration Date” means December 31, 2010; provided, however, that the same shall be
extended for successive periods of one calendar month each in the event any Governmental Body
continues to be engaged in any review or evaluation of the Transactions until such time as such
review or evaluation is completed plus one calendar month thereafter, provided, further however
that in no event shall the Merger Expiration Date be later than June 30, 2011.

     “Organizational Documents” means the articles of incorporation, certificate of incorporation,
charter, bylaws, articles of formation, regulations, operating agreement, certificate of limited
partnership, partnership agreement, and all other similar documents, instruments or certificates
executed, adopted, or filed in connection with the creation, formation, or organization of a
Person, including any amendments thereto.

     “Parties” means the Parent, Merger Sub, and the Company.

     “Permit” means any permit, license, certificate, approval, consent, notice, waiver, franchise,
registration, filing, accreditation, entitlement, or other similar authorization required by any
Law or Governmental Body.

     “Per Share Merger Consideration” means (i) the Aggregate Transaction Consideration
plus the aggregate consideration paid or payable upon exercise of all issued and
outstanding In-the-Money Company Options, divided by (ii) the sum of the number of shares
of Company Common Stock issued and outstanding immediately prior to the Equity Closing plus
the aggregate number of shares of Company Common Stock issuable upon exercise of all In-the-Money
Company Options issued and outstanding immediately prior to the Equity Closing.

     “Person” means any individual, partnership, limited liability company, corporation,
association, joint stock company, trust, entity, joint venture, labor organization, unincorporated
organization, or Governmental Body.

     “Purchase Price Adjustment” means the amount of the Deficit Working Capital, if any.

     “Representatives” means Persons acting on behalf of another Person, including such Person’s
officers, directors, employees, representatives, agents, independent accountants, investment
bankers and counsel.

6

 

     “SEC” means the United States Securities and Exchange Commission.

     “Securities Act” means the Securities Act of 1933, as amended.

     “Severance Obligations” means all severance and other similar payments (including without
limitation, COBRA benefits) paid or payable to employees of the Acquired Entities in connection
with the consummation of the Transactions, and including all Taxes paid or payable relating
thereto.

     “Subsidiary” means, with respect to any Person: (i) any corporation of which more than ten
percent (10%) of the total voting power of all classes of the Equity Interests entitled (without
regard to the occurrence of any contingency) to vote in the election of directors is owned by such
Person directly or through one or more other Subsidiaries of such Person and (ii) any Person other
than a corporation of which at least ten percent (10%) of the Equity Interests (however designated)
entitled (without regard to the occurrence of any contingency) to vote in the election of the
governing body, partners, managers or others that will control the management of such entity are
owned by such Person directly or through one or more other Subsidiaries of such Person.

     “Target Working Capital” means negative $750,000.

     “Tax” means (i) any federal, state, local, or foreign income, gross receipts, license,
payroll, employment, excise, severance, stamp, occupation, premium, windfall profits,
environmental, customs, ad valorem, duties, capital stock, franchise, profits, withholding, social
security, unemployment, disability, real property, personal property, sales, use, transfer,
registration, value added, alternative or add-on minimum, estimated, or other tax of any kind
whatsoever, including any interest, penalty, or addition thereto, whether disputed or not,
including any obligations to indemnify or otherwise assume or succeed to the Tax liability of any
other Person, and (ii) any obligations under any Contracts with respect to any Tax described in
clause (i) above.

     “Termination Date” means the date on which this Agreement is terminated pursuant to
Section 7.1.

     “Transaction Documents” means this Agreement, the Stock Purchase Agreement, the Limited
Releases (as defined in the Stock Purchase Agreement), the Proxies (as defined in the Stock
Purchase Agreement) and each of the other documents, instruments and agreements to be executed,
delivered, and performed in connection herewith and therewith, together with any exhibits or
schedules constituting a part thereof.

     “Transactions” means all of the transactions contemplated by the Transaction Documents,
including: (i) the sale of the shares of Company Common Stock, and Company Options pursuant to the
terms of the Stock Purchase Agreement to Merger Sub; (ii) the Merger; (iii) the execution,
delivery, and performance of all of the documents, instruments and agreements to be executed,
delivered, and performed in connection herewith; and (iv) the performance by Parent, Merger Sub,
the Sellers (as defined in the Stock Purchase Agreement) and the Company of their respective
covenants and obligations (pre- and post-closing, as applicable) under the Transaction Documents.

7

 

     The following additional terms are defined in the sections of the Agreement set forth across
from such terms as set below:

	 	 	 
	Defined Term	 	Location of Definition
	 	 	 
	Agreement

	 	Preamble
	Asset Sale Transaction

	 	Error! Reference source not found.
	Closing Statement

	 	Section 2.3
	Company

	 	Preamble
	Company Common Stock

	 	Recitals
	Company Disclosure Schedule

	 	ARTICLE IV
	Company Stock Certificate

	 	Section 2.9(c)
	Converted Option Holder

	 	Section 2.11(d)
	Converted Option Merger Consideration

	 	Section 2.11(b)
	Converted Options

	 	Section 2.11(b)
	Dispute Letter

	 	Error! Reference source not found.

of the

Company Disclosure Schedule
	Dispute Letter Accrual

	 	Error! Reference source not found.

of the

Company Disclosure Schedule
	Dissenting Shares

	 	Section 2.12
	Effective Time

	 	Section 2.4
	Equity Purchase

	 	Recitals
	Information Statement

	 	Section 5.2(a)
	Merger

	 	Recitals
	Merger Certificate

	 	Section 2.4
	Merger Closing

	 	Section 2.2
	Merger Closing Date

	 	Section 2.2
	Merger Sub

	 	Preamble
	Parent

	 	Preamble
	Paying Agent

	 	Section 2.10(a)
	Preferred Stock

	 	Section 4.4
	Stockholder Consent

	 	Recitals
	Stockholders

	 	Section 2.10(a)
	Stock Purchase Agreement

	 	Recitals
	Surviving Corporation

	 	Section 2.1

8

 

ARTICLE II.

THE MERGER

     Section 2.1. Merger. On the terms and subject to the conditions set forth in this Agreement,
at the Effective Time, in accordance with this Agreement and the DGCL, Merger Sub will be merged
with and into the Company, Merger Sub’s separate corporate existence will cease, and the Company
will continue as the surviving corporation and as a wholly owned Subsidiary of Parent. The Company
as the surviving corporation after the Merger is sometimes referred to herein as the “Surviving
Corporation,” and references to the Company herein shall, for periods after the Effective Time, be
deemed to be references to the Surviving Corporation.

     Section 2.2. Closing. The closing of the Merger (the “Merger Closing”) will take place,
following the satisfaction or waiver of all conditions to the obligations of the Parties to
consummate the Merger (other than conditions with respect to actions the respective Parties will
satisfy at the Merger Closing itself), at the offices of Akin Gump Strauss Hauer & Feld LLP,
Century Tower Plaza, 2029 Century Park East, Suite 2400, Los Angeles, California, commencing at
9:00 a.m. (PST) on the later to occur of (i) the 1st day of the month following the
satisfaction or waiver of all conditions to the obligations of the Parties to consummate the Merger
(other than conditions with respect to actions the respective Parties will satisfy at the Merger
Closing itself), and (ii) the twenty-first (21st) day after delivery of the Information Statement
to the Company’s Stockholders, or such other date as the Parties may mutually determine (the
“Merger Closing Date”).

     Section 2.3. Closing Statement. At least ten (10) days prior to the expected Equity Closing
Date, the Company shall prepare and deliver to Parent a written statement, dated as of the date of
delivery, setting forth the Company’s good faith estimate of the Company Debt, the Closing Costs
and the Purchase Price Adjustment as of the Equity Closing Date, prepared in reasonable detail as
requested by Parent (the “Closing Statement”) in the form of Exhibit B. The Closing
Statement shall be subject to review by Parent and Parent shall give notice of any exceptions
regarding the Closing Statement no later than two (2) days prior to the Equity Closing Date and in
the absence of any such notice the Closing Statement as delivered by the Company shall be
conclusive and binding upon the Parties for purposes of the Merger Closing. Parent and the Company
shall negotiate in good faith to resolve any exceptions Parent may have to the Closing Statement,
but in the absence of such agreement the Closing Statement, as modified by Parent, shall be
conclusive and binding upon the Parties for purposes of the Merger Closing unless the difference
between the Closing Statement submitted by the Company and the Closing Statement as modified by
Parent is greater than $25,000, in which case the mid-point between the two positions shall be used
for purposes of the Merger Closing. In reviewing the Closing Statement, Parent shall have the
right to discuss such matters with the Company and its Representatives and to review the work
papers, schedules, memoranda, and other documents, including third party payoff schedules the
Company and its Representatives prepared or reviewed in determining each of the items set forth on
the Closing Statement.

     Section 2.4. Payments and Deliveries at the Merger Closing. On the Merger Closing Date, the
Parties will cause the Merger to be consummated by filing with the Secretary of State of the State
of Delaware a Certificate of Merger (or like instrument) substantially in the form of Exhibit C
(the “Merger Certificate”), in accordance with the DGCL. The Parties shall

9

 

file such other documents with the Secretary of State of the State of Delaware as may be required
by the provisions of the DGCL and as are necessary to cause the Merger to become effective. The
date and time the Merger becomes effective will be as specified in the Merger Certificate or as
otherwise provide in accordance with the DGCL and is referred to as the “Effective Time.” In
addition at the Merger Closing:

          (a) The Company will deliver to Parent:

               (i) An officer’s certificate, substantially in the form of Exhibit D, duly executed on
the Company’s behalf, as to whether each condition to be satisfied by the Company specified in
Section 6.1 and Section 6.2 has been satisfied as of the Merger Closing Date.

               (ii) A secretary’s certificate, substantially in the form of Exhibit E, duly executed
on the Company’s behalf.

          (b) Parent will deliver to the Company:

               (i) A secretary’s certificate, substantially in the form of Exhibit F, duly executed
on Parent’s behalf.

          (c) The Parties shall also deliver to each other any agreements, closing certificates and
other documents and instruments required to be delivered pursuant to this Agreement.

     Section 2.5. Taking of Necessary Action; Further Action. If, at any time after the Effective
Time, any such further action is necessary or desirable to carry out the purposes of this Agreement
and to vest the Surviving Corporation with full right, title and possession to all assets,
property, rights, privileges, powers, and franchises of the Company and the Company Subsidiaries,
the officers and directors of the Company, Parent, and Merger Sub are fully authorized in the name
of their respective corporations or otherwise to take, and the Company and Parent will cause them
to take, all such lawful and necessary action.

     Section 2.6. Effect of the Merger. At the Effective Time, the effect of the Merger will be as
provided in this Agreement and the DGCL. At the Effective Time all of the Company’s and Merger
Sub’s property, rights, privileges, powers, and franchises will vest in the Surviving Corporation,
and all debts, liabilities, duties and obligations of the Company and Merger Sub will become the
Surviving Corporation’s debts, liabilities, duties and obligations.

     Section 2.7. Charter and Bylaws. Unless Parent otherwise determines, at the Effective Time,
the Merger Sub’s certificate of incorporation will be the Surviving Corporation’s certificate of
incorporation until thereafter amended as provided by Law and such certificate of incorporation.
The Merger Sub’s bylaws, as in effect immediately prior to the Effective Time, will be the
Surviving Corporation’s bylaws until thereafter amended.

     Section 2.8. Directors and Officers. Merger Sub’s directors and officers immediately prior to
the Effective Time will be the Surviving Corporation’s initial directors and officers.

10

 

     Section 2.9. Effect on Capital Stock. At the Effective Time, because of the Merger and without
any action on the part of Parent, Merger Sub, or the Company:

          (a) Cancellation of Parent-Owned and Company-Owned Stock. Each share of Company
Common Stock or Company Option that Merger Sub, Parent, the Company or any direct or indirect
wholly-owned Subsidiary of Merger Sub, Parent or the Company owns, or holds in treasury,
immediately prior to the Effective Time will be canceled and extinguished without conversion.

          (b) Common Stock of Merger Sub. At the Effective Time, by virtue of the Merger and
without any action on the part of the holder thereof, each share of Merger Sub’s common stock
issued and outstanding immediately prior to the Effective Time will be converted into and exchanged
for one validly issued, fully paid, and nonassessable share of the Surviving Corporation’s common
stock. Each stock certificate of Merger Sub evidencing ownership of any such shares will from and
after the Effective Time evidence ownership of shares of the Surviving Corporation’s common stock.

          (c) Conversion of Company Common Stock. Subject to Section 2.12, each share of
Company Common Stock issued and outstanding immediately prior to the Effective Time will be
automatically converted into the right to receive an amount in cash equal to the Per Share Merger
Consideration, without interest, payable to the holder thereof, less any required withholding
taxes, upon surrender of the certificate formerly representing such shares of Company Common Stock
(“Company Stock Certificate”) in the manner provided in Section 2.10. All such shares of
Company Common Stock, when so converted, will no longer be outstanding and will automatically be
canceled and retired and will cease to exist, and the holder of a Company Stock Certificate that,
immediately prior to the Effective Time, represented outstanding shares of Company Common Stock
will cease to have any rights with respect thereto, except the right to receive, upon the surrender
of such Company Stock Certificate, the Per Share Merger Consideration without interest except as
provided in Section 2.12.

          (d) Rights Prior to Surrender, Stock Splits, etc. and Stock Transfer Books. Until
surrendered as contemplated by Section 2.10, each Company Stock Certificate will be deemed
at any time after the Effective Time to represent only the right to receive upon such surrender the
amounts provided for in this Section 2.9, except as provided in Section 2.12. If
between the date hereof and the Effective Time the outstanding shares of Company Common Stock are
changed into a different number of shares or a different class, because of any stock dividend,
subdivision, reclassification, recapitalization, split, combination or exchange of shares, the
amounts provided for in this Section 2.9 with respect to such class of Company Common Stock
will be correspondingly adjusted to reflect such stock dividend, subdivision, reclassification,
recapitalization, split, combination or exchange of shares. After the Effective Time, the
Company’s stock transfer books will be closed and there will be no further transfers of shares of
Company Common Stock following the Effective Time. If, at or after the Effective Time, Company
Stock Certificates are presented to the Surviving Corporation, they will be canceled and exchanged
in accordance with this Agreement.

11

 

     Section 2.10. Surrender of Certificates.

          (a) Surrender of Certificates. At the Effective Time, the Surviving Corporation shall
irrevocably deposit or cause to be deposited with a paying agent appointed by Parent (the “Paying
Agent”), as agent for the holders of shares of Company Common Stock to be cancelled in accordance
with Section 2.9, cash in the aggregate amount required to pay the aggregate amount of the
Per Share Merger Consideration payable on the shares of Company Common Stock outstanding
immediately prior to the Effective Time. Pending distribution pursuant to Section 2.10(b)
of the cash deposited with the Paying Agent, such cash shall be held in trust for the benefit of
the holders of shares of Company Common Stock converted pursuant to the Merger and such cash shall
not be used for any other purposes. Promptly after the Effective Time, the Surviving Corporation
shall cause the Paying Agent to mail to each Person who was, at the Effective Time, a holder of
record of shares of Company Common Stock entitled to receive the Per Share Merger Consideration
payable on shares of Company Common Stock pursuant to Section 2.9 hereof (the
“Stockholders”), a form of letter of transmittal in the form of Exhibit G attached hereto
and instructions for use in effecting the surrender of shares of Company Common Stock pursuant to
such letter of transmittal. Upon surrender to the Paying Agent of a Company Stock Certificate,
together with such letter of transmittal, duly completed and validly executed in accordance with
the instructions thereto, and such other documents as may be required pursuant to such
instructions, the holder of such Company Stock Certificate shall be entitled to receive in exchange
therefor the Per Share Merger Consideration payable on shares of Company Common Stock for each
share of Company Common Stock formerly evidenced by such Company Stock Certificate and such Company
Stock Certificate shall thereupon be cancelled. No interest shall accrue or be paid on the Per
Share Merger Consideration payable upon the surrender of any Company Stock Certificate for the
benefit of the holder of such Company Stock Certificate and any required withholding taxes on the
Per Share Merger Consideration payable on shares of Company Common Stock may be withheld by Parent,
the Surviving Corporation, or the Paying Agent. All interest accrued in respect of the cash
deposited with the Paying Agent shall accrue to the benefit of and be paid to the Surviving
Corporation.

          (b) After surrender to the Paying Agent of any Company Stock Certificate or other instrument
which prior to the Effective Time shall have represented any share of Company Common Stock, the
Paying Agent shall, promptly distribute to the Person in whose name such Company Stock Certificate
or other instrument shall have been registered, a check representing the Per Share Merger
Consideration payable on shares of Company Common Stock that such Person has the right to receive
pursuant to the provisions of this Section 2.10. Until so surrendered and cancelled, each
such Company Stock Certificate or other instrument shall, after the Effective Time, be deemed to
represent only the right to receive the Per Share Merger Consideration payable on shares of Company
Common Stock, and until such surrender and cancellation, no cash shall be paid to the holder of
such outstanding Company Stock Certificate or other instrument in respect thereof. From and after
the Effective Time, the holders of shares of Company Common Stock outstanding immediately prior to
the Effective Time shall cease, except for Dissenting Shares and otherwise as required by law, to
have any rights with respect to such shares of Company Common Stock, other than the right to
receive the Per Share Merger Consideration payable on shares of Company Common Stock as provided in
this Agreement.

12

 

          (c) If payment is to be made to a Person other than the registered holder of the shares of
Company Common Stock represented by the Company Stock Certificate or other instrument so
surrendered in exchange therefor, it shall be a condition to such payment that the Company Stock
Certificate or other instrument so surrendered shall be properly endorsed or otherwise be in proper
form for transfer and that the Person requesting such payment shall pay to the Paying Agent any
transfer or other taxes required as a result of such payment to a Person other than the registered
holder of such shares of Company Common Stock or establish to the satisfaction of the Paying Agent
that such tax has been paid or is not payable.

          (d) If any cash deposited with the Paying Agent for purposes of payment in exchange for the
shares of Company Common Stock remains unclaimed six (6) months after the Effective Time, such cash
shall be returned to the Surviving Corporation, upon demand, and any such holder who has not
converted the shares of Company Common Stock into the Per Share Merger Consideration payable on
shares of Company Common Stock pursuant to this Agreement prior to that time shall thereafter look
only to the Surviving Corporation for payment of the Per Share Merger Consideration payable on
shares of Company Common Stock. Notwithstanding the foregoing, the Surviving Corporation shall not
be liable to any holder of shares of Company Common Stock for any amount paid to a public official
pursuant to applicable unclaimed property laws. Any amounts remaining unclaimed by holders of
shares of Company Common Stock or Converted Options seven (7) years after the Effective Time (or
such earlier date immediately prior to such time as such amounts would otherwise escheat to or
become property of any Governmental Entity) shall, to the extent permitted by applicable Law,
become the property of the Surviving Corporation, free and clear of any claims or interest of any
Person previously entitled thereto.

          (e) Any portion of the Per Share Merger Consideration made available to the Paying Agent to
pay for shares of Company Common Stock for which dissenters’ rights have been perfected as provided
in Section 2.12 shall be returned to the Surviving Corporation upon demand.

          (f) In the event that any Company Stock Certificate or other instrument representing shares of
Company Common Stock shall have been lost, stolen or destroyed, upon the making of an affidavit of
that fact by the Person claiming such certificate or other instrument to be lost, stolen or
destroyed and, if required by the Surviving Corporation, the posting by such holder of a bond in
such reasonable amount as the Surviving Corporation may direct as indemnity against any claim that
may be made against it with respect to such Company Stock Certificate or other instrument, the
Paying Agent will issue in exchange for and in lieu of such lost, stolen or destroyed certificate
or other instrument representing shares of Company Common Stock, the applicable Per Share Merger
Consideration payable on shares of Company Common Stock, pursuant to this Agreement and the Merger,
without interest and less any required withholding taxes.

          (g) All Per Share Merger Consideration payable on shares of Company Common Stock will be
deemed to have been issued in full satisfaction of all rights pertaining to shares of Company
Common Stock.

13

 

     Section 2.11. Stock Options and Warrants.

          (a) Each Company Option that is not an In-the-Money Company Option shall be cancelled at the
Effective Time, without any payment or other consideration therefore.

          (b) All In-the-Money Company Options (the “Converted Options”), whether vested or not vested,
shall be cancelled at the Effective Time, and, in lieu thereof, shall be converted into the right
to receive, per share of Company Common Stock issuable upon exercise in full of such In-the-Money
Company Option, a cash payment equal to the excess of the Per Share Merger Consideration for shares
of Company Common Stock subject to the Converted Option, if such Converted Option were exercised in
full, over the aggregate exercise price payable upon exercise in full of such Converted Option, as
reduced by any required tax withholdings (collectively, the “Converted Option Merger
Consideration”).

          (c) Prior to the Effective Time, the Company shall take all steps necessary to make any
amendments to the terms of such stock option plans, individual option agreements or Options that
are necessary to give effect to the Transactions contemplated by this Agreement. At or prior to
the Effective Time, the Company shall take all reasonable and necessary action to facilitate the
timely exercise of rights and obligations to effectuate the provisions of this Section
2.11.

          (d) At the Effective Time, the Surviving Corporation shall deliver to the Paying Agent a list
of the names and addresses of the holders of the Converted Options (the “Converted Option Holders”)
and, with respect to each Converted Option, deposit or cause to be deposited with the Paying Agent
the aggregate amount of the Converted Option Merger Consideration payable on the Converted Options.
Promptly after the Effective Time, the Surviving Corporation shall cause the Paying Agent to mail
to each Converted Option Holder a letter of transmittal and instruction in the form of Exhibit
G attached hereto, for use in obtaining payment of the Converted Option Merger Consideration to
which such Converted Option Holder is entitled. Upon delivery to the Paying Agent such letter of
transmittal, duly completed and validly executed in accordance with the instructions thereto,
together with such option agreement, warrant or other instrument which prior to the Effective Time
shall have represented any Company Option, and such other documents as may be required pursuant to
such instructions, the Converted Option Holder shall be entitled to receive in exchange for the
Converted Option held the Converted Option Merger Consideration to which such Converted Option
Holder is entitled. No interest shall accrue or be paid on the Converted Option Merger
Consideration payable with respect to any Converted Option and any required withholding taxes on
the Converted Option Merger Consideration payable on the Converted Options may be withheld by
Parent, the Surviving Corporation, or the Paying Agent. All interest accrued in respect of the
cash deposited with the Paying Agent shall accrue to the benefit of and be paid to the Surviving
Corporation.

          (e) From and after the Effective Time, other than as expressly set forth in this Section
2.11 or any written agreement between the Company, the Parent and the holders of Company
Options outstanding immediately prior to the Effective Time, no holder of Company Options shall
have any rights with respect to such Company Options, other than to receive the

14

 

Converted Option Merger Consideration, if any payable thereon as provided herein. The
surrender of any Company Option, the delivery of any letter of transmittal, or the receipt of cash
in cancellation of such Company Option by the holder of such Company Option shall be deemed a
release of any and all rights the holder of such Company Option had or may have had in respect of
such Company Option except as expressly provided by this Agreement.

          (f) All Converted Option Merger Consideration payable on Converted Options will be deemed to
have been issued in full satisfaction of all rights pertaining to the Converted Options.

     Section 2.12. Shares of Dissenting Stockholders. Notwithstanding Section 2.9(c)
hereof, to the extent that holders of shares of Company Common Stock are entitled to appraisal
rights under Section 262 of the DGCL, shares of Company Common Stock issued and outstanding
immediately prior to the Effective Time and held by a holder who has properly exercised and
perfected his or her demand for appraisal rights under the DGCL (the “Dissenting Shares”), shall
not be converted into the right to receive the Per Share Merger Consideration, but the holders of
such Dissenting Shares shall be entitled to receive such consideration as shall be determined
pursuant to DGCL (and at the Effective Time, such Dissenting Shares shall no longer be outstanding
and shall cease to have any rights with respect thereto, except the right to receive such
consideration as shall be determined pursuant to the DGCL); provided, however, that
if any such holder shall have failed to perfect or shall have effectively withdrawn or lost his or
her right to appraisal and payment under the DGCL, such holder’s shares of Company Common Stock
shall thereupon be deemed to have been converted as of the Effective Time into the right to receive
the Per Share Merger Consideration without any interest thereon and such shares shall not be deemed
to be Dissenting Shares. Any payments required to be made with respect to the Dissenting Shares
shall be made by the Surviving Corporation (and not the Company, Merger Sub Parent) and the
Aggregate Transaction Consideration shall be reduced, on a dollar for dollar basis, as if the
holder of such Dissenting Shares had not been a stockholder on the Merger Closing Date. The
Company will give Parent (a) prompt notice of any written demands for the exercise of dissenters or
appraisal rights, withdrawals of demands for the exercise of dissenters or appraisal rights and any
other instruments served under the DGCL, and (b) the opportunity to direct all negotiations and
proceedings with respect to demands for exercise of dissenters or appraisal rights under the DGCL.
The Company will not voluntarily make any payment with respect to any purchase demands and will
not, except with Parent’s prior written consent, settle or offer to settle any such demands.

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

OF PARENT AND MERGER SUB

     Parent and Merger Sub represent and warrant to the Company as follows:

     Section 3.1. Entity Status. Each of Parent and Merger Sub is an entity duly created, formed
or organized, validly existing and in good standing under the Laws of the jurisdiction of its
creation, formation or organization.

15

 

     Section 3.2. Power and Authority; Enforceability. Parent and Merger Sub have the corporate
power and authority to execute and deliver this Agreement and each other Transaction Document to
which they are a party, and to perform and consummate the Transactions. Parent and Merger Sub have
taken all action necessary to authorize the execution and delivery of each other Transaction
Document to which they are a party, the performance of Parent’s and Merger Sub’s obligations
thereunder, and the consummation of the Transactions. This Agreement and each other Transaction
Document has been duly authorized, executed and delivered by Parent or Merger Sub, if Parent or
Merger Sub is a party thereto, and constitutes the legal, valid and binding obligation of Parent or
Merger Sub, if a party thereto, enforceable against Parent or Merger Sub, if a party thereto, in
accordance with its terms, in each case subject to applicable bankruptcy, insolvency and similar
laws affecting the enforceability of creditors’ rights generally, general principles of equity, the
discretion of courts in granting equitable remedies and matters of public policy.

     Section 3.3. No Violation. The execution and the delivery of the Transaction Documents to
which Parent or Merger Sub is a party and the performance and consummation of the Transactions by
Parent or Merger Sub do not and will not (with or without the passage of time or the giving of
notice) (i) Breach any Law to which Parent or Merger Sub is subject or any provision of Parent’s or
Merger Sub’s Organizational Documents, (ii) Breach in any material respect any material Contract to
which Parent or Merger Sub is a party or by which Parent or Merger Sub is bound, (iii) require any
Consent, except (A) any SEC and other filings required to be made by Parent or Merger Sub and (B)
any notifications or filings to any relevant state or federal regulatory agencies, or (iv) Breach
any resolution adopted by the board of directors or the stockholders of Parent or Merger Sub, or
(v) give any Governmental Body or other Person the right to challenge any of the Transactions or to
exercise any remedy or obtain any relief under any Law to which Parent or Merger Sub may be
subject.

     Section 3.4. Consents. No Consent of or filing with any Governmental Body or other Person is
required in connection with the execution or performance of this Agreement or the other Transaction
Documents by Parent or Merger Sub or the consummation by Parent or Merger Sub of the Transactions
except for such Consents or filings which have been obtained as of the date hereof or as to which
the failure to obtain or make would not adversely affect Parent’s or Merger Sub’s ability to
consummate the Transactions in any material respect.

     Section 3.5. Sufficient Funds. As of (i) the date hereof, and (ii) the Merger Closing Date,
Merger Sub has and will have sufficient funds to consummate the Transactions.

ARTICLE IV.

REPRESENTATIONS AND WARRANTIES

OF THE COMPANY

     Except as is provided in the disclosure letter delivered in connection with the execution and
delivery of the Stock Purchase Agreement by the Company (the “Company Disclosure Schedule”), the
Company represents and warrants to Parent and Merger Sub as follows:

16

 

     Section 4.1. Corporate Status. Each Acquired Entity is an entity duly created, formed or
organized, validly existing and in good standing under the Laws of the jurisdiction of its
creation, formation or organization.

     Section 4.2. Power and Authority; Enforceability. The Company has the corporate power and
authority to execute and deliver this Agreement, the Stock Purchase Agreement and each other
Transaction Document to which it is a party and to perform and consummate the Merger and the
Transactions. The Company has taken all action necessary to authorize the execution and delivery
of this Agreement, the Stock Purchase Agreement and each other Transaction Document to which it is
a party, the performance of its obligations hereunder and thereunder, and the consummation of the
Transactions. Without limiting the generality of the foregoing, the board of directors of the
Company, at a meeting duly called and held, unanimously adopted resolutions (a) determining that
the Merger is fair and in the best interests of the Company, the Stockholders of the Company and
the holders of Company Options, (b) approving and declaring advisable this Agreement, the Stock
Purchase Agreement and the Transaction Documents to which the Company is a party, the Merger and
the Transactions, (c) directing that this Agreement and the Merger be submitted to the Company’s
Stockholders for their adoption and approval, and (d) recommending that the Company’s Stockholders
vote or provide a written consent in favor of the adoption of this Agreement and the approval of
the Merger and the consummation of the Transactions. The Stockholder Consent has been obtained in
accordance with applicable Law and is the only vote or approval of the holders of any class or
series of capital stock of the Company and any Acquired Entity which is necessary to adopt this
Agreement, the Stock Purchase Agreement and approve and consummate the Merger and the Transactions.
This Agreement, the Stock Purchase Agreement and each other Transaction Document to which the
Company is a party has been duly authorized, executed and delivered by, the Company, and
constitutes the legal, valid and binding obligation of the Company, if a party thereto, and is
enforceable against the Company in accordance with its terms, in each case subject to applicable
bankruptcy, insolvency and similar laws affecting the enforceability of creditors’ rights
generally, general principles of equity, the discretion of courts in granting equitable remedies
and matters of public policy.

     Section 4.3. No Violation. The execution and the delivery by the Company of this Agreement,
the Stock Purchase Agreement and the Transaction Documents to which the Company is a party and the
performance of the Company’s obligations thereunder, and consummation of the Transactions by the
Company will not (a) Breach any Law to which any Acquired Entity is subject or any provision of the
Organizational Documents of any Acquired Entity, (b) Breach any Contract identified on Section
5.18(a) of the Company Disclosure Schedule, or Permit listed on Section 5.13(b) of the
Company Disclosure Schedule, (c) other than as set forth on Section 5.3 of the Company
Disclosure Schedule, require any Consent, (d) Breach any resolution adopted by the board of
directors or the Stockholders of the Company, (e) give any Governmental Body or other Person the
right to challenge any of the Transactions or to exercise any remedy or obtain any relief under any
Law to which the Acquired Entities may be subject, or (f) result in the imposition or creation of
any Encumbrance upon or with respect to any of assets of the Acquired Entities.

     Section 4.4. Capitalization. The authorized capital stock of the Company consists of
90,000,000 shares of Company Common Stock, par value $0.0001 per share, and 10,000,000

17

 

shares of the Company’s preferred stock, par value $0.0001 per share (the “Preferred Stock”).
As of the close of business on the date of this Agreement, (i) 23,753,460 shares of Company Common
Stock were issued and outstanding, (ii) no shares of Preferred Stock were issued and outstanding,
and (iii) 1,361,574 shares of Company Common Stock were held as treasury shares. As of the close
of business on the date of this Agreement there were (A) 2,349,013 shares of Company Common Stock
authorized and reserved for future issuance under any Company Plans, (B) 17,589,147 shares of
Company Common Stock authorized and reserved for issuance upon conversion of convertible notes, and
(C) 19,578,275 shares of Company Common Stock authorized and reserved for issuance upon exercise of
Company Options. No Equity Interests or Commitments have been issued, reserved for issuance or are
outstanding, other than or pursuant to the Company Options and convertible notes referred to above
that are outstanding as of the date of this Agreement. Except as set forth on Section 5.4
of the Company Disclosure Schedule, there are no Contracts with respect to the voting or transfer
of the Company’s Equity Interests. Other than as set forth on Section 5.4 of the Company
Disclosure Schedule, no Commitments exist or are authorized with respect to the Equity Interests of
the Company and no Commitments will arise in connection with the Transactions.

ARTICLE V.

COVENANTS

     The Parties agree as follows with respect to the period between the execution of this
Agreement and the earlier of the Equity Closing and the Termination Date, unless otherwise stated:

     Section 5.1. General. Each Party will use its Commercially Reasonable Best Efforts to take all
actions and to do all things necessary, proper or advisable to consummate, make effective, and
comply with all of the terms of this Agreement and the Transactions including satisfaction of all
of the conditions to Equity Closing for which it is responsible or otherwise controls as set forth
in ARTICLE VI.

     Section 5.2. Information Statement.

          (a) Covenants of the Company with Respect to the Information Statement. The Company
shall prepare and shall cause to be filed with the SEC on the Equity Closing Date an information
statement (together with any amendments thereof or supplements thereto, the “Information
Statement”) in form and substance reasonably satisfactory to the Parent, relating to the adoption
and approval by written consent of this Agreement and the Merger. The Company shall use its
Commercially Reasonable Best Efforts to respond as promptly as reasonably practicable to any
comments of the SEC with respect to the Information Statement. The Company shall promptly notify
the Parent upon the receipt of any comments from the SEC or its staff or any request from the SEC
or its staff for amendments or supplements to the Information Statement. The Company shall consult
with the Parent prior to responding to any such comments or requests or filing any amendment or
supplement to the Information Statement and shall provide Parent with copies of all correspondence
between the Company and its Representatives on the one hand and the SEC and its staff on the other
hand. None of the information with respect to the Company or its Subsidiaries to be included in
the Information Statement will, at the time of the mailing of the Information Statement or any
amendments or

18

 

supplements thereto, contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. The Information
Statement will comply in all material respects with the provisions of the Exchange Act and the
rules and regulations promulgated thereunder.

          (b) Covenants of the Parent with Respect to the Information Statement. None of the
information with respect to the Parent, Merger Sub or their respective subsidiaries specifically
provided in writing by the Parent or any person authorized to act on its behalf for inclusion in
the Information Statement will, at the time of the mailing of the Information Statement or any
amendments or supplements thereto, contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading.

          (c) Cooperation. The Company and the Parent shall cooperate and consult with each
other in preparation of the Information Statement. Without limiting the generality of the
foregoing, the Parent will furnish to the Company the information relating to it required by the
Exchange Act and the rules and regulations promulgated thereunder to be set forth in the
Information Statement. Notwithstanding anything to the contrary stated above, prior to filing and
mailing the Information Statement or responding to any comments of the SEC with respect thereto,
the party responsible for filing or mailing such document shall provide the other party an
opportunity to review and comment on such document or response and shall discuss with the other
party and include in such document or response, comments reasonably and promptly proposed by the
other party. The Company and the Parent shall use their Commercially Reasonable Best Efforts to
respond to any comments from the SEC within seven calendars days of receipt thereof.

          (d) Mailing of Information Statement; Amendments. Within five (5) days after the
Information Statement has been cleared by the SEC, the Company shall mail the Information Statement
to the holders of shares of Company Common Stock as of the date of the Written Consent. All
documents that each of the Company and the Parent is responsible for filing with the SEC in
connection with the Merger will comply as to form and substance in all material respects with the
applicable requirements of the Securities Act, the Exchange Act and the rules and regulations of
NASDAQ.

ARTICLE VI.

CLOSING CONDITIONS

     Section 6.1. General Conditions. The obligations of the Parties to effect the Merger Closing
shall be subject to the satisfaction of the following conditions unless waived in writing by Parent
and the Company:

          (a) No Injunction. No Law or order, injunction, judgment, decree, ruling, assessment,
or award shall have been enacted, entered, issued or promulgated by any Governmental Body (and be
in effect) which prohibits the consummation of the Merger or any of the other Transactions.

19

 

          (b) Legal Proceedings. No Governmental Body shall have initiated proceedings to
restrain or prohibit the Merger or any of the other Transactions or force rescission, unless such
Governmental Body shall have withdrawn and abandoned any such proceedings prior to the time which
otherwise would have been the Merger Closing Date.

          (c) Regulatory Approval. All regulatory approvals or waivers required to consummate
the Transactions shall have been obtained and shall remain in full force and effect and all
statutory waiting periods in respect thereof shall have expired.

          (d) Equity Purchase Closing. The closing of the Equity Purchase shall have occurred
in accordance with the terms and conditions of the Stock Purchase Agreement.

     Section 6.2. Conditions Precedent to Obligation of Parent and Merger Sub. Parent’s and Merger
Sub’s obligation to consummate the Merger Closing is subject to the satisfaction on or prior to the
Merger Closing Date of each condition precedent listed below, any of which may be waived in writing
by Parent and/or Merger Sub.

          (a) Accuracy of Representations and Warranties of the Company. All representations
and warranties of the Company set forth in Section 4.4 shall have been accurate and
complete in all respects on the date when made and on the Merger Closing Date with the same effect
as if made on and as of the Merger Closing Date, without giving effect to any supplements to the
Company Disclosure Schedule.

ARTICLE VII.

TERMINATION

     Section 7.1. Termination of Agreement. The Parties may terminate this Agreement upon written
notice thereof to each of the other Parties hereto and the Transactions may be abandoned at any
time prior to the Merger Closing Date as provided below:

          (a) by the mutual written consent of Parent and the Company; or

          (b) by Parent if the Stock Purchase Agreement has been terminated or expired or if any Action
seeking to prohibit, restrain, invalidate or collect Damages as a result of the consummation of the
Equity Purchase, the Merger or the other Transactions is pending; or

          (c) by Parent if any of the conditions provided for in Section 6.1 or Section
6.2 of this Agreement has not been satisfied on or before the Merger Expiration Date or shall
have become incapable of satisfaction or fulfillment on or before the Merger Expiration Date (other
than as a result of a Breach of this Agreement by Parent) and Parent has not waived such
conditions; or

          (d) by the Company if any of the conditions provided for in Section 6.1 of this
Agreement has not been satisfied on or before the Merger Expiration Date or shall have become
incapable of satisfaction or fulfillment on or before the Merger Expiration Date (other than as a
result of a Breach of this Agreement by the Acquired Entities) and the Company has not waived such
conditions; or

20

 

          (e) by Parent, if prior to the Equity Closing Date the board of directors of the Company (i)
withdraws, modifies or changes its recommendation of this Agreement, the Stock Purchase Agreement
or the Merger in a manner adverse to Parent or shall have resolved pursuant to valid board action
to do any of the foregoing, or (ii) shall have recommended to the Stockholders of the Company any
Acquisition Proposal or resolved by valid board action to do so.

     Section 7.2. Effect of Termination. Except for the obligations under this ARTICLE VII
and ARTICLE VIII, if this Agreement is terminated under Section 7.1, then all
further obligations of the Parties under this Agreement will terminate. Except as otherwise set
forth herein, such termination shall be without liability of any Party to any other Party;
provided, however that notwithstanding the foregoing, such termination shall not relieve any Party
of Liability for any Breach of this Agreement which occurs prior to termination.

ARTICLE VIII.

MISCELLANEOUS

     Section 8.1. Entire Agreement. The Transaction Documents, together with the exhibits and
schedules hereto and the certificates, documents, instruments and writings that are delivered
pursuant hereto, constitute the entire agreement and understanding of the Parties in respect of the
subject matter contemplated thereby and supersede all prior understandings, agreements, or
representations by or among the Parties, written or oral, to the extent they relate in any way to
the subject matter thereof or the Transactions. Except as expressly contemplated by ARTICLE
VII, there are no third party beneficiaries having rights under or with respect to this
Agreement.

     Section 8.2. Successors. All of the terms, agreements, covenants, representations, warranties,
and conditions of this Agreement are binding upon, and inure to the benefit of and are enforceable
by, the Parties and their respective successors.

     Section 8.3. Assignments. No Party may assign either this Agreement or any of its rights,
interests, or obligations hereunder without the prior written approval of Parent and the Company;
provided, however, that Parent may (a) assign any or all of its rights and interests hereunder to
one or more of its Affiliates and (b) designate one or more of its Affiliates to perform its
obligations hereunder (in any or all of which cases Parent nonetheless will remain responsible for
the performance of all of its obligations hereunder).

     Section 8.4. Notices. All notices, requests, demands, claims and other communications
hereunder will be in writing. Any notice, request, demand, claim or other communication hereunder
will be deemed duly given if (and then three (3) Business Days after) it is sent by registered or
certified mail, return receipt requested, postage prepaid, and addressed to the intended recipient
as set forth below:

If to Parent, Merger Sub and after the Merger Closing to the Company:

VCA Antech, Inc.

12401 West Olympic Boulevard

Los Angeles, California 90064-1022

21

 

Attn: Chief Financial Officer

Tel: (310) 571-6505

Fax: (310) 571-6905

Copy to (which will not constitute notice):

Akin Gump Strauss Hauer & Feld LLP

Century Tower Plaza, 2029 Century Park East, Suite 2400

Los Angeles, CA 90067

Attn: Frank Reddick

Tel: (310) 229-1000

Fax: (310) 229-1001

If to the Company (prior to Merger Closing):

Pet DRx Corporation

215 Centerview Drive, Suite 360

Brentwood, Tennessee

Attn: Chief Executive Officer

Tel: (615) 369-1914

Fax: (404) 365-0107

Copy to (which will not constitute notice):

Bryan Cave LLP

1201 W. Peachtree Street, 14th Floor

Atlanta, Georgia 30309-3488

Attn: Rick Miller

Tel: (404) 572-6787

Fax: (404) 420-0787

Any Party may send any notice, request, demand, claim, or other communication hereunder to the
intended recipient at the address set forth above using any other means (including personal
delivery, expedited courier, messenger service, telecopy, telex, ordinary mail, or electronic
mail), but no such notice, request, demand, claim, or other communication will be deemed to have
been duly given unless and until it actually is received by the intended recipient. Any Party may
change the address to which notices, requests, demands, claims, and other communications hereunder
are to be delivered by giving the other Parties notice in the manner herein set forth.

     Section 8.5. Submission to Jurisdiction; Process Agent. Each Party submits to the jurisdiction
of any federal or state court located in Delaware, in any Action arising out of or relating to this
Agreement and agrees that all claims in respect of the Action may be heard and determined in any
such court. Each Party also agrees not to bring any Action arising out of or relating to this
Agreement in any other court. Each Party agrees that a final judgment in any Action so brought
will be conclusive and may be enforced by Action on the judgment or in any other manner provided at
Law or in equity. Each Party waives any defense of inconvenient forum to the maintenance of any
Action so brought and waives any bond, surety, or other security that might be required of any
other Party with respect thereto. Process in any such

22

 

action, suit or proceeding may be served on any party anywhere in the world, whether within or
without the jurisdiction of any such court.

     Section 8.6. Time. Time is of the essence in the performance of this Agreement.

     Section 8.7. Counterparts. This Agreement may be executed in two or more counterparts, each of
which will be deemed an original but all of which together will constitute one and the same
instrument.

     Section 8.8. Headings. The article and section headings contained in this Agreement are
inserted for convenience only and will not affect in any way the meaning or interpretation of this
Agreement.

     Section 8.9. Governing Law. This Agreement and the performance of the Transactions and
obligations of the Parties hereunder will be governed by and construed in accordance with the laws
of the State of Delaware, without giving effect to any choice of Law principles.

     Section 8.10. Amendments and Waivers. No amendment, modification, replacement, termination or
cancellation of any provision of this Agreement will be valid, unless the same will be in writing
and signed by Parent and the Company. Neither any failure nor any delay by any Party in exercising
any right, power or privilege under the Transaction Documents will operate as a waiver of such
right, power or privilege, and no single or partial exercise of any such right, power or privilege
will preclude any other or further exercise of such right, power or privilege or the exercise of
any other right, power or privilege. To the maximum extent permitted by applicable law, (a) no
claim or right arising out of this Agreement or any of the Transaction Documents can be discharged
by one Party, in whole or in part, by a waiver or renunciation of the claim or right unless in
writing signed by the other Party; (b) no waiver that may be given by a Party will be applicable
except in the specific instance for which it is given; and (c) no notice to or demand on one Party
will be deemed to be a waiver of any obligation of that Party or of the right of the Party giving
such notice or demand to take further action without notice or demand as provided in the
Transaction Documents.

     Section 8.11. Severability. The provisions of this Agreement will be deemed severable and the
invalidity or unenforceability of any provision will not affect the validity or enforceability of
the other provisions hereof; provided that if any provision of this Agreement, as applied to any
Party or to any circumstance, is adjudged by a Governmental Body, arbitrator or mediator not to be
enforceable in accordance with its terms, the Parties agree that the Governmental Body, arbitrator,
or mediator making such determination will have the power to modify the provision in a manner
consistent with its overall objectives such that it is enforceable, and/or to delete specific words
or phrases, and in its reduced or revised form, such provision will then be enforceable and will be
enforced.

     Section 8.12. Expenses. Except as otherwise expressly provided in this Agreement, each Party
will bear its own costs and expenses incurred in connection with the preparation, execution and
performance of this Agreement and the Transactions including all fees and expenses of agents,
Representatives, financial advisors, legal counsel and accountants.

23

 

     Section 8.13. Construction. The Parties have participated jointly in the negotiation and
drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this
Agreement will be construed as if drafted jointly by the Parties and no presumption or burden of
proof will arise favoring or disfavoring any Party because of the authorship of any provision of
this Agreement. Any reference to any federal, state, local, or foreign Law will be deemed also to
refer to such Law as amended and all rules and regulations promulgated thereunder, unless the
context requires otherwise. The words “include,” “includes,” and “including” will be deemed to be
followed by “without limitation” unless preceded by a negative predicate. Pronouns in masculine,
feminine, and neuter genders will be construed to include any other gender, and words in the
singular form shall be construed to include the plural and vice versa, unless the context otherwise
requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of
similar import refer to this Agreement as a whole and not to any particular subdivision unless
expressly so limited. The Parties intend that each representation, warranty, and covenant
contained herein will have independent significance. If any Party has Breached any representation,
warranty, or covenant contained herein in any respect, the fact that there exists another
representation, warranty or covenant relating to the same subject matter (regardless of the
relative levels of specificity) which the Party has not Breached will not detract from or mitigate
the fact that the Party is in Breach of the first representation, warranty, or covenant.

     Section 8.14. Remedies. Except as expressly provided herein, the rights, obligations and
remedies created by this Agreement are cumulative and in addition to any other rights, obligations,
or remedies otherwise available at Law or in equity. Except as expressly provided herein, nothing
herein will be considered an election of remedies.

     Section 8.15. Electronic Signatures.

          (a) Notwithstanding the Electronic Signatures in Global and National Commerce Act (15 U.S.C.
Sec. 7001 et. seq.), the Uniform Electronic Transactions Act, or any other Law relating to or
enabling the creation, execution, delivery, or recordation of any contract or signature by
electronic means, and notwithstanding any course of conduct engaged in by the Parties, no Party
will be deemed to have executed a Transaction Document or other document contemplated thereby
(including any amendment or other change thereto) unless and until such Party shall have executed
such Transaction Document or other document on paper by a handwritten original signature or any
other symbol executed or adopted by a Party with current intention to authenticate such Transaction
Document or such other document contemplated.

          (b) Delivery of a copy of a Transaction Document or such other document bearing an original
signature by facsimile transmission (whether directly from one facsimile device to another by means
of a dial-up connection or whether mediated by the worldwide web), by electronic mail in “portable
document format” (“.pdf”) form, or by any other electronic means intended to preserve the original
graphic and pictorial appearance of a document, will have the same effect as physical delivery of
the paper document bearing the original signature. “Originally signed” or “original signature”
means or refers to a signature that has not been mechanically or electronically reproduced.

[SIGNATURE PAGE FOLLOWS]

24

 

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above
written.

	 	 	 	 	 
	 	PET DRX CORPORATION
 	 
	 	By:  	/s/
Gene E. Burleson 	 
	 	 	Name:  	Gene E.
Burleson 	 
	 	 	Title:  	Chief
Executive Officer 	 
	 
	 	VCA ANTECH, INC.
 	 
	 	By:  	/s/
Robert L. Antin 	 
	 	 	Name:  	Robert L. Antin 	 
	 	 	Title:  	President
& CEO 	 
	 
	 	SNOW MERGER ACQUISITION, INC.
 	 
	 	By:  	/s/
Robert L. Antin 	 
	 	 	Name:  	Robert L. Antin 	 
	 	 	Title:  	President
& CEO 	 
	 

Signature page to Merger Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}]]